0001550695-23-000071.txt : 20231109 0001550695-23-000071.hdr.sgml : 20231109 20231109165030 ACCESSION NUMBER: 0001550695-23-000071 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 57 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231109 DATE AS OF CHANGE: 20231109 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Performant Financial Corp CENTRAL INDEX KEY: 0001550695 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380] IRS NUMBER: 200484934 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-35628 FILM NUMBER: 231393418 BUSINESS ADDRESS: STREET 1: 333 NORTH CANYONS PARKWAY CITY: Livermore STATE: CA ZIP: 94551 BUSINESS PHONE: 925-960-4800 MAIL ADDRESS: STREET 1: 333 NORTH CANYONS PARKWAY CITY: Livermore STATE: CA ZIP: 94551 10-Q 1 pfmt-20230930.htm 10-Q pfmt-20230930
0001550695December 312023Q3false73173173100015506952023-01-012023-09-3000015506952023-11-08xbrli:shares00015506952023-09-30iso4217:USD00015506952022-12-31iso4217:USDxbrli:shares00015506952023-07-012023-09-3000015506952022-07-012022-09-3000015506952022-01-012022-09-300001550695us-gaap:CommonStockMember2023-06-300001550695us-gaap:AdditionalPaidInCapitalMember2023-06-300001550695us-gaap:RetainedEarningsMember2023-06-3000015506952023-06-300001550695us-gaap:CommonStockMember2022-06-300001550695us-gaap:AdditionalPaidInCapitalMember2022-06-300001550695us-gaap:RetainedEarningsMember2022-06-3000015506952022-06-300001550695us-gaap:CommonStockMember2023-07-012023-09-300001550695us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001550695us-gaap:CommonStockMember2022-07-012022-09-300001550695us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001550695us-gaap:RetainedEarningsMember2023-07-012023-09-300001550695us-gaap:RetainedEarningsMember2022-07-012022-09-300001550695us-gaap:CommonStockMember2023-09-300001550695us-gaap:AdditionalPaidInCapitalMember2023-09-300001550695us-gaap:RetainedEarningsMember2023-09-300001550695us-gaap:CommonStockMember2022-09-300001550695us-gaap:AdditionalPaidInCapitalMember2022-09-300001550695us-gaap:RetainedEarningsMember2022-09-3000015506952022-09-300001550695us-gaap:CommonStockMember2022-12-310001550695us-gaap:AdditionalPaidInCapitalMember2022-12-310001550695us-gaap:RetainedEarningsMember2022-12-310001550695us-gaap:CommonStockMember2021-12-310001550695us-gaap:AdditionalPaidInCapitalMember2021-12-310001550695us-gaap:RetainedEarningsMember2021-12-3100015506952021-12-310001550695us-gaap:CommonStockMember2023-01-012023-09-300001550695us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001550695us-gaap:CommonStockMember2022-01-012022-09-300001550695us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001550695us-gaap:RetainedEarningsMember2023-01-012023-09-300001550695us-gaap:RetainedEarningsMember2022-01-012022-09-30pfmt:segment0001550695pfmt:EligibilityBasedMember2023-07-012023-09-300001550695pfmt:EligibilityBasedMember2022-07-012022-09-300001550695pfmt:EligibilityBasedMember2023-01-012023-09-300001550695pfmt:EligibilityBasedMember2022-01-012022-09-300001550695pfmt:ClaimsBasedMember2023-07-012023-09-300001550695pfmt:ClaimsBasedMember2022-07-012022-09-300001550695pfmt:ClaimsBasedMember2023-01-012023-09-300001550695pfmt:ClaimsBasedMember2022-01-012022-09-300001550695us-gaap:HealthCareMember2023-07-012023-09-300001550695us-gaap:HealthCareMember2022-07-012022-09-300001550695us-gaap:HealthCareMember2023-01-012023-09-300001550695us-gaap:HealthCareMember2022-01-012022-09-300001550695pfmt:RecoveryMember2023-07-012023-09-300001550695pfmt:RecoveryMember2022-07-012022-09-300001550695pfmt:RecoveryMember2023-01-012023-09-300001550695pfmt:RecoveryMember2022-01-012022-09-300001550695pfmt:CustomerCareAndOutsourcedServicesMember2023-07-012023-09-300001550695pfmt:CustomerCareAndOutsourcedServicesMember2022-07-012022-09-300001550695pfmt:CustomerCareAndOutsourcedServicesMember2023-01-012023-09-300001550695pfmt:CustomerCareAndOutsourcedServicesMember2022-01-012022-09-30pfmt:reporting_unit0001550695pfmt:BuildingAndLeaseholdImprovementsMember2023-09-300001550695pfmt:BuildingAndLeaseholdImprovementsMember2022-12-310001550695us-gaap:FurnitureAndFixturesMember2023-09-300001550695us-gaap:FurnitureAndFixturesMember2022-12-310001550695us-gaap:ComputerEquipmentMember2023-09-300001550695us-gaap:ComputerEquipmentMember2022-12-310001550695pfmt:TheCreditAgreementMember2023-09-300001550695pfmt:TheCreditAgreementMember2022-12-31xbrli:pure0001550695pfmt:TermLoanMemberpfmt:MUFGUnionBankNAMember2021-12-170001550695pfmt:MUFGUnionBankNAMemberpfmt:RevolvingLoanCommitmentMember2021-12-170001550695pfmt:TermLoanMemberpfmt:MUFGUnionBankNAMember2023-03-132023-03-130001550695us-gaap:DebtInstrumentRedemptionPeriodOneMemberpfmt:MUFGUnionBankNAMember2021-12-170001550695us-gaap:DebtInstrumentRedemptionPeriodTwoMemberpfmt:MUFGUnionBankNAMember2021-12-170001550695us-gaap:DebtInstrumentRedemptionPeriodThreeMemberpfmt:MUFGUnionBankNAMember2021-12-170001550695us-gaap:DebtInstrumentRedemptionPeriodFourMemberpfmt:MUFGUnionBankNAMember2021-12-170001550695srt:MinimumMemberpfmt:MUFGUnionBankNAMember2023-01-012023-09-300001550695srt:MaximumMemberpfmt:MUFGUnionBankNAMember2023-01-012023-09-300001550695srt:MinimumMemberpfmt:MUFGUnionBankNAMemberus-gaap:BaseRateMember2023-01-012023-09-300001550695srt:MaximumMemberpfmt:MUFGUnionBankNAMemberus-gaap:BaseRateMember2023-01-012023-09-300001550695us-gaap:PrimeRateMemberpfmt:MUFGUnionBankNAMember2023-09-300001550695srt:MinimumMemberpfmt:MUFGUnionBankNAMember2021-12-172021-12-170001550695srt:MaximumMemberpfmt:MUFGUnionBankNAMember2021-12-172021-12-170001550695pfmt:RatioAsOfSeptember302023Memberpfmt:MUFGUnionBankNAMember2023-09-300001550695pfmt:RatioAsOfDecember302023Memberpfmt:MUFGUnionBankNAMember2023-09-300001550695pfmt:MUFGUnionBankNAMemberpfmt:PriorToEarlierOfDecember312023Member2023-09-300001550695us-gaap:EmployeeStockOptionMember2022-12-310001550695us-gaap:EmployeeStockOptionMember2022-01-012022-12-310001550695us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001550695us-gaap:EmployeeStockOptionMember2023-09-300001550695pfmt:RestrictedStockandPerformanceStockUnitsMember2022-12-310001550695pfmt:RestrictedStockandPerformanceStockUnitsMember2023-01-012023-09-300001550695pfmt:RestrictedStockandPerformanceStockUnitsMember2023-09-300001550695srt:MinimumMemberpfmt:RestrictedStockandPerformanceStockUnitsMember2023-01-012023-09-300001550695srt:MaximumMemberpfmt:RestrictedStockandPerformanceStockUnitsMember2023-01-012023-09-300001550695us-gaap:RestrictedStockUnitsRSUMember2023-09-300001550695us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001550695us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001550695us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001550695us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001550695us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001550695us-gaap:WarrantMember2023-01-012023-09-300001550695us-gaap:WarrantMember2022-01-012022-09-300001550695pfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMember2023-10-270001550695pfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMember2023-10-272023-10-270001550695srt:MinimumMemberpfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-272023-10-270001550695srt:MaximumMemberpfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-10-272023-10-270001550695srt:MinimumMemberpfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMemberus-gaap:BaseRateMember2023-10-272023-10-270001550695srt:MaximumMemberpfmt:WellsFargoBankMemberus-gaap:SubsequentEventMemberpfmt:NewCreditAgreementMemberus-gaap:BaseRateMember2023-10-272023-10-270001550695pfmt:WellsFargoBankMemberus-gaap:SubsequentEventMember2023-10-270001550695pfmt:SimeonKohlMember2023-07-012023-09-300001550695pfmt:RohitRamchandaniMember2023-07-012023-09-300001550695pfmt:IanJohnstonMember2023-07-012023-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                      to                     
Commission File Number: 001-35628
 
PERFORMANT FINANCIAL CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 20-0484934
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)
Performant Financial Corporation
900 South Pine Island Road, Suite 150
Plantation, FL 33324
(925) 960-4800
(Address, including zip code and telephone number, including area code of registrant’s principal executive offices)
Indicate by check mark whether the registrant (1) has filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer¨Accelerated filer
Emerging growth company
Non-accelerated filer¨Smaller reporting company
o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No  x
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s) Name of exchange on which registered
Common Stock, par value $.0001 per sharePFMT
The Nasdaq Stock Market LLC
The number of shares of Common Stock outstanding as of November 8, 2023 was 76,874,970.


PERFORMANT FINANCIAL CORPORATION
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2023
INDEX

Page
Item 3.
Item 4.
Item 5.
 

i

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(In thousands, except par value amounts)
 September 30,
2023
December 31,
2022
 (Unaudited) 
Assets
Current assets:
Cash and cash equivalents$17,308 $23,384 
Restricted cash81 81 
Trade accounts receivable14,129 15,794 
Contract assets6,850 11,460 
Prepaid expenses and other current assets3,104 3,665 
Income tax receivable516 3,123 
Total current assets41,988 57,507 
Property, equipment, and leasehold improvements, net9,790 10,897 
Goodwill47,372 47,372 
Right-of-use assets646 2,057 
Other assets914 1,000 
Total assets$100,710 $118,833 
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of notes payable, net of unamortized debt issuance costs of $78 and $17, respectively
$1,672 $983 
Accrued salaries and benefits5,643 6,938 
Accounts payable872 1,262 
Other current liabilities2,147 2,252 
Contract liabilities500 438 
Estimated liability for appeals and disputes906 1,106 
Lease liabilities333 1,228 
Total current liabilities12,073 14,207 
Notes payable, net of current portion and unamortized debt issuance costs of $423 and $316, respectively
9,077 18,184 
Lease liabilities326 1,076 
Other liabilities903 881 
Total liabilities22,379 34,348 
Commitments and contingencies (note 3 and note 4)
Stockholders’ equity:
Common stock, $0.0001 par value. Authorized, 500,000 shares at September 30, 2023 and December 31, 2022 respectively; issued and outstanding 76,875 and 75,505 shares at September 30, 2023 and December 31, 2022, respectively
8 7 
Additional paid-in capital144,880 142,261 
Accumulated deficit(66,557)(57,783)
Total stockholders’ equity78,331 84,485 
Total liabilities and stockholders’ equity$100,710 $118,833 
See accompanying notes to consolidated financial statements.
1

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(In thousands, except per share amounts)
(Unaudited)

 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
Revenues$29,962 $27,178 $81,176 $79,942 
Operating expenses:
Salaries and benefits22,980 21,759 67,139 63,101 
Other operating expenses7,632 7,733 22,077 23,945 
Total operating expenses30,612 29,492 89,216 87,046 
Loss from operations(650)(2,314)(8,040)(7,104)
Gain on sale of certain recovery contracts  3 382 
Gain on sale of land and buildings 1,120  1,120 
Interest expense(423)(277)(1,188)(648)
Interest income86  86  
Loss before provision for income taxes(987)(1,471)(9,139)(6,250)
Provision for (benefit from) income taxes(407)(11)(365)52 
Net loss$(580)$(1,460)$(8,774)$(6,302)
Net loss per share
Basic$(0.01)$(0.02)$(0.12)$(0.09)
Diluted$(0.01)$(0.02)$(0.12)$(0.09)
Weighted average shares
Basic76,454 74,021 75,907 72,480 
Diluted76,454 74,021 75,907 72,480 
See accompanying notes to consolidated financial statements.

2

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statement of Changes in Stockholders’ Equity
(In thousands)
(Unaudited)


Three Months Ended September 30, 2023Three Months Ended September 30, 2022
 Common StockAdditional
Paid-In
Capital
Accumulated DeficitTotalCommon StockAdditional
Paid-In
Capital
Accumulated DeficitTotal
 SharesAmountSharesAmount
Balances at beginning of period76,088 $7 $143,890 $(65,977)$77,920 73,818 $7 $140,506 $(56,088)$84,425 
Common stock issued under stock plans, net of shares withheld for employee taxes787 1 (139)— (138)394 — — —  
Stock-based compensation expense— — 1,129 — 1,129 — — 931 — 931 
Net loss— — — (580)(580)— — — (1,460)(1,460)
Balances at end of period76,875 $8 $144,880 $(66,557)$78,331 74,212 $7 $141,437 $(57,548)$83,896 
Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
 Common StockAdditional
Paid-In
Capital
Accumulated DeficitTotalCommon StockAdditional
Paid-In
Capital
Accumulated DeficitTotal
 SharesAmountSharesAmount
Balances at beginning of period75,505 $7 $142,261 $(57,783)$84,485 69,281 $7 $133,662 $(51,246)$82,423 
Common stock issued under stock plans, net of shares withheld for employee taxes1,370 1 (196)— (195)1,068 — — —  
Stock-based compensation expense— — 2,815 — 2,815 — — 2,212 — 2,212 
Proceeds from exercise of stock options— — — —  3,863 — 5,563 — 5,563 
Net loss— — — (8,774)(8,774)— — — (6,302)(6,302)
Balances at end of period76,875 $8 $144,880 $(66,557)$78,331 74,212 $7 $141,437 $(57,548)$83,896 
See accompanying notes to consolidated financial statements.

3

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

 Nine Months Ended  
September 30,
 20232022
Cash flows from operating activities:
Net loss$(8,774)$(6,302)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Loss on disposal of assets and impairment of long-lived assets258 40 
Depreciation and amortization3,805 3,355 
Right-of-use assets amortization1,411 841 
Stock-based compensation2,815 2,212 
Interest expense from debt issuance costs256 71 
Gain on sale of certain recovery contracts(3)(382)
Gain on sale of land and buildings (1,120)
Changes in operating assets and liabilities:
Trade accounts receivable1,665 4,958 
Contract assets4,610 (1,622)
Prepaid expenses and other current assets561 682 
Income tax receivable2,607 (52)
Other assets86 (7)
Accrued salaries and benefits(1,295)(1,944)
Accounts payable(390)(339)
Contract liabilities and other current liabilities(43)(1,515)
Estimated liability for appeals, disputes, and refunds(200)(42)
Lease liabilities(1,645)(997)
Other liabilities 23 (19)
Net cash provided by (used in) operating activities5,747 (2,182)
Cash flows from investing activities:
Purchase of property, equipment, and leasehold improvements(2,956)(2,198)
Proceeds from sale of certain recovery contracts3 382 
Proceeds from sales of property, equipment, and leasehold improvements 4,934 
Net cash (used in) provided by investing activities(2,953)3,118 
Cash flows from financing activities:
Repayment of notes payable(8,250)(375)
Debt issuance costs paid(424)(2)
Taxes paid related to net share settlement of stock awards(196) 
Proceeds from exercise of warrants 5,563 
Net cash (used in) provided by financing activities(8,870)5,186 
Net (decrease) increase in cash, cash equivalents and restricted cash(6,076)6,122 
Cash, cash equivalents and restricted cash at beginning of period23,465 19,550 
Cash, cash equivalents and restricted cash at end of period$17,389 $25,672 
Reconciliation of the Consolidated Statements of Cash Flows to the
Consolidated Balance Sheets:
Cash and cash equivalents$17,308 $25,591 
Restricted cash81 81 
Total cash, cash equivalents and restricted cash at end of period$17,389 $25,672 
Supplemental disclosures of cash flow information:
Cash (received) paid for income taxes$(2,904)$267 
Cash paid for interest$1,084 $449 

See accompanying notes to consolidated financial statements.
4

PERFORMANT FINANCIAL CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
(Unaudited)

1. Organization and Description of Business
(a) Basis of Presentation and Organization
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim unaudited consolidated financial statements furnished herein include all adjustments necessary (consisting only of normal recurring adjustments) for a fair presentation of our financial position at September 30, 2023, and December 31, 2022, the results of our operations for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. Interim financial statements are prepared on a basis consistent with our annual consolidated financial statements. The interim financial statements included herein should be read in conjunction with the consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended December 31, 2022.
Performant Financial Corporation (the "Company", "we", or "our") is a leading provider of technology-enabled audit, recovery and analytics services in the United States with a focus in the healthcare payment integrity services industry. The Company works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. The Company engages clients in both government and commercial markets. Clients of the Company typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. The Company also has a call center which serves clients with multifaceted consumer engagement needs. The Company historically worked in recovery markets such as defaulted student loans, tax receivables, and commercial recovery.
The Company’s consolidated financial statements include the operations of Performant Financial Corporation (Performant), its wholly-owned subsidiary Performant Business Services, Inc. (PBS), and PBS's wholly-owned subsidiaries Performant Recovery, Inc. (PRI), dba Performant Healthcare Solutions, and Performant Technologies, LLC (PTL). Performant is a Delaware corporation headquartered in California and was formed in 2003. PBS is a Nevada corporation founded in 1997. PRI is a California corporation founded in 1976. PTL is a California limited liability company that was formed in 2004. All intercompany balances and transactions have been eliminated in consolidation.
The Company is managed and operated as one business, with a single management team that reports to the Chief Executive Officer.
The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, contract assets, goodwill, right-of-use assets, estimated liability for appeals and disputes, lease liabilities, other liabilities, provision for income taxes, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues. Actual amounts may differ from amounts presently estimated.
(b) Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes
The Company generally derives its revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.
The Company determines revenue recognition through the following steps:
Identification of the contract with a customer.
Identification of the performance obligations in the contract.
Determination of the transaction price.
Allocation of the transaction price to the performance obligations in the contract.
Recognition of revenue when, or as, the performance obligations are satisfied.
5

The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company’s contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to the client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.
The Company’s contracts are composed primarily of variable consideration. Fees earned under the Company’s audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.
The Company generally either applies the as-invoiced practical expedient where its right to consideration corresponds directly to its right to invoice its clients, or the variable consideration allocation exception where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such the Company has elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required.
The Company estimates variable consideration only if it can reasonably measure the progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognizes such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. The Company exercises judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. The Company reviews the constraint on variable consideration quarterly. While the Company believes the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration recognized.
For contracts that contain a refund right, the Company estimates its refund liability for each claim, as needed, and recognizes revenue net of such estimate.
Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on the Company’s performance under the specific contract. These performance-based bonuses are considered variable and may be constrained by the Company until there is not a risk of a significant reversal.
The Company has applied the as-invoiced practical expedient or the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.
For healthcare claims audit contracts, the Company may recognize revenue upon delivering its findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.
For eligibility-based or COB contracts, the Company recognizes revenue when insurance companies or other responsible parties have remitted payments to its clients.
For customer care / outsourced services clients, the Company recognizes revenues based on the volume of processed transactions or the quantity of labor hours provided.
6

The following table presents revenue disaggregated by category (in thousands) for the three and nine months ended September 30, 2023 and 2022:
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
 (in thousands)(in thousands)
Eligibility-based$18,165 $13,142 $44,776 $39,773 
Claims-based10,325 10,377 30,535 28,866 
Healthcare Total28,490 23,519 75,311 68,639 
Recovery  41 33 166 
Customer Care / Outsourced Services1,472 3,618 5,832 11,137 
Total Revenues$29,962 $27,178 $81,176 $79,942 
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022.
Contract assets were $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to the Company’s rights to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time.
Contract assets primarily consist of commissions the Company estimates it has earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.
Contract assets are recorded to accounts receivable when the Company's right to payment becomes unconditional, which is generally when healthcare providers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.
Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively.
Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute the Company’s findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents the Company’s best estimate of the amount probable of being refunded to the Company’s healthcare clients.
(c) Prepaid Expenses and Other Current Assets
At September 30, 2023, prepaid expenses and other current assets were $3.1 million and included approximately $2.3 million related to prepaid software licenses and maintenance agreements, $0.1 million for prepaid insurance, and $0.7 million for various other prepaid expenses. At December 31, 2022, prepaid expenses and other current assets were $3.7 million and included approximately $1.5 million related to prepaid software licenses and maintenance agreements, $1.8 million for prepaid insurance, and $0.4 million for various other prepaid expenses.
7

(d) Impairment of Goodwill and Long-Lived Assets
The balance of goodwill was $47.4 million as of September 30, 2023 and $47.4 million as of December 31, 2022, which was net of accumulated impairment loss of $34.2 million. Goodwill is reviewed for impairment at least annually in December or as certain events or conditions arise during the year. The Company may first assess qualitative factors for indicators of impairment to determine whether it is necessary to perform the quantitative goodwill impairment test. Based on management’s assessment, there were no indicators of impairment and therefore there was no goodwill impairment during the three and nine months ended September 30, 2023.
If a quantitative assessment of goodwill is required, goodwill is considered impaired when the carrying value of the Company, as one reporting unit, exceeds its fair value. The amount of impairment loss is measured as the difference between the carrying value and the fair value of the reporting unit. Impairment testing is based upon the best information available and estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. Significant assumptions and estimates are required, including, but not limited to, our market capitalization, projecting future cash flows and other assumptions, to estimate the fair value of the reporting unit.
Long-lived assets and intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. There was no impairment during the three and nine months ended September 30, 2023.
(e) Other Current Liabilities
As of September 30, 2023, other current liabilities primarily included $1.7 million for services received for which we have not received an invoice, and $0.4 million for estimated workers' compensation claims incurred but not reported, third party fees, and accrued interest under our MUFG Credit Agreement (as defined below in Note 3). As of December 31, 2022, other current liabilities primarily included $1.8 million for services received for which we have not received an invoice, and $0.5 million for accrued interest under our MUFG Credit Agreement, estimated workers' compensation claims incurred but not reported and third party fees and equipment financing payables.
(f) New Accounting Pronouncements
In February 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842) – Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842).” This ASU provides updated guidance on how an entity should measure credit losses on financial instruments, including trade receivables, held at the reporting date. The amendments make each Topic easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. It also addresses transition and open effective date information for Topic 842. ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11 and ASU 2020-02 (collectively, “ASC 326”) are effective for public entities for fiscal years beginning after December 15, 2019, except for Smaller Reporting Companies. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company's adoption of this ASU had no impact on our financial position, results of operations, or cash flows.
8

2. Property, Equipment, and Leasehold Improvements
Property, equipment, and leasehold improvements consist of the following at September 30, 2023 and December 31, 2022 (in thousands):
September 30,
2023
December 31,
2022
Building and leasehold improvements$3,703 $3,785 
Furniture and equipment3,091 3,094 
Computer hardware and software77,604 76,906 
84,398 83,785 
Less accumulated depreciation and amortization(74,608)(72,888)
Property, equipment and leasehold improvements, net$9,790 $10,897 
Depreciation and amortization expense was $1.3 million and $1.1 million for the three months ended September 30, 2023 and 2022, respectively, and $3.8 million and $3.4 million for the nine months ended September 30, 2023 and 2022, respectively.
3. Notes Payable
On October 27, 2023, the Company entered into a new credit agreement (the "New Credit Agreement" as defined below in Note 8).
As of September 30, 2023 and December 31, 2022, $11.3 million and $19.5 million, respectively, was outstanding under the Company's credit agreement with MUFG Union Bank, N.A. (as amended the "MUFG Credit Agreement"). The Company’s interest rate under the MUFG Credit Agreement at September 30, 2023 and December 31, 2022 was 11.5% and 7.5%, respectively.
On December 17, 2021, the Company entered into a credit agreement with MUFG Union Bank, N.A. The MUFG Credit Agreement includes a $20 million term loan commitment, which was fully advanced at closing and a $15 million revolving loan commitment. Subject to certain customary exceptions, the obligations under the MUFG Credit Agreement are, or will be, guaranteed by each of the Company’s existing and future, direct or indirect, domestic subsidiaries. The obligations of the Company under the MUFG Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its domestic subsidiaries that are guarantors under the MUFG Credit Agreement.
On March 13, 2023, the Company entered into a First Amendment to the MUFG Credit Agreement (the “First Amendment”) to amend the MUFG Credit Agreement to, among other things, terminate the revolving loan commitment in full and to establish a new maturity date of December 31, 2024 for the term loan. As a result of the First Amendment to the MUFG Credit Agreement, the Company does not have any further borrowing capacity under the MUFG Credit Agreement. In connection with the First Amendment, the Company voluntarily prepaid $7.5 million of the outstanding principal of the term loan.
Pursuant to the MUFG Credit Agreement, after giving effect to the First Amendment described above, the Company is required to repay the aggregate outstanding principal amount of the term loan under the MUFG Credit Agreement in quarterly installments commencing March 31, 2022 in an amount that would result in amortization of (a) 2.5% of the original term loan principal in the first full year following commencement of amortization, (b) 5.0% of the original term loan principal in the second full year following commencement of amortization, and (c) 10.0% of the original term loan principal in the third full year following commencement of amortization. In addition, the Company must make mandatory prepayments of the term loan principal under the MUFG Credit Agreement with the net cash proceeds received in connection with certain specified events, including certain asset sales, casualty and condemnation events (subject to customary reinvestment rights). Any remaining outstanding principal balance of the term loan under the MUFG Credit Agreement is repayable on the maturity date. Amounts repaid or prepaid by the Company with respect to the term loan under the MUFG Credit Agreement cannot be reborrowed.
Under the MUFG Credit Agreement, after giving effect to the First Amendment described above, the term loan generally may bear interest based on term SOFR (the secured overnight financing right) or a prime rate, as applicable, plus an applicable margin based on the Company’s leverage ratio each quarter that may range between 2.50% per annum and 4.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 3.00% per annum in the case of base rate loans. The prime rate was approximately 8.5% as of September 30, 2023. In addition, a commitment fee based on the unused availability if there are outstanding revolving loan commitments is also payable which may vary from 0.30% per annum to 0.50% per annum, also
9

based on the Company’s leverage ratio, however, the revolving commitment was terminated in connection with the First Amendment described above.
The MUFG Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including, incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The MUFG Credit Agreement, after giving effect to the First Amendment described above, also contains financial covenants, which require the Company to maintain, as of the last day of each fiscal quarter commencing (a) as of September 30, 2023, a total leverage ratio of not greater than (i) 10.00 to 1.00, (b) as of December 31, 2023 and as of the last day of each fiscal quarter thereafter, (i) a total leverage ratio of not greater than 2.50 to 1.00, and (ii) a fixed charge coverage ratio of not less than 1.20 to 1.00 and (c) prior to the earlier December 31, 2023 and the date that the Company’s leverage ratio is not greater than 2.50 to 1.00 and its fixed charge coverage ratio is not less than 1.20 to 1.00, a minimum amount of unrestricted cash subject to a perfected security interest in favor of MUFG Union Bank, N.A. more specifically set forth in the MUFG Credit Agreement. The obligations under the MUFG Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the MUFG Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.
Other than the terms relating to the First Amendment as set forth above, the terms of the original MUFG Credit Agreement remained in full force and effect as of September 30, 2023.
As a result of the New Credit Agreement, the terms of the MUFG Credit Agreement are no longer in effect as of October 27, 2023. Refer to Subsequent Events in Note 8 for details.
Outstanding debt obligations were as follows (in thousands):
September 30, 2023December 31, 2022
Principal amount$11,250 $19,500 
Less unamortized discount and issuance costs(501)(333)
Notes payable, net of unamortized discount and issuance costs10,749 19,167 
Less current maturities, net of unamortized discount and issuance costs(1,672)(983)
Long-term notes payable, net of current maturities and unamortized discount and issuance costs$9,077 $18,184 
The following is a schedule, by years, of maturities of notes payable as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$250 
202411,000 
Total notes payable$11,250 
4. Leases
The Company has entered into various non-cancelable operating lease agreements for office facilities and equipment with lease periods expiring between 2023 and 2028. Certain of these arrangements have free rent periods and/or escalating rent payment provisions. As such, the Company recognizes rent expense under such arrangements on a straight-line basis. Some leases include options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. Leases with an initial term of twelve months or less are not recorded on the balance sheet.
Operating lease expense was $0.2 million and $0.5 million for the three months ended September 30, 2023 and 2022, respectively, and $0.7 million and $1.6 million for the nine months ended September 30, 2023 and 2022, respectively.
10

Supplemental other information related to operating leases were as follows:
September 30,
2023
December 31,
2022
Weighted Average Remaining Lease Term (in years)2.72.2
Weighted Average Discount Rate5.3%6.2%
Supplemental cash flow information related to operating leases were as follows:
September 30,
2023
September 30,
2022
Cash paid for amounts included in the measurement of operating lease liabilities$0.2 million $0.5 million
The following is a schedule, by years, of maturities of lease liabilities as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$189 
2024$212 
2025$139 
2026$61 
2027$60 
2028$52 
Total undiscounted cash flows$713 
Less imputed interest$(54)
Present value of lease liabilities$659 
5. Stock-Based Compensation
(a) Stock Options
Total stock-based compensation expense charged as salaries and benefits expense in the consolidated statements of operations was $1.1 million and $0.9 million for the three months ended September 30, 2023 and 2022 respectively, and $2.8 million and $2.2 million for the nine months ended September 30, 2023 and 2022, respectively.
The following table sets forth a summary of the Company's stock option activity for the nine months ended September 30, 2023:
Outstanding
Options
Weighted
average
exercise price
per share
Weighted
average
remaining
contractual life
(Years)
Aggregate
Intrinsic Value
(in thousands)
Outstanding at December 31, 2022250,000 $10.31 0.90$20 
Granted  — 
Forfeited(178,000)12.16 — 
Exercised  — 
Outstanding at September 30, 202372,000 $5.74 2.80$5 
Vested, exercisable, expected to vest(1) at September 30, 2023
72,000 $5.74 2.80$5 
Exercisable at September 30, 202372,000 $5.74 2.80$5 
 (1) Options expected to vest reflect an estimated forfeiture rate.
The Company recognizes share-based compensation costs as expense on a straight-line basis over the option vesting period, which generally is four years. As of September 30, 2023, all options have vested and there was no unrecognized compensation costs.
11

(b) Restricted Stock Units and Performance Stock Units
The following table summarizes restricted stock unit and performance stock unit activity for the nine months ended September 30, 2023:
Number of AwardsWeighted
average
grant date fair value
per share
Outstanding at December 31, 20223,904,606 $2.85 
Granted2,235,207 2.49 
Forfeited(136,806)3.37 
Vested and converted to shares, net of units withheld for taxes (1,369,862)2.46 
Units withheld for taxes(82,991)2.26 
Outstanding at September 30, 20234,550,154 $2.78 
Expected to vest at September 30, 20234,004,172 $2.78 
Restricted stock units and performance stock units granted under the Performant Financial Corporation Amended and Restated 2012 Stock Incentive Plan generally vest over periods between one year and four years.
As of September 30, 2023, there was approximately $10.5 million of total unrecognized compensation cost related to unvested restricted stock units granted to employees. This unrecognized compensation cost is expected to be recognized over an estimated weighted-average amortization period of approximately three years.
6. Income Taxes
The Company's effective income tax rate was 4% for the nine months ended September 30, 2023 and (1)% for the nine months ended September 30, 2022. The primary driver of the effective income tax rate as of September 30, 2023 is the benefits realized related to the recognition of previously unrecognized tax benefits as a result of an audit closing, receipt of interest on tax refunds during the quarter, and overall losses from operations for the nine months ended September 30, 2023, for which no benefit is recognized due to valuation allowance. The primary driver of the effective income tax rate as of September 30, 2022 was the overall losses from operations for the nine months ended September 30, 2022, for which no benefit is recognized due to valuation allowance.
The Company files income tax returns with the U.S. federal government and various state jurisdictions. The Company operates in a number of state and local jurisdictions, most of which have never audited our records. Accordingly, the Company is subject to state and local income tax examinations based upon the various statutes of limitations in each jurisdiction. For tax years before 2018, the Company has been subject to examination and assessment to the extent of net operating losses carryback refunds requested. The federal examination by the Internal Revenue Service for the 2018 tax year concluded in July of 2023. As of September 30, 2023, the Company no longer has any ongoing audits.
7. Net Income (Loss) per Share
For the three and nine months ended September 30, 2023 and 2022, basic net income (loss) per share is calculated by dividing net income (loss) by the sum of the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is calculated by dividing net income by the weighted average number of shares of common stock and dilutive common share equivalents outstanding during the period. Common share equivalents consist of stock options, restricted stock units, performance stock units, and warrants. When there is a loss in the period, dilutive common share equivalents are excluded from the calculation of diluted earnings per share, as their effect would be anti-dilutive. For example, for the nine months ended September 30, 2023 and 2022, respectively, diluted weighted average shares outstanding are the same as basic average shares outstanding. When there is net income in the period, the Company excludes stock options, restricted stock units, performance stock units, and warrants from the calculation of diluted earnings per share when their combined exercise price and unamortized fair value exceeds the average market price of the Company's common stock because their effect would be anti-dilutive.
12

The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
Weighted average shares outstanding – basic76,454 74,021 75,907 72,480 
Dilutive effect of stock options    
Weighted average shares outstanding – diluted76,454 74,021 75,907 72,480 
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):
September 30, 2023September 30, 2022
Options to purchase common stock72 250 
RSUs4,550 4,024 
Warrants outstanding 2,447 
Total4,622 6,721 
8. Subsequent Events
The Company has evaluated subsequent events through the date these consolidated financial statements are filed with the Securities and Exchange Commission and identified the following event, which did not require adjustments to the consolidated financial statements.
On October 27, 2023 (the “Closing Date”), the Company entered into a new credit agreement with Wells Fargo Bank, National Association (the “New Credit Agreement”). The New Credit Agreement includes a $25 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and contract assets, of which $5.0 million was advanced on the Closing Date. A portion of the revolving loan commitment of up to $2.5 million is available for the issuance of letters of credit. Subject to certain customary exceptions, the Company’s existing and future, direct or indirect, domestic subsidiaries will be jointly and severally obligated as borrowers or guarantors for the obligations under the New Credit Agreement. The obligations of the Company under the New Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its existing subsidiaries (and subject to customary exceptions, will be secured by the assets of future subsidiaries).
The New Credit Agreement matures on October 27, 2026. A portion of the proceeds from the initial borrowing under the New Credit Agreement were used by the Company, together with cash on hand, to refinance its MUFG Credit Agreement (Note 3), and to pay fees and expenses in connection with the New Credit Agreement.
The Company may, at its option, prepay borrowings under the New Credit Agreement, in whole or in part, at any time and from time to time without premium or penalty (except in certain circumstances). Borrowings under the New Credit Agreement are also subject to mandatory prepayment in the event that outstanding borrowings and letter of credit usage exceed the lesser of the aggregate revolving loan commitments and the borrowing base then in effect.
The Company may also increase commitments under the New Credit Agreement in an aggregate principal amount of up to $10 million by obtaining additional commitments from lenders, subject to obtaining commitments from any participating lenders and certain other conditions. Under the New Credit Agreement, loans generally may bear interest based on term SOFR (the secured overnight financing right) or an annual base rate, as applicable, plus, in each case, an applicable margin based on the Company’s average borrowing availability each quarter under the New Credit Agreement that may range between 2.50% per annum and 3.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 2.00% per annum in the case of base rate loans. In addition, a commitment fee of 0.50% per annum based on unused availability of the credit facility is also payable.
The New Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including,
13

incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The New Credit Agreement also contains financial covenants, which require the Company to maintain a minimum amount of liquidity and a consolidated fixed charge coverage ratio of not less than 1.25 to 1.00, provided that the fixed charge coverage ratio is only applicable when borrowing availability falls below a certain threshold. The obligations under the New Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the New Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.
On the Closing Date, the Company terminated the MUFG Credit Agreement. As a result, all outstanding obligations of the Company under the MUFG Credit Agreement have been paid.


14

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
You should read the following discussion in conjunction with our consolidated financial statements (unaudited) and related notes included elsewhere in this report. This report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk Factors” under Item 1A of Part II of this report. In light of these risks, uncertainties and assumptions, the forward-looking events and trends discussed in this report may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Forward-looking statements include, but are not limited to, statements about our ability to generate revenue following long implementation periods associated with new customer contracts; the high level of revenue concentration among our largest customers; our client relationships and our ability to maintain such client relationships; many of our customer contracts are subject to periodic renewal, are not exclusive, do not provide for committed business volumes; downturns in domestic or global economic conditions and other macroeconomic factors; our ability to generate sufficient cash flows to fund our ongoing operations and other liquidity needs; our ability to hire and retain employees with specialized skills that are required for our healthcare business; anticipated trends and challenges in our business and competition in the markets in which we operate; the impact of COVID-19 on our business and operations, opportunities and expectations for the markets in which we operate; our ability to maintain compliance with the covenants in our debt agreements; the adaptability of our technology platform to new markets and processes; failure of our or third parties' operating systems and technology infrastructure could disrupt our operation and the threat of breach of the Company's security measures or failure or unauthorized access to confidential data that we possess; our growth strategy of expanding in our existing markets and considering strategic alliances or acquisitions; maintaining, protecting and enhancing our intellectual property; our expectations regarding future expenses; expected future financial performance; and our ability to comply with and adapt to industry regulations and compliance demands. The forward-looking statements in this report speak only as of the date hereof. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
Overview
We provide technology-enabled audit, recovery, and analytics services in the United States primarily to the healthcare industry. We work with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. We engage clients in both government and commercial markets. Our clients typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. We also have a call center which serves clients with complex consumer engagement needs.
Our revenue model is generally success-based as we earn fees based on the aggregate amount of funds that we enable our clients to recover from our services. Our services do not require significant upfront investments by our clients and we offer our clients the opportunity to recover significant funds that may otherwise be lost. Because our model is based upon the success of our efforts, our business objectives are aligned with those of our clients and we are generally not reliant on their spending budgets.
15

Sources of Revenues
We derive a substantial portion of our revenues from services provided to our clients in the healthcare market. We also derive revenues from our outsourced call center services.
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
 (in thousands)(in thousands)
Eligibility-based$18,165 $13,142 $44,776 $39,773 
Claims-based10,325 10,377 30,535 28,866 
Healthcare Total28,490 23,519 75,311 68,639 
Recovery — 41 33 166 
Customer Care / Outsourced Services1,472 3,618 5,832 11,137 
Total Revenues$29,962 $27,178 $81,176 $79,942 
Healthcare Revenues
We derive revenues from both commercial and government clients by providing healthcare payment integrity services, which include claims-based and eligibility-based services. Revenues earned under claims-based contracts in the healthcare market are driven by auditing, identifying, and sometimes recovering improperly paid claims through both automated and manual review of such claims. Eligibility-based services, which may also be referred to as coordination-of-benefits or COB, involve identifying and recovering payments in situations where our client should not be the primary payer of healthcare claims because a member has other forms of insurance coverage. We are paid contingency fees by our clients based on a percentage of the dollar amount of improper claims recovered as a result of our efforts. The revenues we recognize are net of our estimate of claims that may be overturned by appeal or disputed following payment by the provider.
For our healthcare business, our business strategy is focused on utilizing our technology-enabled services platform to provide claims-based, eligibility-based, and analytical services for healthcare payers. Revenues from our healthcare services were $75.3 million for the nine months ended September 30, 2023 compared to revenues of $68.6 million from our healthcare services during for the nine months ended September 30, 2022.
In October 2017, we were awarded the national exclusive Medicare Secondary Payer, Commercial Payment Center (MSP) contract by the centers for Medicare and Medicaid Services (CMS). In December 2022, we were re-awarded this MSP contract, which commenced in March 2023. This contract has a six-year term, consisting of one base year and five additional one-year options.
Under this MSP contract, we are responsible for coordination-of-benefits claims, which includes identifying and recovering payments in situations where Medicare should not be the primary payer of healthcare claims because a beneficiary has other forms of insurance coverage, such as through an employer group health plan or certain other payers.
In 2016, CMS awarded two new Medicare Recovery Audit Contractor (RAC) contracts to us, for audit Regions 1 and 5. The RAC contract award for Region 1 allows us to continue our audit of payments under Medicare’s Part A and Part B for all provider types other than Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) and home health and hospice within an 11 state region in the Northeast and Midwest. The Region 5 RAC contract provides for the post-payment review of DMEPOS and home health and hospice claims on a nation-wide basis.
In March 2021, CMS re-awarded the Region 1 RAC contract to us after a competitive procurement process. This contract has an eight-and-a-half year term.
In January 2022, we were awarded the indefinite delivery, indefinite quantity contract by the U.S. Department of Health and Human Services, Office of the Inspector General (HHS OIG), which has a base term of one year and four additional one-year options, the first of which has been exercised. Under this contract, we provide medical review and consultative services associated with the oversight activities of the HHS OIG, primarily assessing services and claims for Medicare fee-for-service payments for Part A and Part B. This contract was awarded via a full-and-open competitive procurement.
16

In November 2022, we were re-awarded the Medicare RAC contract for Region 2. This contract allows us to audit payments under Medicare’s Part A and Part B for all provider types other than DMEPOS and home health and hospice within a 14 state region in the Midwest and South. This contract was initially awarded to us through a procurement process in March 2022, and following a voluntary corrective action process that was initiated by CMS, the agency re-affirmed its initial contract award, which commenced in August 2023. This contract has an initial eight-and-a-half-year term.
The scope of services that we provide to our healthcare clients continues to expand as we continue to implement new programs for existing and new healthcare clients. We believe this growth trend should continue as our suite of payment integrity services and our customer relationships continue to mature. We currently anticipate that our healthcare revenues will drive the majority of our overall revenue growth.
Recovery Revenues
During 2021, we sold certain of our non-healthcare recovery contracts and decided not to renew or restart existing contracts in the recovery market, nor pursue new non-healthcare recovery contracts. Accordingly, revenues from recovery markets such as defaulted student loans and tax receivables were de minimis.
Customer Care / Outsourced Services Revenues
We derive revenues from our first party call center and other outsourced services. Our revenues for these services include contingency fees, fees based on dedicated headcount and tasks completed on behalf of our clients.
Costs and Expenses
We generally report two categories of operating expenses: salaries and benefits and other operating expense. Salaries and benefits expenses consist primarily of salaries and performance incentives paid and benefits provided to our employees. Other operating expenses include expenses related to our use of subcontractors, other production related expenses, including costs associated with data processing, retrieval of medical records, printing and mailing services, amortization and other outside services, as well as general corporate and administrative expenses.
Factors Affecting Our Operating Results
Our results of operations are influenced by a number of factors, including costs associated with commencing new contracts, claim recovery volume, contingency fees, regulatory matters, client contract cancellation and macroeconomic factors.
17

Costs Associated with Commencing New Contracts
When we obtain an engagement with a new client or a new contract with an existing client, it typically takes a long period of time to plan our services in detail, which includes integrating our technology, processes and resources with the client’s operations and hiring new employees, before we receive any revenues from the new client or new contract. Due to the upfront costs we incur in connection with the implementation of new contracts, which may not be recoverable in the event of contract termination, and the delays we face in recognizing initial revenue from any such new contracts, our profitability can be negatively impacted by any delays associated with new contract implementations. Our clients may also experience delays in obtaining approvals or managing protests from unsuccessful bidders or delays associated with system implementations, as we had experienced before with certain clients. If we are not able to pay the upfront expenses out of cash from operations or availability of borrowings under our lending arrangements, we may need to scale back our operations or alter our business plans, either of which could have a negative effect on future revenues that we may earn under any such new client or new contract engagements.
Claims Recovery Volume
The number of claims that we are allowed or permitted to audit on behalf of our healthcare clients within our claims-based services has a direct impact on our revenues. Most of our contracts in our claims-based services permit our clients to unilaterally change the amount of claims that we are able to audit on the client’s behalf at any given time. Further, the type and scale of claims which are deemed permissible for us to audit by certain of our healthcare clients may change from time-to-time. Non-permissible claims may result from client product lines which are determined by our clients to be out of scope of our audit services, claims related to excluded providers or excluded provider groups, changes in policy, or other factors such as geographies disrupted by natural disasters or a global pandemic like the COVID-19 pandemic. For example, the COVID-19 pandemic had a negative impact on overall hospital utilization rates in the United States. This negative impact on overall hospital utilization rates has caused delays with the healthcare industry as a whole, which in turn has had a negative impact on our healthcare business.
The level of claims volume provided by our healthcare clients also impacts the revenues we earn from our eligibility-based services. To the extent the claim recovery volume that we are allowed or permitted to audit on behalf of our healthcare clients is negatively impacted by any of the factors set forth above, our revenues and results of operations will be adversely impacted.
Contingency Fees
Our revenues consist primarily of contract-based contingency fees. The contingency fee percentages that we earn are set by our clients or agreed upon during the bid process and may change from time to time either under the terms of existing contracts or pursuant to the terms of contract renewals. Changes in contingency fee percentages set by our clients may have a material effect on our revenues and results of operations.
Regulatory Matters
Each of the markets which we serve is highly regulated. Accordingly, changes in regulations that affect the types of receivables and claims that we are able to service or audit or the manner in which any such receivables and claims can be recovered will affect our revenues and results of operations.
In addition, our entry into the healthcare market was facilitated by the passage of the Tax Relief and Health Care Act of 2006, which mandated CMS to contract with private firms to audit Medicare claims in an effort to increase the recovery of improper Medicare payments. Any changes to the regulations that affect the Medicare program or the audit and recovery of Medicare claims could have a significant impact on our revenues and results of operations.
18

Client Contract Cancellation or Non-Renewal
We derive a substantial portion of our revenues from contracts with a limited number of our largest clients. Substantially all of our contracts (i) entitle our clients to unilaterally terminate their contractual relationship with us at any time without penalty and (ii) are subject to competitive procurement or renewal processes from time to time. Our revenues could decline if we lose one or more of our significant clients, either due to a contract cancellation or our inability to be awarded a new contract in connection with a competitive renewal process. Further, our revenues could be negatively impacted if one or more of our significant clients decides to limit the amount of claims that we are allowed to audit or reduces the level of placements provided under an existing contract, or if the terms of compensation for our services change under any existing contracts, or if any of our significant clients is acquired by an entity that does not wish to continue use our services.
Macroeconomic Factors
A variety of macroeconomic factors may influence our business and results of operations. These macroeconomic factors include fluctuations in Medicare expenditures or claims made to private healthcare providers resulting from changes in healthcare costs or the healthcare industry taken as a whole, as well as changes to fiscal budgets of federal, state and local governments as a result of general economic weakness and lower tax revenues.
Critical Accounting Policies
Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. In many instances, we could have reasonably used different accounting estimates, and in other instances changes in the accounting estimates are reasonably likely to occur from period-to-period. Accordingly, actual results could differ significantly from the estimates made by our management. To the extent that there are material differences between these estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.
Revenue Recognition
We derive our revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.
We determine revenue recognition through the following steps:
Identification of the contract with a customer.
Identification of the performance obligations in the contract.
Determination of the transaction price.
Allocation of the transaction price to the performance obligations in the contract.
Recognition of revenue when, or as, the performance obligations are satisfied.
We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
Our contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to a client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.
Our contracts are composed primarily of variable consideration. Fees earned under our audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount we enable our clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.
19

We generally either apply the as-invoiced practical expedient, where our right to consideration corresponds directly to our right to invoice our clients, or the variable consideration allocation exception, where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such, we have elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception, whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required.
We estimate variable consideration only if we can reasonably measure our progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognize such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. We exercise judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. We review the constraint on variable consideration quarterly. While we believe the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration.
For contracts that contain a refund right, these amounts are considered variable consideration, and we estimate our refund liability for each claim and recognize revenue net of such estimate.
Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on our performance under the specific contract. These performance-based awards are considered variable and may be constrained by us until there is not a risk of a material reversal.
We have applied the as-invoiced practical expedient and the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.
For healthcare claims audit contracts, we may recognize revenue upon delivering our findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.
For eligibility-based or COB contracts, we recognize revenue when insurance companies or other responsible parties have remitted payments to our clients.
For customer care / outsourced services clients, we recognize revenue based on the volume of processed transactions or the quantity of labor hours provided.
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022.
Contract assets totaled $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to our right to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time.
Contract assets primarily consist of commissions that we estimate we have earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.
Contract assets are recorded to accounts receivable when our right to payment becomes unconditional, which is generally when healthcare providers or payers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.
Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively.
20

Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute our findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents our best estimate of the amount probable of being refunded to our healthcare clients.
Recent Accounting Pronouncements
See "New Accounting Pronouncements" in Note 1(f) of the Consolidated Financial Statements included in Part I - Item 1 of this report.
Results of Operations
Three Months Ended September 30, 2023 compared to the Three Months Ended September 30, 2022
The following table represents our historical operating results for the periods presented: 
 Three Months Ended September 30,
 20232022$ Change% Change
 (in thousands)
Consolidated Statement of Operations Data:
Revenues$29,962 $27,178 $2,784 10 %
Operating expenses:
       Salaries and benefits22,980 21,759 (1,221)(6)%
       Other operating expenses7,632 7,733 101 %
Total operating expenses30,612 29,492 (1,120)%
Loss from operations(650)(2,314)1,664 72 %
Gain on sale of land and buildings— 1,120 (1,120)100 %
Interest expense(423)(277)(146)(53)%
Interest income86 — 86 — %
Loss before provision for income taxes(987)(1,471)484 33 %
(Benefit from) Provision for income taxes(407)(11)396 (3,600)%
Net loss$(580)$(1,460)$880 60 %
Revenues
Total revenues were $30.0 million for the three months ended September 30, 2023, an increase of approximately $2.8 million, or 10%, compared to total revenues of $27.2 million for the three months ended September 30, 2022.
Healthcare revenues were $28.5 million for the three months ended September 30, 2023, representing an increase of $5.0 million, or 21%, compared to the three months ended September 30, 2022. Revenues from eligibility-based services during the three months ended September 30, 2023 were $18.2 million, or 38% higher than the three months ended September 30, 2022. Revenues from claims-based services during the three months ended September 30, 2023 were $10.3 million, or 1% lower than the three months ended September 30, 2022. The increase in healthcare revenues was primarily driven by statements of work implemented for our commercial customers.
Customer Care / Outsourced Services revenues were approximately $1.5 million, representing a decrease of $2.1 million, or 59%, compared to the three months ended September 30, 2022. The change was due to a decrease in demand for our outsourced services.
Salaries and Benefits
Salaries and benefits expense was $23.0 million for the three months ended September 30, 2023, an increase of $1.2 million, or 6%, compared to salaries and benefits expense of $21.8 million for the three months ended September 30, 2022. The increase in salaries and benefits expense was in support of the continued growth of our healthcare services.
21

Other Operating Expenses
Other operating expenses were $7.6 million for the three months ended September 30, 2023, compared to $7.7 million for the three months ended September 30, 2022. This slight decrease in other operating expenses was primarily due to a decrease in lease expenses.
Gain on Sale of Land and Buildings
Gain from the sale of land and buildings was $1.1 million for the three months ended September 30, 2022. We sold two office buildings and the related land that were previously utilized by employees working on recovery contracts.
Loss from Operations
As a result of the factors described above, loss from operations was $0.7 million for the three months ended September 30, 2023, compared to loss from operations of $2.3 million for the three months ended September 30, 2022.
Interest Expense
Interest expense was $0.4 million during the three months ended September 30, 2023, compared to $0.3 million for the three months ended September 30, 2022, representing a decrease of approximately $0.1 million. This decrease in interest expense is primarily due to a lower principal balance offset by a higher interest rate during the three months ended September 30, 2023.
Income Taxes
We recognized an income tax expense of $407 thousand for the three months ended September 30, 2023, compared to an income tax expense of $11 thousand for the three months ended September 30, 2022. Our effective income tax rate was 41% and 1% for the three months ended September 30, 2023 and 2022, respectively. The primary driver of the effective income tax rate for the three months ended September 30, 2023 is the benefits realized related to the recognition of previously unrecognized tax benefits as a result of an audit closing, receipt of interest on tax refunds during the quarter, and overall losses from operations for the same period for which no benefit is recognized due to valuation allowance. The primary driver of the effective income tax rate for the three months ended September 30, 2022 was the overall losses from operations for the three months ended September 30, 2022 for which no benefit is recognized due to recognition of a full valuation allowance.
Net Loss
As a result of the factors described above, net loss was $0.6 million for the three months ended September 30, 2023, which represented a decrease in net loss of approximately $0.9 million, or 60%, compared to net loss of $1.5 million for the three months ended September 30, 2022.
22


Nine months ended September 30, 2023 compared to the Nine months ended September 30, 2022
The following table represents our historical operating results for the periods presented: 
 
Nine Months Ended September 30,
 20232022$ Change% Change
 (in thousands)
Consolidated Statement of Operations Data:
Revenues$81,176 $79,942 $1,234 %
Operating expenses:
       Salaries and benefits67,139 63,101 (4,038)(6)%
       Other operating expenses22,077 23,945 1,868 %
Total operating expenses89,216 87,046 (2,170)(2)%
Loss from operations(8,040)(7,104)(936)(13)%
Gain on sale of certain recovery contracts382 (379)(99)%
Gain on sale of land and buildings— 1,120 (1,120)(100)%
Interest expense(1,188)(648)(540)(83)%
Interest income86 — 86 — %
Loss before provision for income taxes(9,139)(6,250)(2,889)(46)%
(Benefit from) Provision for income taxes(365)52 417 802 %
Net loss$(8,774)$(6,302)$(2,472)(39)%
Revenues
Total revenues were $81.2 million for the nine months ended September 30, 2023, an increase of approximately 2%, compared to total revenues of $79.9 million for the nine months ended September 30, 2022.
Healthcare revenues were $75.3 million for the nine months ended September 30, 2023, representing an increase of $6.7 million, or 10%, compared to the nine months ended September 30, 2022. This increase in healthcare revenues was primarily driven by statements of work implemented for our commercial customers. Revenues from claims-based services during the nine months ended September 30, 2023 were $1.7 million higher than revenues for the nine months ended September 30, 2022. Revenues from eligibility-based services during the nine months ended September 30, 2023 were $5.0 million higher than revenues for the nine months ended September 30, 2022.
Recovery revenues were $33 thousand for the nine months ended September 30, 2023, compared to $166 thousand during the nine months ended September 30, 2022.
Customer Care / Outsourced Services revenues were approximately $5.8 million for the nine months ended September 30, 2023 compared to $11.1 million for the nine months ended September 30, 2022. The change was due to decreased demand for our outsourced services.
Salaries and Benefits
Salaries and benefits expense was $67.1 million for the nine months ended September 30, 2023, an increase of $4.0 million, or 6%, compared to salaries and benefits expense of $63.1 million for the nine months ended September 30, 2022. The increase in salaries and benefits expense was primarily driven by a change in the composition of our employee base to support the growth in our healthcare services, partially offset by a reduction in headcount for our customer care / outsourced services.
23

Other Operating Expenses
Other operating expenses were $22.1 million for the nine months ended September 30, 2023, compared to other operating expenses of $23.9 million for the nine months ended September 30, 2022. The decrease in other operating expenses was primarily due to lower lease expenses and a decrease in communication and postage expenses.
Gain on Sale of Land and Buildings
Gain from the sale of land and buildings was $1.1 million for the nine months ended September 30, 2022. We sold two office buildings and the related land that were previously utilized by employees working on recovery contracts.
Loss from Operations
As a result of the factors described above, loss from operations was $8.0 million for the nine months ended September 30, 2023, compared to loss from operations of $7.1 million for the nine months ended September 30, 2022.
Interest Expense
Interest expense was $1.2 million for the nine months ended September 30, 2023, compared to $0.6 million for the nine months ended September 30, 2022, representing an increase of $0.5 million. This increase in interest expense is primarily due to a higher interest rate offset by a lower principal balance during the nine months ended September 30, 2023.
Income Taxes
We recognized an income tax benefit of $365 thousand for the nine months ended September 30, 2023, compared to an income tax expense of $52 thousand for the nine months ended September 30, 2022. Our effective income tax rate was 4% for the nine months ended September 30, 2023, and (1)% for the nine months ended September 30, 2022. The primary driver of the effective income tax rate for the nine months ended September 30, 2023 is the benefits realized related to the recognition of previously unrecognized tax benefits as a result of an audit closing, receipt of interest on tax refunds during the quarter, and overall losses from operations for the same period for which no benefit is recognized due to valuation allowance. The primary driver of the effective tax rate for the nine months ended September 30, 2022 was the overall losses from operations for the nine months ended September 30, 2022 for which no benefit is recognized due to recognition of a full valuation allowance for the same period.
Net Loss
As a result of the factors described above, net loss was $8.8 million for the nine months ended September 30, 2023, which represented an increase in net loss of approximately $2.5 million, or 39%, compared to net loss of $6.3 million for the nine months ended September 30, 2022.
24

Adjusted EBITDA and Adjusted Net Income
To provide investors with additional information regarding our financial results, we have disclosed in the table below adjusted EBITDA and adjusted net income, both of which are non-U.S. GAAP financial measures. We have provided a reconciliation below of adjusted EBITDA to net income and adjusted net income to net income, the most directly comparable U.S. GAAP financial measure to these non-U.S. GAAP financial measures.
We have included adjusted EBITDA and adjusted net income in this report because they are key measures used by our management and board of directors to understand and evaluate our core operating performance and trends and to prepare and approve our annual budget. Accordingly, we believe that adjusted EBITDA and adjusted net income provide useful information to investors and analysts in understanding and evaluating our operating results in the same manner as our management and board of directors.
Our use of adjusted EBITDA and adjusted net income has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:
although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
adjusted EBITDA does not reflect interest expense on our indebtedness;
adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
adjusted EBITDA does not reflect tax payments;
adjusted EBITDA and adjusted net income do not reflect the potentially dilutive impact of equity-based compensation;
adjusted EBITDA and adjusted net income do not reflect the impact of certain non-operating expenses resulting from matters we do not consider to be indicative of our core operating performance; and
other companies may calculate adjusted EBITDA and adjusted net income differently than we do, which reduces its usefulness as a comparative measure.
Because of these limitations, you should consider adjusted EBITDA and adjusted net income alongside other financial performance measures, including net income and our other U.S. GAAP results. The following tables present a reconciliation of adjusted EBITDA and adjusted net income for each of the periods indicated:
25

 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
2023202220232022
(in thousands)(in thousands)
Adjusted EBITDA:
Net income (loss)$(580)$(1,460)$(8,774)$(6,302)
Provision for (benefit from) income taxes(407)(11)(365)52 
Interest expense (1)
423 277 1,188 648 
Interest income(86)— (86)— 
Stock-based compensation1,129 931 2,815 2,212 
Depreciation and amortization1,293 1,095 3,805 3,355 
Severance expenses (3)
64 10 246 189 
Other (4)
34 (373)
Gain on sale of land and buildings (6)
$— $(1,120)$— $(1,120)
Adjusted EBITDA$1,841 $(275)$(1,137)$(1,339)
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
(in thousands)(in thousands)
Adjusted Net Income (Loss):
Net income (loss)$(580)$(1,460)$(8,774)$(6,302)
Stock-based compensation1,129 931 2,815 2,212 
Amortization of debt issuance costs (2)
134 23 256 71 
Severance expenses (3)
64 10 246 189 
Other (4)
34 (373)
Gain on sale of land and buildings (6)
— — — (1,120)
Tax adjustments (5)
(366)(42)(921)(269)
Adjusted net income (loss)$386 $(1,655)$(6,344)$(5,592)

26

Three Months Ended  
September 30,
Nine Months Ended  
September 30,
2023202220212022
(in thousands)(in thousands)
Adjusted Net Income (Loss) Per Diluted Share:
Net income (loss)$(580)$(1,460)$(8,774)$(6,302)
Plus: Adjustment items per reconciliation of adjusted net income (loss)966 (195)2,430 710 
Adjusted net income (loss)$386 $(1,655)$(6,344)$(5,592)
Adjusted net income (loss) per diluted share$0.01 $(0.02)$(0.08)$(0.08)
Diluted average shares outstanding (7)
76,830 74,021 75,907 72,480 
 
(1)Represents interest expense and amortization of debt issuance costs related to our MUFG Credit Agreement.
(2)Represents amortization of debt issuance costs related to our MUFG Credit Agreement.
(3)Represents severance expenses incurred in connection with a reduction in force for our non-healthcare recovery services.
(4)Represents professional fees related to strategic corporate development activities and gain on sale of certain non-healthcare recovery contracts in prior years.
(5)Represents tax adjustments assuming a marginal tax rate of 27.5% at full profitability.
(6)Represents gain on the sale of land and two office buildings in September of 2022.
(7)While net loss for the three months ended September 30, 2023 is ($580), the computation of adjusted net income (loss) results in adjusted net income of $386. Therefore, the calculation of the adjusted earnings per diluted share for the three months ended September 30, 2023 includes dilutive common share equivalents of 376 added to the basic weighted average shares of 76,454.
Liquidity and Capital Resources
Our primary sources of liquidity are cash flows from operations, and cash and cash equivalents on hand. Cash and cash equivalents, which includes restricted cash and consists primarily of cash on deposit with banks, totaled $17.4 million as of September 30, 2023 compared to $23.5 million as of December 31, 2022. The $6.1 million decrease in the balance of our cash and cash equivalents from December 31, 2022 to September 30, 2023, was primarily due to $8.9 million used in financing activities and $3.0.million used in investing activities, offset by $5.7 million provided by operating activities. The $8.9 million in cash used in financing activities was primarily the result of $7.5 million in prepayment of outstanding principal in connection with an amendment to our MUFG Credit Agreement in March of 2023.
On October 27, 2023, we entered into a new credit agreement among the Company and its subsidiaries party thereto, as borrowers, the lenders from time to time party thereto and Wells Fargo Bank, National Association, as administrative agent(the “New Credit Agreement”). The New Credit Agreement includes a $25 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and contract assets, of which $5.0 million was advanced upon closing. A portion of the proceeds from the initial borrowing under the New Credit Agreement were used by the Company, together with cash on hand, to pay off our outstanding notes payable balance as of September 30, 2023 under the credit agreement dated as of December 17, 2021 with MUFG Union Bank, N.A.(the “MUFG Credit Agreement”). The MUFG Credit Agreement originally included a $20 million term loan commitment, which was then amended on March 13, 2023 when we voluntarily prepaid $7.5 million of the outstanding principal of the term loan.
Our ability to fund our business plans, capital expenditures and to fund our other liquidity needs depends on our financial and operating performance, which is subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond our control, and the availability of cash and cash equivalents on hand. Our current financial projections show that we expect to be able to maintain a level of cash flows from operating activities sufficient to permit us to fund our ongoing and planned business operations and to fund our other liquidity needs. If, however, we are required to obtain additional borrowings to fund our ongoing or future business operations, there can be no assurance that we will be successful in obtaining such additional borrowings or upon terms that are acceptable to us.
27

Our New Credit Agreement contains, and any agreements to refinance our debt likely will contain, certain financial covenants, including the maintenance of minimum amount of liquidity and a consolidated fixed charge coverage ratio, as well as restrictive covenants that require us to limit our ability to incur additional debt, including to finance future operations or other capital needs, and to engage in other activities that we may believe are in our long-term best interests, including to dispose of or acquire assets. Conditions may change, however, for a variety of reasons in the future that may affect our ability to maintain compliance with our financial or restrictive covenants. Our failure to comply with these financial covenants or the restrictive covenants may result in an event of default, which, if not cured or waived, could accelerate the maturity of our indebtedness or result in modifications to our credit terms.
Cash flows from operating activities
Cash provided by operating activities was $5.7 million for the nine months ended September 30, 2023, primarily as a result of a decrease in accounts receivable, contract assets, and income tax receivable during the period, offset by a decrease in accrued salaries and benefits and accounts payable. Cash used in operating activities was $2.2 million for the nine months ended September 30, 2022, primarily as a result of changes in accrued salaries and benefits, contract liabilities, and other current liabilities during the period.
Cash flows from investing activities
Cash used in investing activities of $3.0 million for the nine months ended September 30, 2023 primarily related to capital expenditures for information technology, data storage, hardware, telecommunication systems and security enhancements to our information technology systems. Cash provided by investing activities for the nine months ended September 30, 2022 was $3.1 million, primarily related to proceeds from the sale of land and buildings, offset by capital expenditures for information technology, data storage, hardware, telecommunication systems and security enhancements to our information technology systems.
Cash flows from financing activities
Cash used in financing activities of $8.9 million for the nine months ended September 30, 2023 was primarily attributable to repayments of notes payable during the period. Cash provided by financing activities for the nine months ended September 30, 2022 was $5.2 million, primarily attributable to $5.6 million in proceeds from the exercise of warrants by ECMC, offset by $0.4 million in repayments of notes payable.
Notes Payable
As of September 30, 2023, $11.3 million was outstanding under the MUFG Credit Agreement (refer to Note 3 in Part I, Item 1 Notes to the Consolidated Financial Statements). The Company’s annual interest rate at September 30, 2023 was 11.5%.
On October 27, 2023, we entered into the New Credit Agreement with Wells Fargo Bank, National Association that includes a $25 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and contract assets, of which $5.0 million was advanced upon closing. A portion of the revolving loan commitment of up to $2.5 million is available for the issuance of letters of credit. Subject to certain customary exceptions, the Company’s existing and future, direct or indirect, domestic subsidiaries will be jointly and severally obligated as borrowers or guarantors for the obligations under the New Credit Agreement. The obligations of the Company under the New Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its existing subsidiaries (and subject to customary exceptions, will be secured by the assets of future subsidiaries).
The New Credit Agreement matures on October 27, 2026. A portion of the proceeds from the initial borrowing under the New Credit Agreement were used by the Company, together with cash on hand, to refinance our MUFG Credit Agreement, and to pay fees and expenses in connection with the New Credit Agreement.
As a result of the New Credit Agreement, the terms of the MUFG Credit Agreement are no longer in effect as of October 27, 2023.
Under the New Credit Agreement, the Company may, at its option, prepay borrowings, in whole or in part, at any time and from time to time without premium or penalty (except in certain circumstances). Borrowings under the New Credit Agreement are also subject to mandatory prepayment in the event that outstanding borrowings and letters of credit usage exceed the lesser of the aggregate revolving loan commitments and the borrowing base then in effect.
28

The Company may also increase commitments under the New Credit Agreement in an aggregate principal amount of up to $10 million by obtaining additional commitments from lenders, subject to obtaining commitments from any participating lenders and certain other conditions. Under the New Credit Agreement, loans generally may bear interest based on term SOFR (the secured overnight financing right) or an annual base rate, as applicable, plus, in each case, an applicable margin based on the Company’s average borrowing availability each quarter under the New Credit Agreement that may range between 2.50% per annum and 3.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 2.00% per annum in the case of base rate loans. In addition, a commitment fee of 0.50% per annum based on unused availability of the credit facility is also payable.
The New Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including, incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The New Credit Agreement also contains financial covenants, which require the Company to maintain a minimum amount of liquidity and a consolidated fixed charge coverage ratio of not less than 1.25 to 1.00, provided that the fixed charge coverage ratio is only applicable when borrowing availability falls below a certain threshold. The obligations under the New Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the New Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We do not hold or issue financial instruments for trading purposes. We conduct all of our business in U.S. currency and therefore do not have any material direct foreign currency risk. We do have exposure to changes in interest rates with respect to the borrowings under our senior secured credit facility, which bear interest at a variable rate based on SOFR or Prime. For example, if the interest rate on our borrowings increased 100 basis points (1%), our annual interest expense would increase by approximately $0.1 million.
We currently hold our excess cash in an operating account, which is swept into a money market account on an overnight basis, where returns may reflect current interest rates.
As a result, market interest rate changes will impact both our interest expense and interest income. This impact, if applicable, will depend on variables such as the magnitude of interest rate changes and the level of our borrowings under our credit facility or excess cash balances.
ITEM 4. DISCLOSURE CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and the Chief Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.
In designing and evaluating the disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable not absolute, assurance of achieving the desired control objectives. Our disclosure controls and procedures have been designed to meet reasonable assurance standards. Additionally, in designing internal controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Management, with the participation of our Chief Executive Officer and our Chief Accounting Officer, has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Exchange Act, and concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of September 30, 2023.
29

As described in Item 9A of our Annual Report on the Form 10-K for the year ended December 31, 2022, management identified control deficiencies related to the design and operation of information technology general controls (“ITGCs”) around user access and change management for certain information technology (“IT”) systems which resulted in a material weakness. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weakness did not result in any material misstatement of our consolidated financial statements for the periods presented. Subsequent to the identification of the material weakness, we performed supplemental procedures and found no evidence of improper changes or changes with direct or consequential impact on internal controls over financial reporting.
The process of designing and implementing effective internal control measures to improve the Company’s internal controls over financial reporting and to remediate this material weakness is underway. Our efforts include modifying ITGCs over user access and change management, enhancing our documentation to evidence execution of these ITGCs, and implementing additional controls designed to detect issues that could arise over users with elevated access rights. We plan to complete such enhancements in 2023.
We believe that these actions, collectively, will remediate the material weakness. However, the material weakness cannot be considered remediated until the applicable controls operate for a sufficient period of time and our management has concluded, through testing, that these controls are operating effectively. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business but cannot provide assurance that such improvements will be sufficient to provide us with effective internal control over financial reporting.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the third quarter of 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

30

PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are involved in various legal proceedings that arise from our normal business operations. These actions generally derived from student loan recovery services we provided historically, and generally assert claims for violations of the Fair Debt Collection Practices Act or similar federal and state consumer credit laws. While litigation is inherently unpredictable, we believe that none of these legal proceedings, individually or collectively, will have a material adverse effect on our financial condition or our results of operations.
ITEM 1A. RISK FACTORS
Our business, financial condition, results of operations and liquidity are subject to various risks and uncertainties, including those described below, and as a result, the trading price of our common stock could decline.
Risks Related to Our Business
We typically face a long period to start up a new contract which may cause us to incur expenses before we receive revenues from new clients or new contract relationships.
If we are successful in obtaining an engagement with a new client or a new contract with an existing client, we typically have a long implementation period in which the services are planned in detail and we integrate our technology, processes and resources with the client’s operations. If we enter into a contract with a new client, we typically will not receive revenues until implementation is completed and work under the contract actually begins, which can be a substantial period of time. Our clients may also experience delays in obtaining approvals or managing protests from unsuccessful bidders, or delays associated with technology or system implementations, such as the delays experienced with the implementation of our RAC contracts with CMS. We incur significant expenses associated with new contracts before we receive corresponding revenues under any such new contract, because we operate under a model in which we generally hire employees to provide services to a new client once a contract is signed and otherwise incur significant upfront implementation expenses. If we are not able to pay the upfront expenses for commencing new contracts out of cash from operations or availability of cash on hand or borrowings under our lending arrangements, we may be required to scale back our operations or alter our business plans to account for cash shortages, either of which could prevent us from earning future revenues under any such new client or contract engagements. Further, if we are not successful in maintaining contractual commitments after the expenses we incur during our typically long implementation cycle, our cash flows and results of operations could be adversely affected.
Revenues generated from a limited number of our largest clients represent a substantial majority of our revenues. Any termination of or deterioration in our relationship with any of our significant clients would result in a decline in our revenues.
We derive a substantial portion of our revenues from a limited number of our largest clients. Substantially all of our contracts (i) entitle our clients to unilaterally terminate their contractual relationship with us at any time without penalty and (ii) are subject to competitive procurement or renewal processes from time to time. Further, substantially all of our contracts allow our clients to unilaterally change the amount of work available to us. If one of our largest clients terminates any of our existing contracts, or chooses not to renew an existing contract in connection with a competitive procurement or renewal process, our revenues and results of operations may be materially harmed. Further, if one of our significant clients decides to limit the amount of claims that we are allowed to audit or if the terms of compensation for our services change or if there is a reduction in the level of placements provided by any of these clients, our revenues could decline, which would harm our business, financial condition and results of operations. Lastly, our revenues could be adversely affected if one of our significant clients is acquired by an entity that does not wish to continue to use our services.
31

Many of our contracts with our clients are not exclusive and do not commit our clients to provide specified volumes of business. In addition, the terms of these contracts may be changed unilaterally and on short notice by our clients. As a consequence, there is no assurance that we will be able to maintain our revenues and operating results.
Many of our existing contracts enable our clients to terminate their contractual relationship with us at any time without penalty, potentially leading to loss of business or renegotiation of terms. Further, most of our contracts allow our clients to unilaterally change the amount of work available to us or the payment terms at any given time. In addition, many of our contracts are not exclusive, with our clients retaining multiple service providers with whom we must continue to compete for additional work. Therefore, despite our contractual relationships with our clients, our contracts do not provide assurance that we will generate a minimum amount of revenues or that we will receive a specific volume of work. For example, in March 2020, CMS paused medical review activities under our then current RAC contracts related to the COVID-19 pandemic, which were later resumed in August 2020. Further, the Public Health Emergency declared by U.S. Department of Health and Human Services which recently expired as of May 2023 restricted us from auditing claims which related to COVID-19 or other respiratory designations under our RAC contracts. These pauses in medical review activities under our RAC contracts had a negative impact on our revenues and results of operations. If any of our clients modify terms of service, including the success fees we are able to earn, or any of these clients establish more favorable relationships with our competitors, our future revenues may be adversely affected.
Our ability to derive revenues under our current healthcare contracts will depend in part on the number and types of potentially improper claims that we are allowed to audit or otherwise pursue by our clients, and our results of operations may be harmed if the scope of claims that we are allowed to pursue and be compensated for is limited.
Our revenues under our current healthcare contracts depend in part on the number and types of potentially improper claims that we are allowed to audit or otherwise pursue on behalf of our clients. For example, under CMS’s Medicare recovery audit program, RAC contractors have not been permitted to seek the recovery of an improper claim unless that particular type of claim has been pre-approved by CMS to ensure compliance with applicable Medicare payment policies, as well as national and local coverage determinations. As work under the first RAC contract progressed, CMS placed increasing restrictions on the scope of audits permitted by RAC contractors and these restrictions have not been relaxed under our current RAC contracts. Accordingly, the long-term growth of revenues we derive under our three existing RAC contracts, or any additional contracts we may enter into with CMS, will depend on the scope of improper claims that CMS allows us to pursue and our ability to successfully identify improper claims within the permitted scope.
In addition, our commercial healthcare clients also have the ability to unilaterally restrict or expand the type and volume of claims we are allowed to audit or otherwise provide services. Any future limitations on the type or volume of claims that we are permitted to audit or otherwise review on behalf of our clients in the healthcare market could have a material negative impact on our business, financial condition and results of operations.
Our indebtedness could adversely affect our business and financial condition and reduce the funds available to us for other purposes, and our failure to comply with the covenants contained in our New Credit Agreement could result in an event of default that could adversely affect our results of operations.
Our ability to make scheduled payments under our New Credit Agreement and to fund our other liquidity needs depends on our financial and operating performance, which is subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond our control, such as the recent global economic downturn as the result of the COVID-19 pandemic. We cannot make assurances that we will maintain a level of cash flows from operating activities or other capital resources sufficient to permit us to pay the principal and interest on our indebtedness and to fund our other liquidity needs. If our cash flows and capital resources are insufficient to fund our debt service obligations and allow us to maintain compliance with the covenants under our New Credit Agreement or to fund our other liquidity needs, we may be forced to reduce or delay capital expenditures, alter our business plans, curtail the services we provide to our current or future clients, sell assets or operations, seek additional capital or restructure or refinance our indebtedness. We cannot ensure that we would be able to take any of these actions, that these actions would be successful and permit us to meet our scheduled debt service obligations or that these actions would be permitted under the terms of our existing or future debt agreements, including our New Credit Agreement with Wells Fargo Bank, National Association. If we cannot make scheduled payments on our debt, we will be in default and, as a result, our debt holders could declare all outstanding principal and interest to be due and payable, and foreclose against the assets securing our borrowings and we could be forced into bankruptcy or liquidation.
32

Our New Credit Agreement contains, and any agreements to refinance our debt likely will contain, certain financial and restrictive covenants that limit our ability to incur additional debt, including to finance future operations or other capital needs, and to engage in other activities that we may believe are in our long-term best interests, including to dispose of or acquire assets. Our failure to comply with these covenants may result in an event of default, which, if not cured or waived, could accelerate the maturity of our indebtedness or result in modifications to our credit terms. If our indebtedness is accelerated, we may not have sufficient cash resources to satisfy our debt obligations and we may not be able to continue our operations as planned.
The U.S. federal government accounts for a significant portion of our revenues, and any loss of business from, or change in our relationship with the U.S. federal government would result in a significant decrease in our revenues and operating results.
We have historically derived and are likely to continue to derive a significant portion of our revenues from the U.S. federal government. We currently hold five contracts with agencies of the U.S. federal government within our healthcare business. The continuation and exercise of renewal options on our U.S. federal government contracts and any new U.S. federal government contracts are, among other things, contingent upon succeeding within competitive bidding processes, changes in federal government spending, the availability of adequate funding for the applicable federal government agency, or other regulatory changes, such as the pause in activities under our RAC contracts in 2020 as a result of the COVID-19 pandemic, could adversely affect our financial performance. The loss of business from the U.S. federal government, or significant policy changes or financial pressures within the agencies of the U.S. federal government that we serve would result in a significant decrease in our revenues, which would adversely affect our business, financial condition and results of operations.
Downturns in domestic or global economic conditions and other macroeconomic factors could harm our business and results of operations.
Various macroeconomic factors influence our business and results of operations. These include overall healthcare spending in the U.S. and the volume of healthcare claims that we audit on behalf of our clients, which are both impacted by domestic and global economic conditions, rates of unemployment and similar factors, movements in interest rates, and changes in healthcare costs, governmental policies toward Medicare expenditures or the healthcare industry taken as a whole. Changes in the overall economy could lead to a reduction in overall recovery rates by our clients, which in turn could adversely affect our business, financial condition and results of operations. For example, our business and the businesses of our customers have been/were materially and adversely affected by recent inflationary trends and the impact of the COVID-19 pandemic which have caused, and may continue to cause, a slowdown in global economic activity, which has resulted in a significant negative impact on our financial condition and results of operations. Political tensions resulting in economic instability, such as due to military activity or civil hostilities among Russia and Ukraine and the related response, including sanctions or other restrictive actions, by the United States and/or other countries, or other similar events, may have an adverse impact on our business, financial condition, and results of operations.
We may not have sufficient cash flows from operations or availability of funds under our lending arrangements to fund our ongoing operations and our other liquidity needs, which could adversely affect our business and financial condition.
Our ability to fund our business plans, capital expenditures and to fund our other liquidity needs depends on our financial and operating performance, which is subject to prevailing economic and competitive conditions and to certain financial, business and other factors beyond our control and the availability of cash on hand and borrowings under our existing lending facility. We cannot make assurances that we will maintain a level of cash flows from operating activities sufficient to permit us to fund our ongoing and planned business operations and to fund our other liquidity needs. If we are required to obtain borrowings to fund our ongoing or future business operations, there can be no assurance that we will be successful in obtaining such borrowings or upon terms that are acceptable to us. While we believe our financial projections are attainable, there can be no assurances that our financial results will be recognized in a timeframe necessary to meet our ongoing cash requirements. If our cash flows and capital resources are insufficient to fund our planned business operations or to fund our other liquidity needs, we may be forced to reduce or delay capital expenditures, alter our business plans, curtail the services we provide to our current or future clients, sell assets or operations, seek additional capital or restructure or refinance our indebtedness, any of which could have an adverse effect on our financial condition and results of operations.
33

We may not be able to manage our potential growth effectively and our results of operations could be negatively affected.
We believe our RAC contracts, MSP CRC contract, and other commercial healthcare contracts continue to provide the opportunity for growth in our business. However, our focus on growth and the expansion of our healthcare and other businesses may place additional demands on our management, operations and financial resources and will require us to incur additional expenses. We cannot be sure that we will be able to manage our performance under any significant new contracts effectively. In order to successfully perform under any significant new contracts, our expenses will increase to recruit, train and manage additional qualified employees and subcontractors and to expand and enhance our administrative infrastructure and continue to improve our management, financial and information systems and controls. If we cannot manage our growth effectively, our expenses may increase, and our results of operations could be negatively affected.
The growth of our healthcare business will require us to hire and retain employees with specialized skills and failure to do so could harm our ability to grow our business.
The growth of our healthcare business will depend in part on our ability to recruit, train and manage additional qualified employees. Our healthcare-related operations require us to hire registered nurses and experts in Medicare coding. Finding, attracting and retaining employees with these skills is a critical component of providing our healthcare-related recovery and audit services, and our inability to staff these operations appropriately represents a risk to our healthcare service offering and associated revenues. An inability to hire qualified personnel, particularly to serve our healthcare clients, may restrain the growth of our business.
We face significant competition in connection with obtaining, retaining and performing under our client contracts, and an inability to compete effectively in the future could harm our relationships with our clients, which would impact our ability to maintain our revenues and operating results.
We operate in highly competitive markets and face significant competition from other companies in providing our services and sourcing contracts with new clients or new contracts with existing clients. Accordingly, maintaining high levels of service under our contracts, and doing so in a cost-effective manner, are important factors in our ability to maintain existing contracts and obtain new contracts and grow our revenues and net income. Any failure to achieve these objectives could result in the loss of existing contractual relationships either by a client’s decision to terminate existing contractual relationship or in connection with a competitive contract re-bidding process, or the inability to obtain new client contracts, any of which could harm our business, financial condition and results of operations. Some of our current and potential competitors in the markets in which we operate may have greater financial, marketing, technological or other resources than we do. The ability of any of our competitors and potential competitors to adopt new and effective technology to better serve our markets may allow them to gain market strength. Increasing levels of competition in the future could result in lower fees, lower volumes of contracted services or higher costs for resources. Any inability to compete effectively in the markets that we serve could adversely affect our business, financial condition and results of operations.
Public health pandemics such as the novel coronavirus (COVID-19) pandemic have adversely affected and could adversely affect our business, results of operations and financial condition.
Our business and the businesses of our customers are exposed to risks associated with public health pandemics, such as the COVID-19 pandemic that has caused, and may continue to cause, the global slowdown in economic activity. The ultimate impact of any such epidemic or pandemic on our operations and financial performance depends on many factors that are not within our control, including, but not limited to: governmental and business actions that have been and continue to be taken in response to the pandemic; the impact of the pandemic and actions taken in response on global and regional economies and economic activity; the availability of federal, state or local funding programs; general economic uncertainty and financial market volatility; global economic conditions and levels of economic growth; and the pace of economic recovery when any such pandemic subsides.
As a result of the economic hardships caused by the COVID-19 pandemic, certain of our customers have chosen and may continue to choose to delay the services that we provide, and additional customers may choose to similarly delay the audit and recovery services that we provide, either of which could have a material negative impact on our revenues and results of operations. In addition, the COVID-19 pandemic has also had a negative impact on overall hospital utilization rates in the United States. This negative impact on overall hospital utilization rates has caused delays with the healthcare industry as a whole, which in turn has had a negative impact on our healthcare business. Any additional disruptions to the services that we provide to our customers as a result of the COVID-19 pandemic, or as a result of any future pandemics, could result in a negative impact on our revenues and results of operations.
34

Further, a prolonged period of generating lower cash flows from operations as a result of the COVID-19 pandemic could adversely affect our financial condition and the achievement of our strategic objectives. Conditions in the financial and credit markets may also limit the availability of funding or increase the cost of funding, which could adversely affect our business, financial position and results of operations. While we believe our financial projections are attainable, there can be no assurances that our financial results will be recognized in a timeframe necessary to meet our ongoing cash requirements.
Our results of operations may fluctuate on a quarterly or annual basis and cause volatility in the price of our stock.
Our revenues and operating results could vary significantly from period-to-period and may fail to match our past performance because of a variety of factors, some of which are outside of our control. Any of these factors could cause the price of our common stock to fluctuate. Factors that could contribute to the variability of our operating results include, but are not limited to, the following:
• the schedules of government agencies for awarding contracts;
• our ability to maintain contractual commitments after the expenses we incur during our typically long implementation cycle for new customer contracts;
• our ability to successfully identify improper Medicare claims and the number and type of potentially improper claims that CMS authorizes us to pursue under our RAC contracts;
• our ability to continue to generate revenues under our private healthcare contracts;
• the loss or gain of significant clients or changes in the contingency fee rates or other significant terms of our business arrangements with our significant clients;
• technological and operational issues that may affect our clients and regulatory changes in the markets we service; and
• general industry and macroeconomic conditions.
A failure of our operating systems or technology infrastructure, or those of our third-party vendors and subcontractors, could disrupt the operation of our business.
A failure of our operating systems or technology infrastructure, or those of our third-party vendors and subcontractors, could disrupt our operations. Our operating systems and technology infrastructure are susceptible to damage or interruption from various causes, including acts of God and other natural disasters, power losses, computer systems failures, Internet and telecommunications or data network failures, global health crises, operator error, computer viruses, losses of and corruption of data and similar events. The occurrence of any of these events could result in interruptions, delays or cessations in service to our clients, reduce the attractiveness of our recovery services to current or potential clients and adversely impact our financial condition and results of operations. While we have backup systems in many of our operating facilities, an extended outage of utility or network services may harm our ability to operate our business. Further, the situations we plan for and the amount of insurance coverage we maintain for losses as result of failures of our operating systems and infrastructure may not be adequate in any particular case.
35

If our security measures are breached or fail and unauthorized access is obtained to our clients’ confidential data, our services may be perceived as insecure, the attractiveness of our services to current or potential clients may be reduced, and we may incur significant liabilities.
Our services involve the storage and transmission of confidential information relating to our clients and their customers, including health, financial, credit, payment and other personal or confidential information. Although our data security procedures are designed to protect against unauthorized access to confidential information, our computer systems, software and networks may be vulnerable to unauthorized access and disclosure of our clients’ confidential information. Further, we may not effectively adapt our security measures to evolving security risks, address the security and privacy concerns of existing or potential clients as they change over time, or be compliant with federal, state, and local laws and regulations with respect to securing confidential information. Unauthorized access to confidential information relating to our clients and their customers could lead to reputational damage which could deter our clients and potential clients from selecting our services, or result in termination of contracts with those clients affected by any such breach, regulatory action, and claims against us.
Our business is increasingly dependent on critical, complex, and interdependent information technology (IT) systems, including internet-based systems, some of which are managed or hosted by third parties, to support business processes as well as internal and external communications. The size and complexity of our IT systems make us potentially vulnerable to IT system breakdowns, malicious intrusion, and computer viruses, which may result in the impairment of our ability to operate our business effectively. In addition, having a significant portion of our employees work remotely due to the COVID-19 pandemic can strain our information technology infrastructure, which may affect our ability to operate effectively, may make us more susceptible to communications disruptions, and expose us to greater cybersecurity risks.
In the event of any unauthorized access to personal or other confidential information, we may be required to expend significant resources to investigate and remediate vulnerabilities in our security procedures, and we may be subject to fines, penalties, litigation costs, and financial losses that are either not insured against or not fully covered through any insurance maintained by us. If one or more of such failures in our security and privacy measures were to occur, our business, financial condition and results of operations could suffer.
If our software vendors or utility and network providers fail to deliver or perform as expected our business operations could be adversely affected.
Our recovery services depend in part on third-party providers, including software vendors and utility and network providers. Our ability to service our clients depends on these third-party providers meeting our expectations and contractual obligations in a timely and effective manner. Our business could be materially and adversely affected, and we might incur significant additional liabilities, if the services provided by these third-party providers do not meet our expectations or if they terminate or refuse to renew their relationships with us on similar contractual terms.
Litigation may result in substantial costs of defense, damages or settlement, any of which could subject us to significant costs and expenses.
We are party to lawsuits in the normal course of business, particularly in connection with our student loan recovery services. For example, we are regularly subject to claims that we have violated the guidelines and procedures that must be followed under federal and state laws in communicating with consumer debtors. We may not ultimately prevail or otherwise be able to satisfactorily resolve any pending or future litigation, which may result in substantial costs of defense, damages or settlement. In the future, we may be required to alter our business practices or pay substantial damages or settlement costs as a result of litigation proceedings, which could adversely affect our business operations and results of operations.
36

If we are unable to adequately protect our proprietary technology, our competitive position could be harmed, or we could be required to incur significant costs to enforce our rights.
The success of our business depends in part upon our proprietary technology platform. We rely on a combination of copyright, trademark, and trade secret laws, as well as on confidentiality procedures and non-compete agreements, to establish and protect our proprietary technology rights. The steps we have taken to deter misappropriation of our proprietary technology may be insufficient to protect our proprietary information. In particular, we may not be able to protect our trade secrets, know-how and other proprietary information adequately. Although we use reasonable efforts to protect this proprietary information and technology, our employees, consultants and other parties may unintentionally or willfully disclose our information or technology to competitors. Enforcing a claim that a third party illegally obtained and is using any of our proprietary information or technology is expensive and time consuming, and the outcome is unpredictable. We rely, in part, on nondisclosure, confidentiality and invention assignment agreements with our employees, consultants and other parties to protect our trade secrets, know-how and other intellectual property and proprietary information. These agreements may not be self-executing, or they may be breached, and we may not have adequate remedies for such breach. Moreover, third parties may independently develop similar or equivalent proprietary information or otherwise gain access to our trade secrets, know-how and other proprietary information. Any infringement, misappropriation or other violation of our patents, trademarks, copyrights, trade secrets, or other intellectual property rights could adversely affect any competitive advantage we currently derive or may derive from our proprietary technology platform and we may incur significant costs associated with litigation that may be necessary to enforce our intellectual property rights.
Claims by others that we infringe their intellectual property could force us to incur significant costs or revise the way we conduct our business.
Our competitors protect their proprietary rights by means of patents, trade secrets, copyrights, trademarks and other intellectual property. Any party asserting that we infringe, misappropriate or violate their intellectual property rights may force us to defend ourselves, and potentially our clients, against the alleged claim. These claims and any resulting lawsuit, if successful, could be time-consuming and expensive to defend, subject us to significant liability for damages or invalidation of our proprietary rights, prevent us from operating all or a portion of our business or force us to redesign our services or technology platform or cause an interruption or cessation of our business operations, any of which could adversely affect our business and operating results. In addition, any litigation relating to the infringement of intellectual property rights could harm our relationships with current and prospective clients. The risk of such claims and lawsuits could increase if we increase the size and scope of our services in our existing markets or expand into new markets.
Risks Related to Regulations and Legislation
We identified a material weakness in our internal control over financial reporting. If we are unable to remediate this material weakness, or if we experience additional material weaknesses or other deficiencies in the future, or otherwise fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately or timely report our financial results, which could result in loss of investor confidence and adversely impact our stock price.
As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, or the Exchange Act, the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, the Dodd-Frank Act and other applicable securities rules and regulations. In particular, we are subject to reporting obligations under Section 404 of the Sarbanes-Oxley Act that require us to include a management report on our internal control over financial reporting in our annual report, which contains management’s assessment of the effectiveness of our internal control over financial reporting, and are further required to adhere to the auditor attestation requirements with respect to the to the effectiveness of our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act.
37

Internal controls related to the operation of technology systems are critical to maintaining adequate internal control over financial reporting. As disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, during the fourth quarter of fiscal 2022, management identified a material weakness in the design and operation of internal control related to information technology general controls (ITGCs) in the areas of user access and program change-management over certain information technology (IT) systems that support our financial reporting processes. We have begun the process of designing and implementing measures to improve our internal controls over financial reporting and to remediate this material weakness. While there can be no assurance that our efforts will be successful, we plan to remediate this material weakness during fiscal 2023. Our ability to comply with the annual internal control report requirements will depend on the effectiveness of our financial reporting and data systems and controls across our company. We expect these systems and controls to involve significant expenditures and to may become more complex as our business grows. To effectively manage this complexity, we will need to continue to improve our operational, financial, and management controls, and our reporting systems and procedures. Our inability to successfully remediate our existing or any future material weaknesses or other deficiencies in our internal control over financial reporting or any failure to implement required new or improved controls, or difficulties encountered in the implementation or operation of these controls, could harm our operating results and cause us to fail to meet our financial reporting obligations or result in material misstatements in our financial statements, which could limit our liquidity and access to capital markets, adversely affect our business and investor confidence in our financial statements, and adversely impact our stock price.
Future legislative or regulatory changes affecting the markets in which we operate could impair our business and operations.
The markets in which we operate are highly regulated, and any future changes in the regulatory landscape could have a material effect on our business and financial condition. For example, the Medicare program, is a subject of significant legislative and regulatory focus, and we cannot anticipate how future changes in government policy may affect our business and operations. Any future changes in the legislation and regulations that govern these markets, may require us to adapt our business to the new circumstances and we may be unable to do so in a manner that does not adversely affect our business and operations.
We are subject to extensive regulations regarding the use and disclosure of confidential personal information and failure to comply with these regulations could cause us to incur liabilities and expenses.
We are subject to a wide array of federal and state laws and regulations regarding the use and disclosure of confidential personal information and security. For example, the federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), as amended, and related state laws subject us to substantial restrictions and requirements with respect to the use and disclosure of the personal health information that we obtain in connection with our contracts with CMS and we must establish administrative, physical and technical safeguards to protect the confidentiality of this information. Similar protections extend to the type of personal financial and other information we acquire from our student loan, state tax and federal receivables clients. We are required to notify affected individuals and government agencies of data security breaches involving protected health and certain personally identifiable information. These laws and regulations also require that we develop, implement and maintain written, comprehensive information security programs containing safeguards that are appropriate to protect personally identifiable information or health information against unauthorized access, misuse, destruction or modification. Federal law generally does not preempt state law in the area of protection of personal information, and as a result we must also comply with state laws and regulations. Regulation of privacy, data use and security require that we incur significant expenses, which could increase in the future as a result of additional regulations, all of which adversely affects our results of operations. Failure to comply with these laws and regulations can result in penalties and in some cases expose us to civil lawsuits.
38

Our legacy student loan recovery business is subject to extensive regulation and consumer protection laws and our failure to comply with these regulations and laws may subject us to liability and result in significant costs.
Our student loan recovery business is subject to regulation and oversight by various state and federal agencies, particularly in the area of consumer protection. The Fair Debt Collection Practices Act (FDCPA), and related state laws provide specific guidelines that we must follow in communicating with holders of student loans and regulates the manner in which we can recover defaulted student loans. Some state attorney generals have been active in this area of consumer protection regulation. We are subject, and may be subject in the future, to inquiries and audits from state and federal regulators, as well as frequent litigation from private plaintiffs regarding compliance under the FDCPA and related state regulations. We are also subject to the Fair Credit Reporting Act (FCRA), which regulates consumer credit reporting and may impose liability on us to the extent adverse credit information reported to a credit bureau is false or inaccurate. Our compliance with the FDCPA, FCRA and other federal and state regulations that affect our student loan recovery business may result in significant costs, including litigation costs. We are also subject to regulations promulgated by the United States Consumer Financial Protection Bureau (CFPB), which, among other things, establishes regulations regarding consumer financial protection laws. In addition, the CFPB has investigatory and enforcement authority with respect to whether persons are engaged in unlawful acts or practices in connection with the collection of consumer debts.
Risks Related to our Common Stock
The price of our common stock could be volatile, and you may not be able to sell your shares at or above the public offering price.
Since our initial public offering in August 2012, the price of our common stock, as reported by NASDAQ Global Select Market, has ranged from a low sales price of $0.54 on June 1, 2020 to a high sales price of $14.09 on March 4, 2013. The trading price of our common stock may be significantly affected by various factors, including: quarterly fluctuations in our operating results; the financial projections we may provide to the public, any changes in those projections or our failure to meet those projections; changes in investors’ and analysts’ perception of the business risks and conditions of our business; our ability to meet the earnings estimates and other performance expectations of financial analysts or investors; unfavorable commentary or downgrades of our stock by equity research analysts; changes in our capital structure, such as future issuances of debt or equity securities; our success or failure to obtain new contract awards; lawsuits threatened or filed against us; strategic actions by us or our competitors, such as acquisitions or restructurings; new legislation or regulatory actions; changes in our relationship with any of our significant clients; fluctuations in the stock prices of our peer companies or in stock markets in general; and general economic conditions.
Our significant stockholders have the ability to influence significant corporate activities and our significant stockholders' interests may not coincide with yours.
Prescott Group Management, L.L.C., First Light Asset Management, LLC, Parthenon Capital Partners, and Mill Road Capital Management LLC beneficially owned approximately 20.5%, 12.0%, 5.2% and 4.6% of our common stock, respectively, as of September 30, 2023. As a result of their ownership, these significant stockholders have the ability to influence the outcome of matters submitted to a vote of stockholders and, through our board of directors, the ability to influence decision making with respect to our business direction and policies. Mill Road Capital Management LLC currently has a representative sitting on our Board of Directors. These significant stockholders may have interests different from our other stockholders’ interests and may vote in a manner adverse to those interests. Matters over which these significant stockholders can, directly or indirectly, exercise influence include:
• mergers and other business combination transactions, including proposed transactions that would result in our
stockholders receiving a premium price for their shares;
• other acquisitions or dispositions of businesses or assets;
• incurrence of indebtedness and the issuance of equity securities;
• repurchase of stock and payment of dividends; and
• the issuance of shares to management under our equity incentive plans.
39

In addition, even though Parthenon Capital Partners does not currently have a representative sitting on our Board of Directors, Parthenon Capital Partners does have a contractual right to designate a number of directors proportionate to its stock ownership if and when Parthenon owns greater than 10% of our common stock. Further, under our amended and restated certificate of incorporation, Parthenon Capital Partners does not have any obligation to present to us, and Parthenon Capital Partners may separately pursue, corporate opportunities of which it becomes aware, even if those opportunities are ones that we would have pursued if granted the opportunity.
General Risks
We may undertake strategic transactions or other corporate restructuring that prove unsuccessful, strain or divert our resources and harm our results of operations and stock price.
We may consider strategic transactions or other corporate restructurings that could include the acquisition of other companies in our industry or in new markets, or the sale or divestiture of, or the wind down of existing portions of our business. We may not be able to successfully complete any such strategic transaction and, if completed, any such acquisition or divestiture may fail to achieve the intended financial results. We may not be able to successfully integrate any acquired businesses with our own and we may be unable to maintain our standards, controls and policies. Further, acquisitions may place additional constraints on our resources by diverting the attention of our management from other business concerns. Moreover, any acquisition may result in a potentially dilutive issuance of equity securities, the incurrence of additional debt, the amortization expenses related to intangible assets, and the potential impairment charges related to intangible assets or goodwill, all of which could adversely affect our results of operations and stock price. Further, despite any projected cost savings related to any proposed divestiture or wind down of any existing portion of our business, any such divestiture or wind down could result in an adverse effect on our revenues and results of operations.
Our business may be harmed if we lose members of our management team or other key employees.
We are highly dependent on members of our management team and other key employees and our future success depends in part on our ability to retain these people. Our inability to continue to attract and retain members of our management team and other key employees could adversely affect our business, financial condition and results of operations.
Anti-takeover provisions contained in our certificate of incorporation and bylaws could impair a takeover attempt that our stockholders may find beneficial.
Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could have the effect of rendering more difficult or discouraging an acquisition deemed undesirable by our board of directors. Our corporate governance documents include the following provisions: establishing a classified board of directors so that not all members of our board are elected at one time; providing that directors may be removed by stockholders only for cause; authorizing blank check preferred stock, which could be issued with voting, liquidation, dividend and other rights superior to our common stock; limiting the ability of our stockholders to call and bring business before special meetings and to take action by written consent in lieu of a meeting; limiting our ability to engage in certain business combinations with any “interested stockholder,” other than Parthenon Capital Partners, for a three-year period following the time that the stockholder became an interested stockholder; requiring advance notice of stockholder proposals for business to be conducted at meetings of our stockholders and for nominations of candidates for election to our board of directors; requiring a super majority vote for certain amendments to our amended and restated certificate of incorporation and amended and restated bylaws; and limiting the determination of the number of directors on our board of directors and the filling of vacancies or newly created seats on the board, to our board of directors then in office. These provisions, alone or together, could have the effect of delaying or deterring a change in control, could limit the opportunity for our stockholders to receive a premium for their shares of our common stock, and could also affect the price that some investors are willing to pay for our common stock.
40

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
    None.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
    None.
ITEM 4. MINE SAFETY DISCLOSURES
    Not Applicable.
ITEM 5. OTHER INFORMATION
(c)
During the three months ended September 30, 2023, no director or officer (as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934) of our Company adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities, whether or not intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
41

ITEM 6. EXHIBITS
(A) Exhibits:
Exhibit No.Description
31.1
31.2
32.1(1)
32.2(1)
101.INS(2)
XBRL Instance Document
101.SCH(2)
XBRL Taxonomy Extension Scheme
101.CAL(2)
XBRL Taxonomy Extension Calculation Linkbase
101.DEF(2)
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB(2)
XBRL Taxonomy Extension Label Linkbase
101.PRE(2)
XBRL Taxonomy Extension Presentation Linkbase
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
(1)The material contained in Exhibit 32.1 and Exhibit 32.2 is not deemed “filed” with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing, except to the extent that the registrant specifically incorporates it by reference.
(2)In accordance with Rule 406T of Regulation S-T, the information furnished in these exhibits will not be deemed “filed” for purposes of Section 18 of the Exchange Act. Such exhibits will not be deemed to be incorporated by reference into any filing under the Securities Act or Exchange Act.
42

    Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 PERFORMANT FINANCIAL CORPORATION
Date:November 9, 2023  
 By: /s/ Simeon M. Kohl
  
Simeon M. Kohl
 Chief Executive Officer (Principal Executive Officer)
 By: /s/ Rohit Ramchandani
  Rohit Ramchandani
  Chief Financial Officer
43
EX-31.1 2 ex093023311cert.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, Simeon M. Kohl, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Performant Financial Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2023
/s/ Simeon M. Kohl
Simeon M. Kohl
Chief Executive Officer

EX-31.2 3 ex093023312cert.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION

I, Rohit Ramchandani, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Performant Financial Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: November 9, 2023
/s/ Rohit Ramchandani
Rohit Ramchandani
Chief Financial Officer (Principal Financial Officer)

EX-32.1 4 ex093023321cert.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Simeon M. Kohl, Chief Executive Officer of Performant Financial Corporation, do hereby certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Performant Financial Corporation on Form 10-Q for the quarter ended September 30, 2023 to which this certification is attached fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Performant Financial Corporation.
Date: November 9, 2023
By:
/s/ Simeon M. Kohl
Simeon M. Kohl
Chief Executive Officer


EX-32.2 5 ex093023322cert.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Rohit Ramchandani, Chief Financial Officer (Principal Financial Officer) of Performant Financial Corporation, do hereby certify to the best of my knowledge, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Performant Financial Corporation on Form 10-Q for the quarter ended September 30, 2023 to which this certification is attached fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Performant Financial Corporation.
Date: November 9, 2023
By:
/s/ Rohit Ramchandani
Rohit Ramchandani
Chief Financial Officer (Principal Financial Officer)



EX-101.SCH 6 pfmt-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Organization and Description of Business link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Property, Equipment, and Leasehold Improvements link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Net Income (Loss) per Share link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Organization and Description of Business (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Organization and Description of Business (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Property, Equipment, and Leasehold Improvements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Net Income (Loss) per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Organization and Description of Business - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Property, Equipment, and Leasehold Improvements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Notes Payable - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Notes Payable - Schedule of Outstanding Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Notes Payable - Schedule of Outstanding Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Notes Payable - Schedule of Maturities of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Leases - Schedule of Lease Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 pfmt-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 pfmt-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 pfmt-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Pay vs Performance Disclosure [Line Items] Accrued liabilities, current Accrued Liabilities, Current Statistical Measurement [Domain] Statistical Measurement [Domain] Maximum borrowing capacity under credit facility Line of Credit Facility, Maximum Borrowing Capacity Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Award Type [Domain] Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Outstanding at beginning of period (in shares) Outstanding at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Debt instrument, interest rate Line of Credit Facility, Interest Rate at Period End Notes Payable Debt Disclosure [Text Block] Units withheld for taxes (in usd per share) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Withheld For Taxes, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Withheld For Taxes, Weighted Average Grant Date Fair Value Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Weighted average remaining contractual life (Years) Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Accounts payable Accounts Payable, Current Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Computer hardware and software Computer Equipment [Member] Restatement Determination Date: Restatement Determination Date [Axis] Other liabilities Increase (Decrease) in Other Noncurrent Liabilities Commitments and contingencies (note 3 and note 4) Commitments and Contingencies Lessee, Operating Lease, Liability, Payment, Due [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Insider Trading Policies and Procedures [Line Items] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Five Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Vested, exercisable, expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Other assets Increase (Decrease) in Other Noncurrent Assets Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Income Taxes Income Tax Disclosure [Text Block] Premium insurance financing payables Premium Insurance Financing Payables Premium Insurance Financing Payables Current liabilities: Liabilities, Current [Abstract] Goodwill, accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Debt issuance costs, net of current portion Debt Issuance Costs, Noncurrent, Net Subsequent Event Type [Domain] Subsequent Event Type [Domain] Weighted average grant date fair value per share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Non-cash impairment charge Impairment, Long-Lived Asset, Held-for-Use Diluted (in usd per share) Earnings Per Share, Diluted PEO Total Compensation Amount PEO Total Compensation Amount Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Trade accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Vested, exercisable, expected to vest (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Balance at beginning of period (in shares) Balance at end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Proceeds from exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Letters of credit Letters of Credit Outstanding, Amount Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Net loss Net loss Net loss Net Income (Loss) Income tax receivable Increase (Decrease) in Income Taxes Receivable Total current liabilities Liabilities, Current SOFR Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name Leases Lessee, Operating Leases [Text Block] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Proceeds from exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Options vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Executive Category: Executive Category [Axis] Notes payable, net of current portion and unamortized debt issuance costs of $423 and $316, respectively Notes Payable, Noncurrent Number of Awards Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Exercised (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Name Measure Name Claims-based Claims-based [Member] Claims-based Name Forgone Recovery, Individual Name Revolving Loan Commitment Revolving Loan Commitment [Member] Revolving Loan Commitment Goodwill Goodwill Goodwill Schedule of Property, Equipment, and Leasehold Improvements Property, Plant and Equipment [Table Text Block] Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Underlying Securities Award Underlying Securities Amount Entity Small Business Entity Small Business Local Phone Number Local Phone Number Trade accounts receivable Increase (Decrease) in Accounts Receivable Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Remainder of 2023 Long-Term Debt, Maturity, Remainder of Fiscal Year Warrants outstanding Warrant [Member] Lease liabilities Operating Lease, Liability, Noncurrent Gain on sale of certain recovery contracts Gain on sale of certain recovery contracts Gain (Loss) On Sale Of Recovery Contracts Gain (Loss) On Sale Of Recovery Contracts Restricted cash Restricted cash Restricted Cash and Cash Equivalents, Current Restricted Stock Units (RSUs) RSUs Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Debt issuance costs paid Payments of Debt Issuance Costs Units withheld for taxes (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instrument Other Than Options, Withheld For Taxes Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instrument Other Than Options, Withheld For Taxes Term Loan Term Loan [Member] Term Loan Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Outstanding Debt Schedule of Long-Term Debt Instruments [Table Text Block] Less unamortized discount and issuance costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Healthcare Total Health Care [Member] Schedule of Maturities of Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Product and Service [Domain] Product and Service [Domain] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Schedule of Lease Cost Lease, Cost [Table Text Block] Contract assets Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Antidilutive securities (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Award Type [Axis] Award Type [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Document Quarterly Report Document Quarterly Report Debt prepayment costs Payment for Debt Extinguishment or Debt Prepayment Cost Income tax receivable Income Taxes Receivable, Current Interest expense Interest Expense Property, equipment and leasehold improvements, gross Property, Plant and Equipment, Gross Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Trading Arrangement: Trading Arrangement [Axis] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected to vest (in usd per share) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Price Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Price Entity File Number Entity File Number Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Restricted Stock Activity Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Lease liabilities Operating Lease, Liability, Current Entity Shell Company Entity Shell Company 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Aggregate principal amount Line of Credit Facility, Increase (Decrease), Net Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Operating lease expense Operating Lease, Cost Impairment of Goodwill and Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Weighted average shares Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Common stock, issued shares (in shares) Common Stock, Shares, Issued Vested and converted to shares, net of units withheld for taxes (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Contract liabilities Contract liabilities Contract with Customer, Liability, Current Security Exchange Name Security Exchange Name Notes payable, net of unamortized discount and issuance costs Long-Term Debt Employee Stock Option Options to purchase common stock Employee Stock Option [Member] Unrecognized compensation expense, recognition term Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Maximum Maximum [Member] Workers' compensation liability, incurred Workers' Compensation Liability, Incurred Workers' Compensation Liability, Incurred Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Document Type Document Type Tabular List, Table Tabular List [Table Text Block] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Subsequent Event [Table] Subsequent Event [Table] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Weighted average exercise price per share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Allowance for doubtful accounts Accounts Receivable, Allowance for Credit Loss, Current Subsequent Event Subsequent Event [Member] Other current liabilities Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Income Statement [Abstract] Income Statement [Abstract] Contract assets Increase (Decrease) in Contract with Customer, Asset Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Title of 12(b) Security Title of 12(b) Security Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Wells Fargo Bank Wells Fargo Bank [Member] Wells Fargo Bank Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Outstanding at beginning of period (in usd per share) Outstanding at end of period (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Customer Care / Outsourced Services Customer Care And Outsourced Services [Member] Customer Care And Outsourced Services [Member] Common stock issued under stock plans, net of shares withheld for employee taxes Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Proceeds from sale of certain recovery contracts Proceeds From Sale Of Recovery Contracts Proceeds From Sale Of Recovery Contracts Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Entity Tax Identification Number Entity Tax Identification Number Statistical Measurement [Axis] Statistical Measurement [Axis] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Debt instrument interest rate floor rate Debt Instrument Interest Rate Floor Rate Debt Instrument, Interest Rate, Floor Rate Accumulated deficit Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Name Outstanding Recovery, Individual Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current assets: Assets, Current [Abstract] Leases [Abstract] Leases [Abstract] Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Debt issuance costs, current portion Debt Issuance Costs, Current, Net Cash paid for amounts included in the measurement of operating lease liabilities Operating Lease, Payments Common stock, outstanding shares (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Other operating expenses Other Cost and Expense, Operating Common stock, par or stated value per share (in usd per share) Common Stock, Par or Stated Value Per Share Estimated liability for appeals and disputes Estimated liability for appeals Estimated Litigation Liability, Current Net cash (used in) provided by investing activities Net Cash Provided by (Used in) Investing Activities Outstanding Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Debt Instrument [Axis] Debt Instrument [Axis] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Present value of lease liabilities Operating Lease, Liability Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Total liabilities Liabilities Amortization of principal, percentage Debt Instrument, Debt Covenant, Amortization Of Principal, Percentage Debt Instrument, Debt Covenant, Amortization Of Principal, Percentage Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Total leverage ratio Debt Instrument, Debt Covenant, Total Leverage Ratio Debt Instrument, Debt Covenant, Total Leverage Ratio Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Property, Equipment, and Leasehold Improvements Property, Plant and Equipment Disclosure [Text Block] All Executive Categories All Executive Categories [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Estimated liability for appeals, disputes, and refunds Increase (Decrease) In Estimated Liability For Appeals And Disputes Increase (Decrease) In Estimated Liability For Appeals And Disputes Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Net loss per share Earnings Per Share [Abstract] Earnings Per Share [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Common stock, $0.0001 par value. Authorized, 500,000 shares at September 30, 2023 and December 31, 2022 respectively; issued and outstanding 76,875 and 75,505 shares at September 30, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Right-of-use assets amortization Operating Lease, Right-of-Use Asset, Periodic Reduction Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current All Individuals All Individuals [Member] Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Entity Filer Category Entity Filer Category Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Aggregate Intrinsic Value (in thousands) Share Based Compensation Arrangement By Share Based Payment Award Intrinsic Value [Abstract] Share Based Compensation Arrangement by Share Based Payment Award Intrinsic Value [Abstract] PEO Name PEO Name Ratio as of December 31, 2023 Ratio As Of December 30, 2023 [Member] Ratio As Of December 30, 2023 Base Rate Base Rate [Member] Granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Prepaid expenses and other current assets, prepaid insurance Prepaid Insurance Expected to vest (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested And Expected To Vest, Number Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested And Expected To Vest, Number Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes Revenue Recognition, Interest [Policy Text Block] Stock-based compensation expense APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Redemption Period Three Debt Instrument, Redemption, Period Three [Member] Depreciation and amortization Depreciation and amortization expense Depreciation, Depletion and Amortization Loss on disposal of assets and impairment of long-lived assets Gain (Loss) on Sale of Assets and Asset Impairment Charges Furniture and equipment Furniture and Fixtures [Member] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Accrued salaries and benefits Increase (Decrease) in Employee Related Liabilities Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Proceeds from exercise of warrants Proceeds from Warrant Exercises Total stockholders’ equity Equity, Attributable to Parent The Credit Agreement The Credit Agreement [Member] The Credit Agreement Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Subsequent Events [Abstract] Subsequent Events [Abstract] Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Entity Emerging Growth Company Entity Emerging Growth Company Debt Leverage Ratio [Domain] Debt Leverage Ratio [Domain] Debt Leverage Ratio [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Schedule of Reconciliation of Basic to Diluted Weighted Average Shares Reconciliation Of Basic To Diluted Weighted Average Shares Table [Table Text Block] Reconciliation of basic to diluted weighted average shares. Document Fiscal Period Focus Document Fiscal Period Focus 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Title Trading Arrangement, Individual Title Balance at beginning of period (in usd per share) Balance at end of period (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Prior to earlier of December 31, 2023 Prior To Earlier Of December 31, 2023 [Member] Prior To Earlier Of December 31, 2023 Common Stock Common Stock [Member] Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Product and Service [Axis] Product and Service [Axis] Net Income (Loss) per Share Earnings Per Share [Text Block] Fixed charge coverage ratio Debt Instrument, Debt Covenant, Fixed Charge Coverage Ratio Debt Instrument, Debt Covenant, Fixed Charge Coverage Ratio Document Fiscal Year Focus Document Fiscal Year Focus Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Minimum Minimum [Member] Property, equipment, and leasehold improvements, net Property, equipment and leasehold improvements, net Property, Plant and Equipment, Net Organization and Description of Business Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Exercise Price Award Exercise Price Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Assets Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Lease liabilities Increase (Decrease) in Operating Lease Liability Taxes paid related to net share settlement of stock awards Payment, Tax Withholding, Share-Based Payment Arrangement Cash (received) paid for income taxes Income Taxes Paid, Net Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Accumulated Deficit Retained Earnings [Member] Less current maturities, net of unamortized discount and issuance costs Long-Term Debt, Current Maturities Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Debt Leverage Ratio [Axis] Debt Leverage Ratio [Axis] Debt Leverage Ratio Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Basic (in usd per share) Earnings Per Share, Basic Right-of-use assets Operating Lease, Right-of-Use Asset Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Basis of Presentation and Organization Consolidation, Policy [Policy Text Block] Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Termination Date Trading Arrangement Termination Date Accounts payable Increase (Decrease) in Accounts Payable Common stock, authorized shares (in shares) Common Stock, Shares Authorized Repayment of notes payable Repayments Of Long Term Notes Payable Repayments of long term notes payable. Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Total notes payable Long-Term Debt, Gross Recovery Recovery [Member] Recovery [Member] Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Current maturities of notes payable, net of unamortized debt issuance costs of $78 and $17, respectively Notes Payable, Current All Adjustments to Compensation All Adjustments to Compensation [Member] Award Timing Disclosures [Line Items] Building and leasehold improvements Building And Leasehold Improvements [Member] Building and leasehold improvements. Compensation Amount Outstanding Recovery Compensation Amount MUFG Union Bank, N.A. MUFG Union Bank, N.A. [Member] MUFG Union Bank, N.A. Prepaid expenses and other current assets, prepaid software licenses and maintenance agreement Prepaid Expense And Other Assets, Prepaid Software Licenses And Maintenance Agreements Prepaid Expense And Other Assets, Prepaid Software Licenses And Maintenance Agreements Forfeited (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Subsequent Event Type [Axis] Subsequent Event Type [Axis] New Credit Agreement New Credit Agreement [Member] New Credit Agreement Forfeited (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Prepaid expenses and other current assets Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Insider Trading Arrangements [Line Items] 2024 Long-Term Debt, Maturity, Year One Interest expense from debt issuance costs Interest Expense, Debt Issuance Costs And Amortization Interest expense from debt issuance costs and amortization of discount note payable. Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Redemption Period One Debt Instrument, Redemption, Period One [Member] Common stock issued under stock plans, net of shares withheld for employee taxes (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Simeon Kohl [Member] Simeon Kohl Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Dilutive effect of stock options (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Adjustment to Compensation, Amount Adjustment to Compensation Amount Proceeds from sales of property, equipment, and leasehold improvements Proceeds from Sale of Property, Plant, and Equipment Contract liabilities and other current liabilities Increase (Decrease) in Other Current Liabilities Document Period End Date Document Period End Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Adoption Date Trading Arrangement Adoption Date Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Exercisable (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Entity Central Index Key Entity Central Index Key Gain on sale of land and buildings Gain on sale of land and buildings Gain (Loss) on Disposition of Property Plant Equipment Total stock-based compensation expense Share-Based Payment Arrangement, Expense Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Provision for (benefit from) income taxes Income Tax Expense (Benefit) Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract] Ratio as of September 30, 2023 Ratio As Of September 30, 2023 [Member] Ratio As Of September 30, 2023 Accrued salaries and benefits Employee-related Liabilities, Current Number of operating segments Number of Operating Segments Name Trading Arrangement, Individual Name Schedule of Disaggregated Revenue by Category Disaggregation of Revenue [Table Text Block] Lender Name [Axis] Lender Name [Axis] Weighted Average Remaining Lease Term (in years) Operating Lease, Weighted Average Remaining Lease Term Revenues Total Revenues Revenue from Contract with Customer, Excluding Assessed Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Amendment Flag Amendment Flag Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Ian Johnston [Member] Ian Johnston Weighted Average Discount Rate Operating Lease, Weighted Average Discount Rate, Percent Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Redemption Period Four Debt Instrument, Redemption, Period Four [Member] Basis spread on variable rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Long-term notes payable, net of current maturities and unamortized discount and issuance costs Long-Term Debt, Excluding Current Maturities Diluted (in shares) Weighted average shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Operating expenses: Operating Expenses [Abstract] Purchase of property, equipment, and leasehold improvements Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid-In Capital Additional Paid-in Capital [Member] Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Cover [Abstract] Vested, exercisable, expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Subsequent Events Subsequent Events [Text Block] Prepaid expenses and other current assets, various other prepaid expenses Other Prepaid Expense, Current Salaries and benefits Labor and Related Expense Other liabilities Other Liabilities, Noncurrent Vested and converted to shares, net of units withheld for taxes (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Non-NEOs Non-NEOs [Member] Total undiscounted cash flows Lessee, Operating Lease, Liability, to be Paid Total operating expenses Operating Expenses Rohit Ramchandani [Member] Rohit Ramchandani Prime Rate Prime Rate [Member] Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Basic (in shares) Weighted average shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Loss from operations Operating Income (Loss) Redemption Period Two Debt Instrument, Redemption, Period Two [Member] Number of reporting units Number of Reporting Units Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Unused commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Statement [Line Items] Statement [Line Items] Vested, exercisable, expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restricted Stock and Performance Stock Units Restricted Stock and Performance Stock Units [Member] Restricted Stock and Performance Stock Units [Member] Eligibility-based Eligibility-based [Member] Eligibility-based Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Principal amount Principal amount Long-Term Line of Credit EX-101.PRE 10 pfmt-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover Page - shares
9 Months Ended
Sep. 30, 2023
Nov. 08, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 001-35628  
Entity Registrant Name PERFORMANT FINANCIAL CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-0484934  
Entity Address, Address Line One 900 South Pine Island Road,  
Entity Address, Address Line Two Suite 150  
Entity Address, City or Town Plantation  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33324  
City Area Code (925)  
Local Phone Number 960-4800  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $.0001 per share  
Trading Symbol PFMT  
Security Exchange Name NASDAQ  
Entity Common Stock, Shares Outstanding (in shares)   76,874,970
Entity Central Index Key 0001550695  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 17,308 $ 23,384
Restricted cash 81 81
Trade accounts receivable 14,129 15,794
Contract assets 6,850 11,460
Prepaid expenses and other current assets 3,104 3,665
Income tax receivable 516 3,123
Total current assets 41,988 57,507
Property, equipment, and leasehold improvements, net 9,790 10,897
Goodwill 47,372 47,372
Right-of-use assets 646 2,057
Other assets 914 1,000
Total assets 100,710 118,833
Current liabilities:    
Current maturities of notes payable, net of unamortized debt issuance costs of $78 and $17, respectively 1,672 983
Accrued salaries and benefits 5,643 6,938
Accounts payable 872 1,262
Other current liabilities 2,147 2,252
Contract liabilities 500 438
Estimated liability for appeals and disputes 906 1,106
Lease liabilities 333 1,228
Total current liabilities 12,073 14,207
Notes payable, net of current portion and unamortized debt issuance costs of $423 and $316, respectively 9,077 18,184
Lease liabilities 326 1,076
Other liabilities 903 881
Total liabilities 22,379 34,348
Commitments and contingencies (note 3 and note 4)
Stockholders’ equity:    
Common stock, $0.0001 par value. Authorized, 500,000 shares at September 30, 2023 and December 31, 2022 respectively; issued and outstanding 76,875 and 75,505 shares at September 30, 2023 and December 31, 2022, respectively 8 7
Additional paid-in capital 144,880 142,261
Accumulated deficit (66,557) (57,783)
Total stockholders’ equity 78,331 84,485
Total liabilities and stockholders’ equity $ 100,710 $ 118,833
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
shares in Thousands, $ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Debt issuance costs, current portion $ 78 $ 17
Debt issuance costs, net of current portion $ 423 $ 316
Common stock, par or stated value per share (in usd per share) $ 0.0001 $ 0.0001
Common stock, authorized shares (in shares) 500,000 500,000
Common stock, issued shares (in shares) 76,875 76,875
Common stock, outstanding shares (in shares) 75,505 75,505
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenues $ 29,962 $ 27,178 $ 81,176 $ 79,942
Operating expenses:        
Salaries and benefits 22,980 21,759 67,139 63,101
Other operating expenses 7,632 7,733 22,077 23,945
Total operating expenses 30,612 29,492 89,216 87,046
Loss from operations (650) (2,314) (8,040) (7,104)
Gain on sale of certain recovery contracts 0 0 3 382
Gain on sale of land and buildings 0 1,120 0 1,120
Interest expense (423) (277) (1,188) (648)
Interest income 86 0 86 0
Loss before provision for income taxes (987) (1,471) (9,139) (6,250)
Provision for (benefit from) income taxes (407) (11) (365) 52
Net loss $ (580) $ (1,460) $ (8,774) $ (6,302)
Net loss per share        
Basic (in usd per share) $ (0.01) $ (0.02) $ (0.12) $ (0.09)
Diluted (in usd per share) $ (0.01) $ (0.02) $ (0.12) $ (0.09)
Weighted average shares        
Basic (in shares) 76,454 74,021 75,907 72,480
Diluted (in shares) 76,454 74,021 75,907 72,480
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   69,281    
Beginning balance at Dec. 31, 2021 $ 82,423 $ 7 $ 133,662 $ (51,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued under stock plans, net of shares withheld for employee taxes (in shares)   1,068    
Common stock issued under stock plans, net of shares withheld for employee taxes 0      
Stock-based compensation expense 2,212   2,212  
Proceeds from exercise of stock options $ 5,563   5,563  
Proceeds from exercise of stock options (in shares) 3,863      
Net loss $ (6,302)     (6,302)
Ending balance (in shares) at Sep. 30, 2022   74,212    
Ending balance at Sep. 30, 2022 83,896 $ 7 141,437 (57,548)
Beginning balance (in shares) at Jun. 30, 2022   73,818    
Beginning balance at Jun. 30, 2022 84,425 $ 7 140,506 (56,088)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued under stock plans, net of shares withheld for employee taxes (in shares)   394    
Common stock issued under stock plans, net of shares withheld for employee taxes 0      
Stock-based compensation expense 931   931  
Net loss (1,460)     (1,460)
Ending balance (in shares) at Sep. 30, 2022   74,212    
Ending balance at Sep. 30, 2022 $ 83,896 $ 7 141,437 (57,548)
Beginning balance (in shares) at Dec. 31, 2022 75,505 75,505    
Beginning balance at Dec. 31, 2022 $ 84,485 $ 7 142,261 (57,783)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued under stock plans, net of shares withheld for employee taxes (in shares)   1,370    
Common stock issued under stock plans, net of shares withheld for employee taxes (195) $ 1 (196)  
Stock-based compensation expense 2,815   2,815  
Proceeds from exercise of stock options 0      
Net loss $ (8,774)     (8,774)
Ending balance (in shares) at Sep. 30, 2023 75,505 76,875    
Ending balance at Sep. 30, 2023 $ 78,331 $ 8 144,880 (66,557)
Beginning balance (in shares) at Jun. 30, 2023   76,088    
Beginning balance at Jun. 30, 2023 77,920 $ 7 143,890 (65,977)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued under stock plans, net of shares withheld for employee taxes (in shares)   787    
Common stock issued under stock plans, net of shares withheld for employee taxes (138) $ 1 (139)  
Stock-based compensation expense 1,129   1,129  
Net loss $ (580)     (580)
Ending balance (in shares) at Sep. 30, 2023 75,505 76,875    
Ending balance at Sep. 30, 2023 $ 78,331 $ 8 $ 144,880 $ (66,557)
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (8,774) $ (6,302)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Loss on disposal of assets and impairment of long-lived assets 258 40
Depreciation and amortization 3,805 3,355
Right-of-use assets amortization 1,411 841
Stock-based compensation 2,815 2,212
Interest expense from debt issuance costs 256 71
Gain on sale of certain recovery contracts (3) (382)
Gain on sale of land and buildings 0 (1,120)
Changes in operating assets and liabilities:    
Trade accounts receivable 1,665 4,958
Contract assets 4,610 (1,622)
Prepaid expenses and other current assets 561 682
Income tax receivable 2,607 (52)
Other assets 86 (7)
Accrued salaries and benefits (1,295) (1,944)
Accounts payable (390) (339)
Contract liabilities and other current liabilities (43) (1,515)
Estimated liability for appeals, disputes, and refunds (200) (42)
Lease liabilities (1,645) (997)
Other liabilities 23 (19)
Net cash provided by (used in) operating activities 5,747 (2,182)
Cash flows from investing activities:    
Purchase of property, equipment, and leasehold improvements (2,956) (2,198)
Proceeds from sale of certain recovery contracts 3 382
Proceeds from sales of property, equipment, and leasehold improvements 0 4,934
Net cash (used in) provided by investing activities (2,953) 3,118
Cash flows from financing activities:    
Repayment of notes payable (8,250) (375)
Debt issuance costs paid (424) (2)
Taxes paid related to net share settlement of stock awards (196) 0
Proceeds from exercise of warrants 0 5,563
Net cash (used in) provided by financing activities (8,870) 5,186
Net (decrease) increase in cash, cash equivalents and restricted cash (6,076) 6,122
Cash, cash equivalents and restricted cash at beginning of period 23,465 19,550
Cash, cash equivalents and restricted cash at end of period 17,389 25,672
Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets:    
Cash and cash equivalents 17,308 25,591
Restricted cash 81 81
Total cash, cash equivalents and restricted cash at end of period 17,389 25,672
Supplemental disclosures of cash flow information:    
Cash (received) paid for income taxes (2,904) 267
Cash paid for interest $ 1,084 $ 449
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Organization and Description of Business Organization and Description of Business
(a) Basis of Presentation and Organization
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim unaudited consolidated financial statements furnished herein include all adjustments necessary (consisting only of normal recurring adjustments) for a fair presentation of our financial position at September 30, 2023, and December 31, 2022, the results of our operations for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. Interim financial statements are prepared on a basis consistent with our annual consolidated financial statements. The interim financial statements included herein should be read in conjunction with the consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended December 31, 2022.
Performant Financial Corporation (the "Company", "we", or "our") is a leading provider of technology-enabled audit, recovery and analytics services in the United States with a focus in the healthcare payment integrity services industry. The Company works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. The Company engages clients in both government and commercial markets. Clients of the Company typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. The Company also has a call center which serves clients with multifaceted consumer engagement needs. The Company historically worked in recovery markets such as defaulted student loans, tax receivables, and commercial recovery.
The Company’s consolidated financial statements include the operations of Performant Financial Corporation (Performant), its wholly-owned subsidiary Performant Business Services, Inc. (PBS), and PBS's wholly-owned subsidiaries Performant Recovery, Inc. (PRI), dba Performant Healthcare Solutions, and Performant Technologies, LLC (PTL). Performant is a Delaware corporation headquartered in California and was formed in 2003. PBS is a Nevada corporation founded in 1997. PRI is a California corporation founded in 1976. PTL is a California limited liability company that was formed in 2004. All intercompany balances and transactions have been eliminated in consolidation.
The Company is managed and operated as one business, with a single management team that reports to the Chief Executive Officer.
The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, contract assets, goodwill, right-of-use assets, estimated liability for appeals and disputes, lease liabilities, other liabilities, provision for income taxes, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues. Actual amounts may differ from amounts presently estimated.
(b) Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes
The Company generally derives its revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.
The Company determines revenue recognition through the following steps:
Identification of the contract with a customer.
Identification of the performance obligations in the contract.
Determination of the transaction price.
Allocation of the transaction price to the performance obligations in the contract.
Recognition of revenue when, or as, the performance obligations are satisfied.
The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company’s contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to the client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.
The Company’s contracts are composed primarily of variable consideration. Fees earned under the Company’s audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.
The Company generally either applies the as-invoiced practical expedient where its right to consideration corresponds directly to its right to invoice its clients, or the variable consideration allocation exception where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such the Company has elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required.
The Company estimates variable consideration only if it can reasonably measure the progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognizes such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. The Company exercises judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. The Company reviews the constraint on variable consideration quarterly. While the Company believes the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration recognized.
For contracts that contain a refund right, the Company estimates its refund liability for each claim, as needed, and recognizes revenue net of such estimate.
Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on the Company’s performance under the specific contract. These performance-based bonuses are considered variable and may be constrained by the Company until there is not a risk of a significant reversal.
The Company has applied the as-invoiced practical expedient or the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.
For healthcare claims audit contracts, the Company may recognize revenue upon delivering its findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.
For eligibility-based or COB contracts, the Company recognizes revenue when insurance companies or other responsible parties have remitted payments to its clients.
For customer care / outsourced services clients, the Company recognizes revenues based on the volume of processed transactions or the quantity of labor hours provided.
The following table presents revenue disaggregated by category (in thousands) for the three and nine months ended September 30, 2023 and 2022:
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
 (in thousands)(in thousands)
Eligibility-based$18,165 $13,142 $44,776 $39,773 
Claims-based10,325 10,377 30,535 28,866 
Healthcare Total28,490 23,519 75,311 68,639 
Recovery — 41 33 166 
Customer Care / Outsourced Services1,472 3,618 5,832 11,137 
Total Revenues$29,962 $27,178 $81,176 $79,942 
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022.
Contract assets were $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to the Company’s rights to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time.
Contract assets primarily consist of commissions the Company estimates it has earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.
Contract assets are recorded to accounts receivable when the Company's right to payment becomes unconditional, which is generally when healthcare providers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.
Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively.
Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute the Company’s findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents the Company’s best estimate of the amount probable of being refunded to the Company’s healthcare clients.
(c) Prepaid Expenses and Other Current Assets
At September 30, 2023, prepaid expenses and other current assets were $3.1 million and included approximately $2.3 million related to prepaid software licenses and maintenance agreements, $0.1 million for prepaid insurance, and $0.7 million for various other prepaid expenses. At December 31, 2022, prepaid expenses and other current assets were $3.7 million and included approximately $1.5 million related to prepaid software licenses and maintenance agreements, $1.8 million for prepaid insurance, and $0.4 million for various other prepaid expenses.
(d) Impairment of Goodwill and Long-Lived Assets
The balance of goodwill was $47.4 million as of September 30, 2023 and $47.4 million as of December 31, 2022, which was net of accumulated impairment loss of $34.2 million. Goodwill is reviewed for impairment at least annually in December or as certain events or conditions arise during the year. The Company may first assess qualitative factors for indicators of impairment to determine whether it is necessary to perform the quantitative goodwill impairment test. Based on management’s assessment, there were no indicators of impairment and therefore there was no goodwill impairment during the three and nine months ended September 30, 2023.
If a quantitative assessment of goodwill is required, goodwill is considered impaired when the carrying value of the Company, as one reporting unit, exceeds its fair value. The amount of impairment loss is measured as the difference between the carrying value and the fair value of the reporting unit. Impairment testing is based upon the best information available and estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. Significant assumptions and estimates are required, including, but not limited to, our market capitalization, projecting future cash flows and other assumptions, to estimate the fair value of the reporting unit.
Long-lived assets and intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. There was no impairment during the three and nine months ended September 30, 2023.
(e) Other Current Liabilities
As of September 30, 2023, other current liabilities primarily included $1.7 million for services received for which we have not received an invoice, and $0.4 million for estimated workers' compensation claims incurred but not reported, third party fees, and accrued interest under our MUFG Credit Agreement (as defined below in Note 3). As of December 31, 2022, other current liabilities primarily included $1.8 million for services received for which we have not received an invoice, and $0.5 million for accrued interest under our MUFG Credit Agreement, estimated workers' compensation claims incurred but not reported and third party fees and equipment financing payables.
(f) New Accounting Pronouncements
In February 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842) – Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842).” This ASU provides updated guidance on how an entity should measure credit losses on financial instruments, including trade receivables, held at the reporting date. The amendments make each Topic easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. It also addresses transition and open effective date information for Topic 842. ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11 and ASU 2020-02 (collectively, “ASC 326”) are effective for public entities for fiscal years beginning after December 15, 2019, except for Smaller Reporting Companies. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company's adoption of this ASU had no impact on our financial position, results of operations, or cash flows.
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Property, Equipment, and Leasehold Improvements
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Property, Equipment, and Leasehold Improvements Property, Equipment, and Leasehold Improvements
Property, equipment, and leasehold improvements consist of the following at September 30, 2023 and December 31, 2022 (in thousands):
September 30,
2023
December 31,
2022
Building and leasehold improvements$3,703 $3,785 
Furniture and equipment3,091 3,094 
Computer hardware and software77,604 76,906 
84,398 83,785 
Less accumulated depreciation and amortization(74,608)(72,888)
Property, equipment and leasehold improvements, net$9,790 $10,897 
Depreciation and amortization expense was $1.3 million and $1.1 million for the three months ended September 30, 2023 and 2022, respectively, and $3.8 million and $3.4 million for the nine months ended September 30, 2023 and 2022, respectively.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Notes Payable
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Notes Payable Notes Payable
On October 27, 2023, the Company entered into a new credit agreement (the "New Credit Agreement" as defined below in Note 8).
As of September 30, 2023 and December 31, 2022, $11.3 million and $19.5 million, respectively, was outstanding under the Company's credit agreement with MUFG Union Bank, N.A. (as amended the "MUFG Credit Agreement"). The Company’s interest rate under the MUFG Credit Agreement at September 30, 2023 and December 31, 2022 was 11.5% and 7.5%, respectively.
On December 17, 2021, the Company entered into a credit agreement with MUFG Union Bank, N.A. The MUFG Credit Agreement includes a $20 million term loan commitment, which was fully advanced at closing and a $15 million revolving loan commitment. Subject to certain customary exceptions, the obligations under the MUFG Credit Agreement are, or will be, guaranteed by each of the Company’s existing and future, direct or indirect, domestic subsidiaries. The obligations of the Company under the MUFG Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its domestic subsidiaries that are guarantors under the MUFG Credit Agreement.
On March 13, 2023, the Company entered into a First Amendment to the MUFG Credit Agreement (the “First Amendment”) to amend the MUFG Credit Agreement to, among other things, terminate the revolving loan commitment in full and to establish a new maturity date of December 31, 2024 for the term loan. As a result of the First Amendment to the MUFG Credit Agreement, the Company does not have any further borrowing capacity under the MUFG Credit Agreement. In connection with the First Amendment, the Company voluntarily prepaid $7.5 million of the outstanding principal of the term loan.
Pursuant to the MUFG Credit Agreement, after giving effect to the First Amendment described above, the Company is required to repay the aggregate outstanding principal amount of the term loan under the MUFG Credit Agreement in quarterly installments commencing March 31, 2022 in an amount that would result in amortization of (a) 2.5% of the original term loan principal in the first full year following commencement of amortization, (b) 5.0% of the original term loan principal in the second full year following commencement of amortization, and (c) 10.0% of the original term loan principal in the third full year following commencement of amortization. In addition, the Company must make mandatory prepayments of the term loan principal under the MUFG Credit Agreement with the net cash proceeds received in connection with certain specified events, including certain asset sales, casualty and condemnation events (subject to customary reinvestment rights). Any remaining outstanding principal balance of the term loan under the MUFG Credit Agreement is repayable on the maturity date. Amounts repaid or prepaid by the Company with respect to the term loan under the MUFG Credit Agreement cannot be reborrowed.
Under the MUFG Credit Agreement, after giving effect to the First Amendment described above, the term loan generally may bear interest based on term SOFR (the secured overnight financing right) or a prime rate, as applicable, plus an applicable margin based on the Company’s leverage ratio each quarter that may range between 2.50% per annum and 4.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 3.00% per annum in the case of base rate loans. The prime rate was approximately 8.5% as of September 30, 2023. In addition, a commitment fee based on the unused availability if there are outstanding revolving loan commitments is also payable which may vary from 0.30% per annum to 0.50% per annum, also
based on the Company’s leverage ratio, however, the revolving commitment was terminated in connection with the First Amendment described above.
The MUFG Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including, incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The MUFG Credit Agreement, after giving effect to the First Amendment described above, also contains financial covenants, which require the Company to maintain, as of the last day of each fiscal quarter commencing (a) as of September 30, 2023, a total leverage ratio of not greater than (i) 10.00 to 1.00, (b) as of December 31, 2023 and as of the last day of each fiscal quarter thereafter, (i) a total leverage ratio of not greater than 2.50 to 1.00, and (ii) a fixed charge coverage ratio of not less than 1.20 to 1.00 and (c) prior to the earlier December 31, 2023 and the date that the Company’s leverage ratio is not greater than 2.50 to 1.00 and its fixed charge coverage ratio is not less than 1.20 to 1.00, a minimum amount of unrestricted cash subject to a perfected security interest in favor of MUFG Union Bank, N.A. more specifically set forth in the MUFG Credit Agreement. The obligations under the MUFG Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the MUFG Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.
Other than the terms relating to the First Amendment as set forth above, the terms of the original MUFG Credit Agreement remained in full force and effect as of September 30, 2023.
As a result of the New Credit Agreement, the terms of the MUFG Credit Agreement are no longer in effect as of October 27, 2023. Refer to Subsequent Events in Note 8 for details.
Outstanding debt obligations were as follows (in thousands):
September 30, 2023December 31, 2022
Principal amount$11,250 $19,500 
Less unamortized discount and issuance costs(501)(333)
Notes payable, net of unamortized discount and issuance costs10,749 19,167 
Less current maturities, net of unamortized discount and issuance costs(1,672)(983)
Long-term notes payable, net of current maturities and unamortized discount and issuance costs$9,077 $18,184 
The following is a schedule, by years, of maturities of notes payable as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$250 
202411,000 
Total notes payable$11,250 
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases Leases
The Company has entered into various non-cancelable operating lease agreements for office facilities and equipment with lease periods expiring between 2023 and 2028. Certain of these arrangements have free rent periods and/or escalating rent payment provisions. As such, the Company recognizes rent expense under such arrangements on a straight-line basis. Some leases include options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. Leases with an initial term of twelve months or less are not recorded on the balance sheet.
Operating lease expense was $0.2 million and $0.5 million for the three months ended September 30, 2023 and 2022, respectively, and $0.7 million and $1.6 million for the nine months ended September 30, 2023 and 2022, respectively.
Supplemental other information related to operating leases were as follows:
September 30,
2023
December 31,
2022
Weighted Average Remaining Lease Term (in years)2.72.2
Weighted Average Discount Rate5.3%6.2%
Supplemental cash flow information related to operating leases were as follows:
September 30,
2023
September 30,
2022
Cash paid for amounts included in the measurement of operating lease liabilities$0.2 million $0.5 million
The following is a schedule, by years, of maturities of lease liabilities as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$189 
2024$212 
2025$139 
2026$61 
2027$60 
2028$52 
Total undiscounted cash flows$713 
Less imputed interest$(54)
Present value of lease liabilities$659 
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
(a) Stock Options
Total stock-based compensation expense charged as salaries and benefits expense in the consolidated statements of operations was $1.1 million and $0.9 million for the three months ended September 30, 2023 and 2022 respectively, and $2.8 million and $2.2 million for the nine months ended September 30, 2023 and 2022, respectively.
The following table sets forth a summary of the Company's stock option activity for the nine months ended September 30, 2023:
Outstanding
Options
Weighted
average
exercise price
per share
Weighted
average
remaining
contractual life
(Years)
Aggregate
Intrinsic Value
(in thousands)
Outstanding at December 31, 2022250,000 $10.31 0.90$20 
Granted— — — 
Forfeited(178,000)12.16 — 
Exercised— — — 
Outstanding at September 30, 202372,000 $5.74 2.80$
Vested, exercisable, expected to vest(1) at September 30, 2023
72,000 $5.74 2.80$
Exercisable at September 30, 202372,000 $5.74 2.80$
 (1) Options expected to vest reflect an estimated forfeiture rate.
The Company recognizes share-based compensation costs as expense on a straight-line basis over the option vesting period, which generally is four years. As of September 30, 2023, all options have vested and there was no unrecognized compensation costs.
(b) Restricted Stock Units and Performance Stock Units
The following table summarizes restricted stock unit and performance stock unit activity for the nine months ended September 30, 2023:
Number of AwardsWeighted
average
grant date fair value
per share
Outstanding at December 31, 20223,904,606 $2.85 
Granted2,235,207 2.49 
Forfeited(136,806)3.37 
Vested and converted to shares, net of units withheld for taxes (1,369,862)2.46 
Units withheld for taxes(82,991)2.26 
Outstanding at September 30, 20234,550,154 $2.78 
Expected to vest at September 30, 20234,004,172 $2.78 
Restricted stock units and performance stock units granted under the Performant Financial Corporation Amended and Restated 2012 Stock Incentive Plan generally vest over periods between one year and four years.
As of September 30, 2023, there was approximately $10.5 million of total unrecognized compensation cost related to unvested restricted stock units granted to employees. This unrecognized compensation cost is expected to be recognized over an estimated weighted-average amortization period of approximately three years.
XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The Company's effective income tax rate was 4% for the nine months ended September 30, 2023 and (1)% for the nine months ended September 30, 2022. The primary driver of the effective income tax rate as of September 30, 2023 is the benefits realized related to the recognition of previously unrecognized tax benefits as a result of an audit closing, receipt of interest on tax refunds during the quarter, and overall losses from operations for the nine months ended September 30, 2023, for which no benefit is recognized due to valuation allowance. The primary driver of the effective income tax rate as of September 30, 2022 was the overall losses from operations for the nine months ended September 30, 2022, for which no benefit is recognized due to valuation allowance.
The Company files income tax returns with the U.S. federal government and various state jurisdictions. The Company operates in a number of state and local jurisdictions, most of which have never audited our records. Accordingly, the Company is subject to state and local income tax examinations based upon the various statutes of limitations in each jurisdiction. For tax years before 2018, the Company has been subject to examination and assessment to the extent of net operating losses carryback refunds requested. The federal examination by the Internal Revenue Service for the 2018 tax year concluded in July of 2023. As of September 30, 2023, the Company no longer has any ongoing audits.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net Income (Loss) per Share Net Income (Loss) per ShareFor the three and nine months ended September 30, 2023 and 2022, basic net income (loss) per share is calculated by dividing net income (loss) by the sum of the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is calculated by dividing net income by the weighted average number of shares of common stock and dilutive common share equivalents outstanding during the period. Common share equivalents consist of stock options, restricted stock units, performance stock units, and warrants. When there is a loss in the period, dilutive common share equivalents are excluded from the calculation of diluted earnings per share, as their effect would be anti-dilutive. For example, for the nine months ended September 30, 2023 and 2022, respectively, diluted weighted average shares outstanding are the same as basic average shares outstanding. When there is net income in the period, the Company excludes stock options, restricted stock units, performance stock units, and warrants from the calculation of diluted earnings per share when their combined exercise price and unamortized fair value exceeds the average market price of the Company's common stock because their effect would be anti-dilutive.
The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
Weighted average shares outstanding – basic76,454 74,021 75,907 72,480 
Dilutive effect of stock options— — — — 
Weighted average shares outstanding – diluted76,454 74,021 75,907 72,480 
Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):
September 30, 2023September 30, 2022
Options to purchase common stock72 250 
RSUs4,550 4,024 
Warrants outstanding— 2,447 
Total4,622 6,721 
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
The Company has evaluated subsequent events through the date these consolidated financial statements are filed with the Securities and Exchange Commission and identified the following event, which did not require adjustments to the consolidated financial statements.
On October 27, 2023 (the “Closing Date”), the Company entered into a new credit agreement with Wells Fargo Bank, National Association (the “New Credit Agreement”). The New Credit Agreement includes a $25 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and contract assets, of which $5.0 million was advanced on the Closing Date. A portion of the revolving loan commitment of up to $2.5 million is available for the issuance of letters of credit. Subject to certain customary exceptions, the Company’s existing and future, direct or indirect, domestic subsidiaries will be jointly and severally obligated as borrowers or guarantors for the obligations under the New Credit Agreement. The obligations of the Company under the New Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its existing subsidiaries (and subject to customary exceptions, will be secured by the assets of future subsidiaries).
The New Credit Agreement matures on October 27, 2026. A portion of the proceeds from the initial borrowing under the New Credit Agreement were used by the Company, together with cash on hand, to refinance its MUFG Credit Agreement (Note 3), and to pay fees and expenses in connection with the New Credit Agreement.
The Company may, at its option, prepay borrowings under the New Credit Agreement, in whole or in part, at any time and from time to time without premium or penalty (except in certain circumstances). Borrowings under the New Credit Agreement are also subject to mandatory prepayment in the event that outstanding borrowings and letter of credit usage exceed the lesser of the aggregate revolving loan commitments and the borrowing base then in effect.
The Company may also increase commitments under the New Credit Agreement in an aggregate principal amount of up to $10 million by obtaining additional commitments from lenders, subject to obtaining commitments from any participating lenders and certain other conditions. Under the New Credit Agreement, loans generally may bear interest based on term SOFR (the secured overnight financing right) or an annual base rate, as applicable, plus, in each case, an applicable margin based on the Company’s average borrowing availability each quarter under the New Credit Agreement that may range between 2.50% per annum and 3.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 2.00% per annum in the case of base rate loans. In addition, a commitment fee of 0.50% per annum based on unused availability of the credit facility is also payable.
The New Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including,
incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The New Credit Agreement also contains financial covenants, which require the Company to maintain a minimum amount of liquidity and a consolidated fixed charge coverage ratio of not less than 1.25 to 1.00, provided that the fixed charge coverage ratio is only applicable when borrowing availability falls below a certain threshold. The obligations under the New Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the New Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.On the Closing Date, the Company terminated the MUFG Credit Agreement. As a result, all outstanding obligations of the Company under the MUFG Credit Agreement have been paid.
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure        
Net loss $ (580) $ (1,460) $ (8,774) $ (6,302)
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Simeon Kohl [Member]  
Trading Arrangements, by Individual  
Arrangement Duration 731 days
Rohit Ramchandani [Member]  
Trading Arrangements, by Individual  
Arrangement Duration 731 days
Ian Johnston [Member]  
Trading Arrangements, by Individual  
Arrangement Duration 731 days
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Presentation and Organization Basis of Presentation and Organization
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim unaudited consolidated financial statements furnished herein include all adjustments necessary (consisting only of normal recurring adjustments) for a fair presentation of our financial position at September 30, 2023, and December 31, 2022, the results of our operations for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. Interim financial statements are prepared on a basis consistent with our annual consolidated financial statements. The interim financial statements included herein should be read in conjunction with the consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended December 31, 2022.
Performant Financial Corporation (the "Company", "we", or "our") is a leading provider of technology-enabled audit, recovery and analytics services in the United States with a focus in the healthcare payment integrity services industry. The Company works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. The Company engages clients in both government and commercial markets. Clients of the Company typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. The Company also has a call center which serves clients with multifaceted consumer engagement needs. The Company historically worked in recovery markets such as defaulted student loans, tax receivables, and commercial recovery.
The Company’s consolidated financial statements include the operations of Performant Financial Corporation (Performant), its wholly-owned subsidiary Performant Business Services, Inc. (PBS), and PBS's wholly-owned subsidiaries Performant Recovery, Inc. (PRI), dba Performant Healthcare Solutions, and Performant Technologies, LLC (PTL). Performant is a Delaware corporation headquartered in California and was formed in 2003. PBS is a Nevada corporation founded in 1997. PRI is a California corporation founded in 1976. PTL is a California limited liability company that was formed in 2004. All intercompany balances and transactions have been eliminated in consolidation.
The Company is managed and operated as one business, with a single management team that reports to the Chief Executive Officer.
The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, contract assets, goodwill, right-of-use assets, estimated liability for appeals and disputes, lease liabilities, other liabilities, provision for income taxes, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues. Actual amounts may differ from amounts presently estimated.
Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes
The Company generally derives its revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.
The Company determines revenue recognition through the following steps:
Identification of the contract with a customer.
Identification of the performance obligations in the contract.
Determination of the transaction price.
Allocation of the transaction price to the performance obligations in the contract.
Recognition of revenue when, or as, the performance obligations are satisfied.
The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
The Company’s contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to the client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.
The Company’s contracts are composed primarily of variable consideration. Fees earned under the Company’s audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.
The Company generally either applies the as-invoiced practical expedient where its right to consideration corresponds directly to its right to invoice its clients, or the variable consideration allocation exception where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such the Company has elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required.
The Company estimates variable consideration only if it can reasonably measure the progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognizes such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. The Company exercises judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. The Company reviews the constraint on variable consideration quarterly. While the Company believes the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration recognized.
For contracts that contain a refund right, the Company estimates its refund liability for each claim, as needed, and recognizes revenue net of such estimate.
Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on the Company’s performance under the specific contract. These performance-based bonuses are considered variable and may be constrained by the Company until there is not a risk of a significant reversal.
The Company has applied the as-invoiced practical expedient or the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.
For healthcare claims audit contracts, the Company may recognize revenue upon delivering its findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.
For eligibility-based or COB contracts, the Company recognizes revenue when insurance companies or other responsible parties have remitted payments to its clients.
For customer care / outsourced services clients, the Company recognizes revenues based on the volume of processed transactions or the quantity of labor hours provided.
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022.
Contract assets were $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to the Company’s rights to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time.
Contract assets primarily consist of commissions the Company estimates it has earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.
Contract assets are recorded to accounts receivable when the Company's right to payment becomes unconditional, which is generally when healthcare providers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.
Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively.
Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute the Company’s findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents the Company’s best estimate of the amount probable of being refunded to the Company’s healthcare clients.
Impairment of Goodwill and Long-Lived Assets Goodwill is reviewed for impairment at least annually in December or as certain events or conditions arise during the year. The Company may first assess qualitative factors for indicators of impairment to determine whether it is necessary to perform the quantitative goodwill impairment test. Based on management’s assessment, there were no indicators of impairment and therefore there was no goodwill impairment during the three and nine months ended September 30, 2023.If a quantitative assessment of goodwill is required, goodwill is considered impaired when the carrying value of the Company, as one reporting unit, exceeds its fair value. The amount of impairment loss is measured as the difference between the carrying value and the fair value of the reporting unit. Impairment testing is based upon the best information available and estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. Significant assumptions and estimates are required, including, but not limited to, our market capitalization, projecting future cash flows and other assumptions, to estimate the fair value of the reporting unit.Long-lived assets and intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. There was no impairment during the three and nine months ended September 30, 2023.
New Accounting Pronouncements New Accounting PronouncementsIn February 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842) – Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842).” This ASU provides updated guidance on how an entity should measure credit losses on financial instruments, including trade receivables, held at the reporting date. The amendments make each Topic easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. It also addresses transition and open effective date information for Topic 842. ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11 and ASU 2020-02 (collectively, “ASC 326”) are effective for public entities for fiscal years beginning after December 15, 2019, except for Smaller Reporting Companies. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company's adoption of this ASU had no impact on our financial position, results of operations, or cash flows.
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Disaggregated Revenue by Category
The following table presents revenue disaggregated by category (in thousands) for the three and nine months ended September 30, 2023 and 2022:
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
 (in thousands)(in thousands)
Eligibility-based$18,165 $13,142 $44,776 $39,773 
Claims-based10,325 10,377 30,535 28,866 
Healthcare Total28,490 23,519 75,311 68,639 
Recovery — 41 33 166 
Customer Care / Outsourced Services1,472 3,618 5,832 11,137 
Total Revenues$29,962 $27,178 $81,176 $79,942 
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Property, Equipment, and Leasehold Improvements (Tables)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property, Equipment, and Leasehold Improvements Property, equipment, and leasehold improvements consist of the following at September 30, 2023 and December 31, 2022 (in thousands):
September 30,
2023
December 31,
2022
Building and leasehold improvements$3,703 $3,785 
Furniture and equipment3,091 3,094 
Computer hardware and software77,604 76,906 
84,398 83,785 
Less accumulated depreciation and amortization(74,608)(72,888)
Property, equipment and leasehold improvements, net$9,790 $10,897 
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Notes Payable (Tables)
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Outstanding Debt
Outstanding debt obligations were as follows (in thousands):
September 30, 2023December 31, 2022
Principal amount$11,250 $19,500 
Less unamortized discount and issuance costs(501)(333)
Notes payable, net of unamortized discount and issuance costs10,749 19,167 
Less current maturities, net of unamortized discount and issuance costs(1,672)(983)
Long-term notes payable, net of current maturities and unamortized discount and issuance costs$9,077 $18,184 
Schedule of Maturities of Long-term Debt
The following is a schedule, by years, of maturities of notes payable as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$250 
202411,000 
Total notes payable$11,250 
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Lease Cost
Supplemental other information related to operating leases were as follows:
September 30,
2023
December 31,
2022
Weighted Average Remaining Lease Term (in years)2.72.2
Weighted Average Discount Rate5.3%6.2%
Supplemental cash flow information related to operating leases were as follows:
September 30,
2023
September 30,
2022
Cash paid for amounts included in the measurement of operating lease liabilities$0.2 million $0.5 million
Schedule of Maturities of Lease Liabilities
The following is a schedule, by years, of maturities of lease liabilities as of September 30, 2023 (in thousands):
Year Ending December 31,Amount
Remainder of 2023$189 
2024$212 
2025$139 
2026$61 
2027$60 
2028$52 
Total undiscounted cash flows$713 
Less imputed interest$(54)
Present value of lease liabilities$659 
XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table sets forth a summary of the Company's stock option activity for the nine months ended September 30, 2023:
Outstanding
Options
Weighted
average
exercise price
per share
Weighted
average
remaining
contractual life
(Years)
Aggregate
Intrinsic Value
(in thousands)
Outstanding at December 31, 2022250,000 $10.31 0.90$20 
Granted— — — 
Forfeited(178,000)12.16 — 
Exercised— — — 
Outstanding at September 30, 202372,000 $5.74 2.80$
Vested, exercisable, expected to vest(1) at September 30, 2023
72,000 $5.74 2.80$
Exercisable at September 30, 202372,000 $5.74 2.80$
 (1) Options expected to vest reflect an estimated forfeiture rate.
Schedule of Restricted Stock Activity The following table summarizes restricted stock unit and performance stock unit activity for the nine months ended September 30, 2023:
Number of AwardsWeighted
average
grant date fair value
per share
Outstanding at December 31, 20223,904,606 $2.85 
Granted2,235,207 2.49 
Forfeited(136,806)3.37 
Vested and converted to shares, net of units withheld for taxes (1,369,862)2.46 
Units withheld for taxes(82,991)2.26 
Outstanding at September 30, 20234,550,154 $2.78 
Expected to vest at September 30, 20234,004,172 $2.78 
XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Basic to Diluted Weighted Average Shares The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):
 Three Months Ended  
September 30,
Nine Months Ended  
September 30,
 2023202220232022
Weighted average shares outstanding – basic76,454 74,021 75,907 72,480 
Dilutive effect of stock options— — — — 
Weighted average shares outstanding – diluted76,454 74,021 75,907 72,480 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):
September 30, 2023September 30, 2022
Options to purchase common stock72 250 
RSUs4,550 4,024 
Warrants outstanding— 2,447 
Total4,622 6,721 
XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business - Narrative (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2023
USD ($)
Sep. 30, 2023
USD ($)
segment
reporting_unit
Dec. 31, 2022
USD ($)
Accounting Policies [Abstract]      
Number of operating segments | segment   1  
Allowance for doubtful accounts $ 0 $ 0 $ 0
Contract assets 6,850,000 6,850,000 11,460,000
Contract liabilities 500,000 500,000 438,000
Estimated liability for appeals 906,000 906,000 1,106,000
Prepaid expenses and other current assets 3,104,000 3,104,000 3,665,000
Prepaid expenses and other current assets, prepaid software licenses and maintenance agreement 2,300,000 2,300,000 1,500,000
Prepaid expenses and other current assets, prepaid insurance 100,000 100,000 1,800,000
Prepaid expenses and other current assets, various other prepaid expenses 700,000 700,000 400,000
Goodwill 47,372,000 47,372,000 47,372,000
Goodwill, accumulated impairment loss 34,200,000 $ 34,200,000 34,200,000
Number of reporting units | reporting_unit   1  
Non-cash impairment charge 0 $ 0  
Accrued liabilities, current 1,700,000 1,700,000 1,800,000
Workers' compensation liability, incurred $ 400,000 $ 400,000  
Premium insurance financing payables     $ 500,000
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Total Revenues $ 29,962 $ 27,178 $ 81,176 $ 79,942
Healthcare Total        
Disaggregation of Revenue [Line Items]        
Total Revenues 28,490 23,519 75,311 68,639
Eligibility-based        
Disaggregation of Revenue [Line Items]        
Total Revenues 18,165 13,142 44,776 39,773
Claims-based        
Disaggregation of Revenue [Line Items]        
Total Revenues 10,325 10,377 30,535 28,866
Recovery        
Disaggregation of Revenue [Line Items]        
Total Revenues 0 41 33 166
Customer Care / Outsourced Services        
Disaggregation of Revenue [Line Items]        
Total Revenues $ 1,472 $ 3,618 $ 5,832 $ 11,137
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property, equipment and leasehold improvements, gross $ 84,398 $ 83,785
Less accumulated depreciation and amortization (74,608) (72,888)
Property, equipment and leasehold improvements, net 9,790 10,897
Building and leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property, equipment and leasehold improvements, gross 3,703 3,785
Furniture and equipment    
Property, Plant and Equipment [Line Items]    
Property, equipment and leasehold improvements, gross 3,091 3,094
Computer hardware and software    
Property, Plant and Equipment [Line Items]    
Property, equipment and leasehold improvements, gross $ 77,604 $ 76,906
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Property, Equipment, and Leasehold Improvements - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Property, Plant and Equipment [Abstract]        
Depreciation and amortization expense $ 1,300 $ 1,100 $ 3,805 $ 3,355
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Notes Payable - Narrative (Details) - USD ($)
$ in Thousands
9 Months Ended
Mar. 13, 2023
Dec. 17, 2021
Sep. 30, 2023
Dec. 31, 2022
Line of Credit Facility [Line Items]        
Principal amount     $ 11,250 $ 19,500
MUFG Union Bank, N.A. | Ratio as of September 30, 2023        
Line of Credit Facility [Line Items]        
Total leverage ratio     10.00  
MUFG Union Bank, N.A. | Ratio as of December 31, 2023        
Line of Credit Facility [Line Items]        
Total leverage ratio     2.50  
Fixed charge coverage ratio     1.20  
MUFG Union Bank, N.A. | Prior to earlier of December 31, 2023        
Line of Credit Facility [Line Items]        
Total leverage ratio     2.50  
Fixed charge coverage ratio     1.20  
MUFG Union Bank, N.A. | Minimum        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (as a percent)     2.50%  
Unused commitment fee percentage   0.30%    
MUFG Union Bank, N.A. | Maximum        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (as a percent)     4.00%  
Unused commitment fee percentage   0.50%    
MUFG Union Bank, N.A. | Base Rate | Minimum        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (as a percent)     1.50%  
MUFG Union Bank, N.A. | Base Rate | Maximum        
Line of Credit Facility [Line Items]        
Basis spread on variable rate (as a percent)     3.00%  
MUFG Union Bank, N.A. | Prime Rate        
Line of Credit Facility [Line Items]        
Debt instrument interest rate floor rate     8.50%  
MUFG Union Bank, N.A. | Redemption Period One        
Line of Credit Facility [Line Items]        
Amortization of principal, percentage   2.50%    
MUFG Union Bank, N.A. | Redemption Period Two        
Line of Credit Facility [Line Items]        
Amortization of principal, percentage   5.00%    
MUFG Union Bank, N.A. | Redemption Period Three        
Line of Credit Facility [Line Items]        
Amortization of principal, percentage   10.00%    
MUFG Union Bank, N.A. | Redemption Period Four        
Line of Credit Facility [Line Items]        
Amortization of principal, percentage   10.00%    
The Credit Agreement        
Line of Credit Facility [Line Items]        
Principal amount     $ 11,300 $ 19,500
Debt instrument, interest rate     11.50% 7.50%
Term Loan | MUFG Union Bank, N.A.        
Line of Credit Facility [Line Items]        
Principal amount   $ 20,000    
Debt prepayment costs $ 7,500      
Revolving Loan Commitment | MUFG Union Bank, N.A.        
Line of Credit Facility [Line Items]        
Maximum borrowing capacity under credit facility   $ 15,000    
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Notes Payable - Schedule of Outstanding Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Disclosure [Abstract]    
Principal amount $ 11,250 $ 19,500
Less unamortized discount and issuance costs (501) (333)
Notes payable, net of unamortized discount and issuance costs 10,749 19,167
Less current maturities, net of unamortized discount and issuance costs (1,672) (983)
Long-term notes payable, net of current maturities and unamortized discount and issuance costs $ 9,077 $ 18,184
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Notes Payable - Schedule of Maturities of Long-term Debt (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Debt Disclosure [Abstract]  
Remainder of 2023 $ 250
2024 11,000
Total notes payable $ 11,250
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases [Abstract]        
Operating lease expense $ 0.2 $ 0.5 $ 0.7 $ 1.6
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Leases [Abstract]      
Weighted Average Remaining Lease Term (in years) 2 years 8 months 12 days   2 years 2 months 12 days
Weighted Average Discount Rate 5.30%   6.20%
Cash paid for amounts included in the measurement of operating lease liabilities $ 0.2 $ 0.5  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Leases - Schedule of Maturities of Lease Liabilities (Details)
$ in Thousands
Sep. 30, 2023
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
Remainder of 2023 $ 189
2024 212
2025 139
2026 61
2027 60
2028 52
Total undiscounted cash flows 713
Less imputed interest (54)
Present value of lease liabilities $ 659
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total stock-based compensation expense $ 1,100,000 $ 900,000 $ 2,800,000 $ 2,200,000
Employee Stock Option        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options vesting period     4 years  
Unrecognized compensation expense 0   $ 0  
Restricted Stock and Performance Stock Units | Minimum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options vesting period     1 year  
Restricted Stock and Performance Stock Units | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Options vesting period     4 years  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Unrecognized compensation expense $ 10,500,000   $ 10,500,000  
Unrecognized compensation expense, recognition term     3 years  
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Outstanding Options      
Exercised (in shares)   (3,863,000)  
Options to purchase common stock      
Outstanding Options      
Balance at beginning of period (in shares) 250,000    
Granted (in shares) 0    
Forfeited (in shares) (178,000)    
Exercised (in shares) 0    
Balance at end of period (in shares) 72,000   250,000
Vested, exercisable, expected to vest (in shares) 72,000    
Exercisable (in shares) 72,000    
Weighted average exercise price per share      
Balance at beginning of period (in usd per share) $ 10.31    
Granted (in usd per share) 0    
Forfeited (in usd per share) 12.16    
Exercised (in usd per share) 0    
Balance at end of period (in usd per share) 5.74   $ 10.31
Vested, exercisable, expected to vest (in usd per share) 5.74    
Exercisable (in usd per share) $ 5.74    
Weighted average remaining contractual life (Years)      
Outstanding 2 years 9 months 18 days   10 months 24 days
Vested, exercisable, expected to vest 2 years 9 months 18 days    
Exercisable 2 years 9 months 18 days    
Aggregate Intrinsic Value (in thousands)      
Outstanding $ 5   $ 20
Vested, exercisable, expected to vest 5    
Exercisable $ 5    
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) - Restricted Stock and Performance Stock Units
9 Months Ended
Sep. 30, 2023
$ / shares
shares
Number of Awards  
Outstanding at beginning of period (in shares) | shares 3,904,606
Granted (in shares) | shares 2,235,207
Forfeited (in shares) | shares (136,806)
Vested and converted to shares, net of units withheld for taxes (in shares) | shares (1,369,862)
Units withheld for taxes (in shares) | shares (82,991)
Outstanding at end of period (in shares) | shares 4,550,154
Expected to vest (in shares) | shares 4,004,172
Weighted average grant date fair value per share  
Outstanding at beginning of period (in usd per share) | $ / shares $ 2.85
Granted (in usd per share) | $ / shares 2.49
Forfeited (in usd per share) | $ / shares 3.37
Vested and converted to shares, net of units withheld for taxes (in usd per share) | $ / shares 2.46
Units withheld for taxes (in usd per share) | $ / shares 2.26
Outstanding at end of period (in usd per share) | $ / shares 2.78
Expected to vest (in usd per share) | $ / shares $ 2.78
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Income Taxes (Details)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]    
Effective income tax rate (as a percent) 4.00% (1.00%)
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Earnings Per Share [Abstract]        
Weighted average shares outstanding – basic (in shares) 76,454 74,021 75,907 72,480
Dilutive effect of stock options (in shares) 0 0 0 0
Weighted average shares outstanding – diluted (in shares) 76,454 74,021 75,907 72,480
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
shares in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 4,622 6,721
Options to purchase common stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 72 250
RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 4,550 4,024
Warrants outstanding    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities (in shares) 0 2,447
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events (Details)
Oct. 27, 2023
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2022
USD ($)
Subsequent Event [Line Items]      
Principal amount   $ 11,250,000 $ 19,500,000
Wells Fargo Bank | Subsequent Event      
Subsequent Event [Line Items]      
Fixed charge coverage ratio 1.25    
New Credit Agreement | Wells Fargo Bank | Subsequent Event      
Subsequent Event [Line Items]      
Maximum borrowing capacity under credit facility $ 25,000,000    
Principal amount 5,000,000    
Letters of credit 2,500,000    
Aggregate principal amount $ 10,000,000    
Unused commitment fee percentage 0.50%    
New Credit Agreement | Wells Fargo Bank | Subsequent Event | Minimum | SOFR      
Subsequent Event [Line Items]      
Basis spread on variable rate (as a percent) 2.50%    
New Credit Agreement | Wells Fargo Bank | Subsequent Event | Minimum | Base Rate      
Subsequent Event [Line Items]      
Basis spread on variable rate (as a percent) 1.50%    
New Credit Agreement | Wells Fargo Bank | Subsequent Event | Maximum | SOFR      
Subsequent Event [Line Items]      
Basis spread on variable rate (as a percent) 3.00%    
New Credit Agreement | Wells Fargo Bank | Subsequent Event | Maximum | Base Rate      
Subsequent Event [Line Items]      
Basis spread on variable rate (as a percent) 2.00%    
XML 51 pfmt-20230930_htm.xml IDEA: XBRL DOCUMENT 0001550695 2023-01-01 2023-09-30 0001550695 2023-11-08 0001550695 2023-09-30 0001550695 2022-12-31 0001550695 2023-07-01 2023-09-30 0001550695 2022-07-01 2022-09-30 0001550695 2022-01-01 2022-09-30 0001550695 us-gaap:CommonStockMember 2023-06-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001550695 us-gaap:RetainedEarningsMember 2023-06-30 0001550695 2023-06-30 0001550695 us-gaap:CommonStockMember 2022-06-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001550695 us-gaap:RetainedEarningsMember 2022-06-30 0001550695 2022-06-30 0001550695 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001550695 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001550695 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001550695 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001550695 us-gaap:CommonStockMember 2023-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001550695 us-gaap:RetainedEarningsMember 2023-09-30 0001550695 us-gaap:CommonStockMember 2022-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001550695 us-gaap:RetainedEarningsMember 2022-09-30 0001550695 2022-09-30 0001550695 us-gaap:CommonStockMember 2022-12-31 0001550695 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001550695 us-gaap:RetainedEarningsMember 2022-12-31 0001550695 us-gaap:CommonStockMember 2021-12-31 0001550695 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001550695 us-gaap:RetainedEarningsMember 2021-12-31 0001550695 2021-12-31 0001550695 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001550695 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001550695 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001550695 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001550695 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001550695 pfmt:EligibilityBasedMember 2023-07-01 2023-09-30 0001550695 pfmt:EligibilityBasedMember 2022-07-01 2022-09-30 0001550695 pfmt:EligibilityBasedMember 2023-01-01 2023-09-30 0001550695 pfmt:EligibilityBasedMember 2022-01-01 2022-09-30 0001550695 pfmt:ClaimsBasedMember 2023-07-01 2023-09-30 0001550695 pfmt:ClaimsBasedMember 2022-07-01 2022-09-30 0001550695 pfmt:ClaimsBasedMember 2023-01-01 2023-09-30 0001550695 pfmt:ClaimsBasedMember 2022-01-01 2022-09-30 0001550695 us-gaap:HealthCareMember 2023-07-01 2023-09-30 0001550695 us-gaap:HealthCareMember 2022-07-01 2022-09-30 0001550695 us-gaap:HealthCareMember 2023-01-01 2023-09-30 0001550695 us-gaap:HealthCareMember 2022-01-01 2022-09-30 0001550695 pfmt:RecoveryMember 2023-07-01 2023-09-30 0001550695 pfmt:RecoveryMember 2022-07-01 2022-09-30 0001550695 pfmt:RecoveryMember 2023-01-01 2023-09-30 0001550695 pfmt:RecoveryMember 2022-01-01 2022-09-30 0001550695 pfmt:CustomerCareAndOutsourcedServicesMember 2023-07-01 2023-09-30 0001550695 pfmt:CustomerCareAndOutsourcedServicesMember 2022-07-01 2022-09-30 0001550695 pfmt:CustomerCareAndOutsourcedServicesMember 2023-01-01 2023-09-30 0001550695 pfmt:CustomerCareAndOutsourcedServicesMember 2022-01-01 2022-09-30 0001550695 pfmt:BuildingAndLeaseholdImprovementsMember 2023-09-30 0001550695 pfmt:BuildingAndLeaseholdImprovementsMember 2022-12-31 0001550695 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001550695 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001550695 us-gaap:ComputerEquipmentMember 2023-09-30 0001550695 us-gaap:ComputerEquipmentMember 2022-12-31 0001550695 pfmt:TheCreditAgreementMember 2023-09-30 0001550695 pfmt:TheCreditAgreementMember 2022-12-31 0001550695 pfmt:TermLoanMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 pfmt:RevolvingLoanCommitmentMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 pfmt:TermLoanMember pfmt:MUFGUnionBankNAMember 2023-03-13 2023-03-13 0001550695 us-gaap:DebtInstrumentRedemptionPeriodOneMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 us-gaap:DebtInstrumentRedemptionPeriodTwoMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 us-gaap:DebtInstrumentRedemptionPeriodThreeMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 us-gaap:DebtInstrumentRedemptionPeriodFourMember pfmt:MUFGUnionBankNAMember 2021-12-17 0001550695 srt:MinimumMember pfmt:MUFGUnionBankNAMember 2023-01-01 2023-09-30 0001550695 srt:MaximumMember pfmt:MUFGUnionBankNAMember 2023-01-01 2023-09-30 0001550695 srt:MinimumMember pfmt:MUFGUnionBankNAMember us-gaap:BaseRateMember 2023-01-01 2023-09-30 0001550695 srt:MaximumMember pfmt:MUFGUnionBankNAMember us-gaap:BaseRateMember 2023-01-01 2023-09-30 0001550695 pfmt:MUFGUnionBankNAMember us-gaap:PrimeRateMember 2023-09-30 0001550695 srt:MinimumMember pfmt:MUFGUnionBankNAMember 2021-12-17 2021-12-17 0001550695 srt:MaximumMember pfmt:MUFGUnionBankNAMember 2021-12-17 2021-12-17 0001550695 pfmt:MUFGUnionBankNAMember pfmt:RatioAsOfSeptember302023Member 2023-09-30 0001550695 pfmt:MUFGUnionBankNAMember pfmt:RatioAsOfDecember302023Member 2023-09-30 0001550695 pfmt:MUFGUnionBankNAMember pfmt:PriorToEarlierOfDecember312023Member 2023-09-30 0001550695 us-gaap:EmployeeStockOptionMember 2022-12-31 0001550695 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001550695 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001550695 us-gaap:EmployeeStockOptionMember 2023-09-30 0001550695 pfmt:RestrictedStockandPerformanceStockUnitsMember 2022-12-31 0001550695 pfmt:RestrictedStockandPerformanceStockUnitsMember 2023-01-01 2023-09-30 0001550695 pfmt:RestrictedStockandPerformanceStockUnitsMember 2023-09-30 0001550695 srt:MinimumMember pfmt:RestrictedStockandPerformanceStockUnitsMember 2023-01-01 2023-09-30 0001550695 srt:MaximumMember pfmt:RestrictedStockandPerformanceStockUnitsMember 2023-01-01 2023-09-30 0001550695 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001550695 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001550695 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001550695 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001550695 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001550695 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001550695 us-gaap:WarrantMember 2023-01-01 2023-09-30 0001550695 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001550695 pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember 2023-10-27 0001550695 pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember 2023-10-27 2023-10-27 0001550695 srt:MinimumMember pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-27 2023-10-27 0001550695 srt:MaximumMember pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2023-10-27 2023-10-27 0001550695 srt:MinimumMember pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2023-10-27 2023-10-27 0001550695 srt:MaximumMember pfmt:NewCreditAgreementMember pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember us-gaap:BaseRateMember 2023-10-27 2023-10-27 0001550695 pfmt:WellsFargoBankMember us-gaap:SubsequentEventMember 2023-10-27 0001550695 pfmt:SimeonKohlMember 2023-07-01 2023-09-30 0001550695 pfmt:RohitRamchandaniMember 2023-07-01 2023-09-30 0001550695 pfmt:IanJohnstonMember 2023-07-01 2023-09-30 shares iso4217:USD iso4217:USD shares pfmt:segment pfmt:reporting_unit pure 0001550695 --12-31 2023 Q3 false P731D P731D P731D 10-Q true 2023-09-30 false 001-35628 PERFORMANT FINANCIAL CORPORATION DE 20-0484934 900 South Pine Island Road, Suite 150 Plantation FL 33324 (925) 960-4800 Yes Yes Accelerated Filer false true false Common Stock, par value $.0001 per share PFMT NASDAQ 76874970 17308000 23384000 81000 81000 14129000 15794000 6850000 11460000 3104000 3665000 516000 3123000 41988000 57507000 9790000 10897000 47372000 47372000 646000 2057000 914000 1000000 100710000 118833000 78000 17000 1672000 983000 5643000 6938000 872000 1262000 2147000 2252000 500000 438000 906000 1106000 333000 1228000 12073000 14207000 423000 316000 9077000 18184000 326000 1076000 903000 881000 22379000 34348000 0.0001 0.0001 500000000 500000000 76875000 76875000 75505000 75505000 8000 7000 144880000 142261000 -66557000 -57783000 78331000 84485000 100710000 118833000 29962000 27178000 81176000 79942000 22980000 21759000 67139000 63101000 7632000 7733000 22077000 23945000 30612000 29492000 89216000 87046000 -650000 -2314000 -8040000 -7104000 0 0 3000 382000 0 1120000 0 1120000 423000 277000 1188000 648000 86000 0 86000 0 -987000 -1471000 -9139000 -6250000 -407000 -11000 -365000 52000 -580000 -1460000 -8774000 -6302000 -0.01 -0.02 -0.12 -0.09 -0.01 -0.02 -0.12 -0.09 76454000 74021000 75907000 72480000 76454000 74021000 75907000 72480000 76088000 7000 143890000 -65977000 77920000 73818000 7000 140506000 -56088000 84425000 787000 1000 -139000 -138000 394000 0 1129000 1129000 931000 931000 -580000 -580000 -1460000 -1460000 76875000 8000 144880000 -66557000 78331000 74212000 7000 141437000 -57548000 83896000 75505000 7000 142261000 -57783000 84485000 69281000 7000 133662000 -51246000 82423000 1370000 1000 -196000 -195000 1068000 0 2815000 2815000 2212000 2212000 0 3863000 5563000 5563000 -8774000 -8774000 -6302000 -6302000 76875000 8000 144880000 -66557000 78331000 74212000 7000 141437000 -57548000 83896000 -8774000 -6302000 -258000 -40000 3805000 3355000 1411000 841000 2815000 2212000 256000 71000 3000 382000 0 1120000 -1665000 -4958000 -4610000 1622000 -561000 -682000 -2607000 52000 -86000 7000 -1295000 -1944000 -390000 -339000 -43000 -1515000 -200000 -42000 -1645000 -997000 23000 -19000 5747000 -2182000 2956000 2198000 3000 382000 0 4934000 -2953000 3118000 8250000 375000 424000 2000 196000 0 0 5563000 -8870000 5186000 -6076000 6122000 23465000 19550000 17389000 25672000 17308000 25591000 81000 81000 17389000 25672000 -2904000 267000 1084000 449000 Organization and Description of Business<div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Basis of Presentation and Organization</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim unaudited consolidated financial statements furnished herein include all adjustments necessary (consisting only of normal recurring adjustments) for a fair presentation of our financial position at September 30, 2023, and December 31, 2022, the results of our operations for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. Interim financial statements are prepared on a basis consistent with our annual consolidated financial statements. The interim financial statements included herein should be read in conjunction with the consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended December 31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performant Financial Corporation (the "Company", "we", or "our") is a leading provider of technology-enabled audit, recovery and analytics services in the United States with a focus in the healthcare payment integrity services industry. The Company works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. The Company engages clients in both government and commercial markets. Clients of the Company typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. The Company also has a call center which serves clients with multifaceted consumer engagement needs. The Company historically worked in recovery markets such as defaulted student loans, tax receivables, and commercial recovery. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s consolidated financial statements include the operations of Performant Financial Corporation (Performant), its wholly-owned subsidiary Performant Business Services, Inc. (PBS), and PBS's wholly-owned subsidiaries Performant Recovery, Inc. (PRI), dba Performant Healthcare Solutions, and Performant Technologies, LLC (PTL). Performant is a Delaware corporation headquartered in California and was formed in 2003. PBS is a Nevada corporation founded in 1997. PRI is a California corporation founded in 1976. PTL is a California limited liability company that was formed in 2004. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as one business, with a single management team that reports to the Chief Executive Officer.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, contract assets, goodwill, right-of-use assets, estimated liability for appeals and disputes, lease liabilities, other liabilities, provision for income taxes, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues. Actual amounts may differ from amounts presently estimated.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b) Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally derives its revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines revenue recognition through the following steps:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the contract with a customer.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the performance obligations in the contract.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Determination of the transaction price.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocation of the transaction price to the performance obligations in the contract.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognition of revenue when, or as, the performance obligations are satisfied.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to the client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts are composed primarily of variable consideration. Fees earned under the Company’s audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally either applies the as-invoiced practical expedient where its right to consideration corresponds directly to its right to invoice its clients, or the variable consideration allocation exception where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such the Company has elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates variable consideration only if it can reasonably measure the progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognizes such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. The Company exercises judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. The Company reviews the constraint on variable consideration quarterly. While the Company believes the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration recognized.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that contain a refund right, the Company estimates its refund liability for each claim, as needed, and recognizes revenue net of such estimate. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on the Company’s performance under the specific contract. These performance-based bonuses are considered variable and may be constrained by the Company until there is not a risk of a significant reversal.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied the as-invoiced practical expedient or the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For healthcare claims audit contracts, the Company may recognize revenue upon delivering its findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For eligibility-based or COB contracts, the Company recognizes revenue when insurance companies or other responsible parties have remitted payments to its clients.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For customer care / outsourced services clients, the Company recognizes revenues based on the volume of processed transactions or the quantity of labor hours provided.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by category (in thousands) for the three and nine months ended September 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended  <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended  <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eligibility-based</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,776 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims-based</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,519 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recovery </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Care / Outsourced Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,618 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,962 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,178 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,176 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,942 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets were $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to the Company’s rights to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily consist of commissions the Company estimates it has earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets are recorded to accounts receivable when the Company's right to payment becomes unconditional, which is generally when healthcare providers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute the Company’s findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents the Company’s best estimate of the amount probable of being refunded to the Company’s healthcare clients. </span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c) Prepaid Expenses and Other Current Assets</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2023, prepaid expenses and other current assets wer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e $3.1 million and included approximately $2.3 million related to prepaid software licenses and maintenance agreements, $0.1 million for prepaid insurance, and $0.7 million for various other prepaid expenses. At December 31, 2022, prepaid expenses and other current assets were $3.7 million and included approximately $1.5 million related to prepaid software licenses and maintenance agreements, $1.8 million for prepaid insurance, and $0.4 million for various other prepaid expenses.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d) Impairment of Goodwill and Long-Lived Assets </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The balance of goodwill was $47.4 million as of September 30, 2023 and $47.4 million as of December 31, 2022, which was net of accumulated impairment loss of $34.2 million. Goodwill is reviewed for impairment at least annually in December or as certain events or conditions arise during the year. The Company may first assess qualitative factors for indicators of impairment to determine whether it is necessary to perform the quantitative goodwill impairment test. Based on management’s assessment, there were no indicators of impairment and therefore there was no goodwill impairment during the three and nine months ended September 30, 2023.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a quantitative assessment of goodwill is required, goodwill is considered impaired when the carrying value of the Company, as one reporting unit, exceeds its fair value. The amount of impairment loss is measured as the difference between the carrying value and the fair value of the reporting unit. Impairment testing is based upon the best information available and estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. Significant assumptions and estimates are required, including, but not limited to, our market capitalization, projecting future cash flows and other assumptions, to estimate the fair value of the reporting unit.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets and intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. There was no impairment during the three and nine months ended September 30, 2023. </span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(e) Other Current Liabilities</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, other current liabilities primarily included $1.7 million for services received for which we have not received an invoice, and $0.4 million for estimated workers' compensation claims incurred but not reported, third party fees, and accrued interest under our MUFG Credit Agreement (as defined below in Note 3). As of December 31, 2022, other current liabilities primarily included $1.8 million for services received for which we have not received an invoice, and $0.5 million for accrued interest under our MUFG Credit Agreement, estimated workers' compensation claims incurred but not reported and third party fees and equipment financing payables. </span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(f) New Accounting Pronouncements</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842) – Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842).” This ASU provides updated guidance on how an entity should measure credit losses on financial instruments, including trade receivables, held at the reporting date. The amendments make each Topic easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. It also addresses transition and open effective date information for Topic 842. ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11 and ASU 2020-02 (collectively, “ASC 326”) are effective for public entities for fiscal years beginning after December 15, 2019, except for Smaller Reporting Companies. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company's adoption of this ASU had no impact on our financial position, results of operations, or cash flows.</span></div> Basis of Presentation and Organization<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. In the opinion of management, the interim unaudited consolidated financial statements furnished herein include all adjustments necessary (consisting only of normal recurring adjustments) for a fair presentation of our financial position at September 30, 2023, and December 31, 2022, the results of our operations for the three and nine months ended September 30, 2023 and 2022, and cash flows for the nine months ended September 30, 2023 and 2022. Interim financial statements are prepared on a basis consistent with our annual consolidated financial statements. The interim financial statements included herein should be read in conjunction with the consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended December 31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performant Financial Corporation (the "Company", "we", or "our") is a leading provider of technology-enabled audit, recovery and analytics services in the United States with a focus in the healthcare payment integrity services industry. The Company works with healthcare payers through claims auditing and eligibility-based (also known as coordination-of-benefits or COB) services to identify improper payments. The Company engages clients in both government and commercial markets. Clients of the Company typically operate in complex and highly regulated environments and contract for their payment integrity needs in order to reduce losses on improper healthcare payments. The Company also has a call center which serves clients with multifaceted consumer engagement needs. The Company historically worked in recovery markets such as defaulted student loans, tax receivables, and commercial recovery. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s consolidated financial statements include the operations of Performant Financial Corporation (Performant), its wholly-owned subsidiary Performant Business Services, Inc. (PBS), and PBS's wholly-owned subsidiaries Performant Recovery, Inc. (PRI), dba Performant Healthcare Solutions, and Performant Technologies, LLC (PTL). Performant is a Delaware corporation headquartered in California and was formed in 2003. PBS is a Nevada corporation founded in 1997. PRI is a California corporation founded in 1976. PTL is a California limited liability company that was formed in 2004. All intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is managed and operated as one business, with a single management team that reports to the Chief Executive Officer.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the consolidated financial statements, in conformity with U.S. GAAP, requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, primarily accounts receivable, contract assets, goodwill, right-of-use assets, estimated liability for appeals and disputes, lease liabilities, other liabilities, provision for income taxes, and disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenues. Actual amounts may differ from amounts presently estimated.</span></div> 1 Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally derives its revenues primarily from providing audit, recovery, and analytics services. Revenues are recognized upon completion of these services for its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines revenue recognition through the following steps:</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the contract with a customer.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Identification of the performance obligations in the contract.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Determination of the transaction price.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Allocation of the transaction price to the performance obligations in the contract.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recognition of revenue when, or as, the performance obligations are satisfied.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts generally contain a single performance obligation, delivered over time as a series of services that are substantially the same and have the same pattern of transfer to the client, as the promise to transfer the individual services is not separately identifiable from other promises in the contracts and, therefore, not distinct.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s contracts are composed primarily of variable consideration. Fees earned under the Company’s audit and recovery service contracts consist primarily of contingency fees based on a specified percentage of the amount the Company enables its clients to recover. The contingency fee percentage for a particular recovery depends on the type of recovery or claim facilitated.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally either applies the as-invoiced practical expedient where its right to consideration corresponds directly to its right to invoice its clients, or the variable consideration allocation exception where the variable consideration is attributable to one or more, but not all, of the services promised in a series of distinct services that form part of a single performance obligation. As such the Company has elected the optional exemptions related to the as-invoiced practical expedient and the variable consideration allocation exception whereby the disclosure of the amount of transaction price allocated to the remaining performance obligations is not required. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates variable consideration only if it can reasonably measure the progress toward complete satisfaction of the performance obligation using an output method based on reliable information, and recognizes such revenue over the performance period only if it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur. Any change made to the measure of progress toward complete satisfaction of our performance obligation is recorded as a change in estimate. The Company exercises judgment to estimate the amount of constraint on variable consideration based on the facts and circumstances of the relevant contract operations and availability and reliability of data. The Company reviews the constraint on variable consideration quarterly. While the Company believes the estimates made are reasonable and appropriate, different assumptions and estimates could materially impact the amount of variable consideration recognized.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts that contain a refund right, the Company estimates its refund liability for each claim, as needed, and recognizes revenue net of such estimate. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under certain contracts, consideration can include periodic performance-based bonuses which can be awarded based on the Company’s performance under the specific contract. These performance-based bonuses are considered variable and may be constrained by the Company until there is not a risk of a significant reversal.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has applied the as-invoiced practical expedient or the variable consideration allocation exception to contracts with performance obligations that have an average remaining duration of less than a year.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For healthcare claims audit contracts, the Company may recognize revenue upon delivering its findings from claims audits, when sufficient reliable information is available for estimating the variable consideration earned based on an output metric that reasonably measures the Company's satisfaction of its performance obligation.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For eligibility-based or COB contracts, the Company recognizes revenue when insurance companies or other responsible parties have remitted payments to its clients.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For customer care / outsourced services clients, the Company recognizes revenues based on the volume of processed transactions or the quantity of labor hours provided.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade accounts receivable are recorded at the invoiced amount and do not bear interest. Amounts collected on trade accounts receivable are included in cash used in operating activities in the consolidated statements of cash flows. The Company determines the allowance for doubtful accounts by specific identification. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0 as of September 30, 2023 and December 31, 2022. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets were $6.9 million and $11.5 million as of September 30, 2023 and December 31, 2022, respectively. Contract assets relate to the Company’s rights to consideration for services completed but not invoiced at the reporting date, and receipt of payment is conditional upon factors other than the passage of time. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily consist of commissions the Company estimates it has earned from claims audit findings submitted to healthcare clients. Changes in contract assets result from additional consideration earned for services provided, offset by amounts invoiced during the period.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets are recorded to accounts receivable when the Company's right to payment becomes unconditional, which is generally when healthcare providers have paid our clients. There was no impairment loss related to contract assets for the three and nine months ended September 30, 2023 and 2022.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities totaled $0.5 million and $0.4 million as of September 30, 2023 and December 31, 2022, respectively. </span></div>Healthcare providers of our clients have the right to appeal claims audit findings and may pursue additional appeals if the initial appeal is found in favor of healthcare clients. For COB contracts, insurance companies or other responsible parties may dispute the Company’s findings regarding our clients not being the primary payer of healthcare claims. Total estimated liability for appeals and disputes was $0.9 million as of September 30, 2023 and $1.1 million as of December 31, 2022. This represents the Company’s best estimate of the amount probable of being refunded to the Company’s healthcare clients. <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue disaggregated by category (in thousands) for the three and nine months ended September 30, 2023 and 2022:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:46.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.675%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.678%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended  <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended  <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eligibility-based</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,165 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,142 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,776 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims-based</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,490 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,519 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,311 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,639 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recovery </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer Care / Outsourced Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,618 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,832 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,137 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,962 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,178 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,176 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,942 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 18165000 13142000 44776000 39773000 10325000 10377000 30535000 28866000 28490000 23519000 75311000 68639000 0 41000 33000 166000 1472000 3618000 5832000 11137000 29962000 27178000 81176000 79942000 0 0 6900000 11500000 500000 400000 900000 1100000 3100000 2300000 100000 700000 3700000 1500000 1800000 400000 47400000 47400000 34200000 34200000 Goodwill is reviewed for impairment at least annually in December or as certain events or conditions arise during the year. The Company may first assess qualitative factors for indicators of impairment to determine whether it is necessary to perform the quantitative goodwill impairment test. Based on management’s assessment, there were no indicators of impairment and therefore there was no goodwill impairment during the three and nine months ended September 30, 2023.If a quantitative assessment of goodwill is required, goodwill is considered impaired when the carrying value of the Company, as one reporting unit, exceeds its fair value. The amount of impairment loss is measured as the difference between the carrying value and the fair value of the reporting unit. Impairment testing is based upon the best information available and estimates of fair value which incorporate assumptions marketplace participants would use in making their estimates of fair value. Significant assumptions and estimates are required, including, but not limited to, our market capitalization, projecting future cash flows and other assumptions, to estimate the fair value of the reporting unit.Long-lived assets and intangible assets that are subject to amortization are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets or intangibles may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to future undiscounted net cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. There was no impairment during the three and nine months ended September 30, 2023. 1 0 0 1700000 400000 1800000 500000 New Accounting PronouncementsIn February 2020, the Financial Accounting Standards Board (FASB) issued ASU 2020-02, “Financial Instruments - Credit Losses (Topic 326) and Leases (Topic 842) – Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 119 and Update to SEC Section on Effective Date Related to Accounting Standards Update No. 2016-02, Leases (Topic 842).” This ASU provides updated guidance on how an entity should measure credit losses on financial instruments, including trade receivables, held at the reporting date. The amendments make each Topic easier to understand and easier to apply by eliminating inconsistencies and providing clarifications. It also addresses transition and open effective date information for Topic 842. ASU 2016-13, ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11 and ASU 2020-02 (collectively, “ASC 326”) are effective for public entities for fiscal years beginning after December 15, 2019, except for Smaller Reporting Companies. This ASU is effective for the Company for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. The Company's adoption of this ASU had no impact on our financial position, results of operations, or cash flows. Property, Equipment, and Leasehold Improvements<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment, and leasehold improvements consist of the following at September 30, 2023 and December 31, 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,398 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and leasehold improvements, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense was $1.3 million and $1.1 million for the three months ended September 30, 2023 and 2022, respectively, and $3.8 million and $3.4 million for the nine months ended September 30, 2023 and 2022, respectively.</span></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, equipment, and leasehold improvements consist of the following at September 30, 2023 and December 31, 2022 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and leasehold improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,703 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,785 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,091 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware and software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,604 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,906 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,398 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,608)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, equipment and leasehold improvements, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,790 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,897 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 3703000 3785000 3091000 3094000 77604000 76906000 84398000 83785000 74608000 72888000 9790000 10897000 1300000 1100000 3800000 3400000 Notes Payable<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 27, 2023, the Company entered into a new credit agreement (the "New Credit Agreement" as defined below in Note 8).</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023 and December 31, 2022, $11.3 million and $19.5 million, respectively, was outstanding under the Company's credit agreement with MUFG Union Bank, N.A. (as amended the "MUFG Credit Agreement"). The Company’s interest rate under the MUFG Credit Agreement at September 30, 2023 and December 31, 2022 was 11.5% and 7.5%, respectively.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2021, the Company entered into a credit agreement with MUFG Union Bank, N.A. The MUFG Credit Agreement includes a $20 million term loan commitment, which was fully advanced at closing and a $15 million revolving loan commitment. Subject to certain customary exceptions, the obligations under the MUFG Credit Agreement are, or will be, guaranteed by each of the Company’s existing and future, direct or indirect, domestic subsidiaries. The obligations of the Company under the MUFG Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its domestic subsidiaries that are guarantors under the MUFG Credit Agreement.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 13, 2023, the Company entered into a First Amendment to the MUFG Credit Agreement (the “First Amendment”) to amend the MUFG Credit Agreement to, among other things, terminate the revolving loan commitment in full and to establish a new maturity date of December 31, 2024 for the term loan. As a result of the First Amendment to the MUFG Credit Agreement, the Company does not have any further borrowing capacity under the MUFG Credit Agreement. In connection with the First Amendment, the Company voluntarily prepaid $7.5 million of the outstanding principal of the term loan. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the MUFG Credit Agreement, after giving effect to the First Amendment described above, the Company is required to repay the aggregate outstanding principal amount of the term loan under the MUFG Credit Agreement in quarterly installments commencing March 31, 2022 in an amount that would result in amortization of (a) 2.5% of the original term loan principal in the first full year following commencement of amortization, (b) 5.0% of the original term loan principal in the second full year following commencement of amortization, and (c) 10.0% of the original term loan principal in the third full year following commencement of amortization. In addition, the Company must make mandatory prepayments of the term loan principal under the MUFG Credit Agreement with the net cash proceeds received in connection with certain specified events, including certain asset sales, casualty and condemnation events (subject to customary reinvestment rights). Any remaining outstanding principal balance of the term loan under the MUFG Credit Agreement is repayable on the maturity date. Amounts repaid or prepaid by the Company with respect to the term loan under the MUFG Credit Agreement cannot be reborrowed.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the MUFG Credit Agreement, after giving effect to the First Amendment described above, the term loan generally may bear interest based on term SOFR (the secured overnight financing right) or a prime rate, as applicable, plus an applicable margin based on the Company’s leverage ratio each quarter that may range between 2.50% per annum and 4.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 3.00% per annum in the case of base rate loans. The prime rate was approximately 8.5% as of September 30, 2023. In addition, a commitment fee based on the unused availability if there are outstanding revolving loan commitments is also payable which may vary from 0.30% per annum to 0.50% per annum, also </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based on the Company’s leverage ratio, however, the revolving commitment was terminated in connection with the First Amendment described above.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The MUFG Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including, incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The MUFG Credit Agreement, after giving effect to the First Amendment described above, also contains financial covenants, which require the Company to maintain, as of the last day of each fiscal quarter commencing (a) as of September 30, 2023, a total leverage ratio of not greater than (i) 10.00 to 1.00, (b) as of December 31, 2023 and as of the last day of each fiscal quarter thereafter, (i) a total leverage ratio of not greater than 2.50 to 1.00, and (ii) a fixed charge coverage ratio of not less than 1.20 to 1.00 and (c) prior to the earlier December 31, 2023 and the date that the Company’s leverage ratio is not greater than 2.50 to 1.00 and its fixed charge coverage ratio is not less than 1.20 to 1.00, a minimum amount of unrestricted cash subject to a perfected security interest in favor of MUFG Union Bank, N.A. more specifically set forth in the MUFG Credit Agreement. The obligations under the MUFG Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the MUFG Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the terms relating to the First Amendment as set forth above, the terms of the original MUFG Credit Agreement remained in full force and effect as of September 30, 2023. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the New Credit Agreement, the terms of the MUFG Credit Agreement are no longer in effect as of October 27, 2023. Refer to Subsequent Events in Note 8 for details. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding debt obligations were as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,167 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities, net of unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes payable, net of current maturities and unamortized discount and issuance costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,077 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,184 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule, by years, of maturities of notes payable as of September 30, 2023 (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 11300000 19500000 19500000 0.115 0.075 20000000 15000000 7500000 0.025 0.050 0.100 0.100 0.0250 0.0400 0.0150 0.0300 0.085 0.0030 0.0050 10.00 2.50 1.20 2.50 1.20 <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding debt obligations were as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.159%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,500 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(333)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,749 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,167 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current maturities, net of unamortized discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term notes payable, net of current maturities and unamortized discount and issuance costs</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,077 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,184 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 11250000 19500000 19500000 501000 333000 10749000 19167000 1672000 983000 9077000 18184000 <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule, by years, of maturities of notes payable as of September 30, 2023 (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:88.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,250 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 250000 11000000 11250000 Leases<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into various non-cancelable operating lease agreements for office facilities and equipment with lease periods expiring between 2023 and 2028. Certain of these arrangements have free rent periods and/or escalating rent payment provisions. As such, the Company recognizes rent expense under such arrangements on a straight-line basis. Some leases include options to renew. The Company does not assume renewals in its determination of the lease term unless the renewals are deemed to be reasonably assured at lease commencement. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. Leases with an initial term of twelve months or less are not recorded on the balance sheet.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense was $0.2 million and $0.5 million for the three months ended September 30, 2023 and 2022, respectively, and $0.7 million and $1.6 million for the nine months ended September 30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental other information related to operating leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases were as follows:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.2 million </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.5 million</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule, by years, of maturities of lease liabilities as of September 30, 2023 (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 200000 500000 700000 1600000 <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental other information related to operating leases were as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to operating leases were as follows:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.451%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.2 million </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.5 million</span></td><td colspan="3" style="display:none"></td></tr></table></div> P2Y8M12D P2Y2M12D 0.053 0.062 200000 500000 <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a schedule, by years, of maturities of lease liabilities as of September 30, 2023 (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">713 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">659 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 189000 212000 139000 61000 60000 52000 713000 54000 659000 Stock-Based Compensation<div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Stock Options</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense charged as salaries and benefits expense in the consolidated statements of operations was $1.1 million and $0.9 million for the three months ended September 30, 2023 and 2022 respectively, and $2.8 million and $2.2 million for the nine months ended September 30, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the Company's stock option activity for the nine months ended September 30, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise price<br/>per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested, exercisable, expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> at September 30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> (1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options expected to vest reflect an estimated forfeiture rate.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes share-based compensation costs as expense on a straight-line basis over the option vesting period, which generally is four years. As of September 30, 2023, all options have vested and there was no unrecognized compensation costs.</span></div><div style="margin-bottom:9pt;margin-top:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b) Restricted Stock Units and Performance Stock Units</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock unit and performance stock unit activity for the nine months ended September 30, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant date fair value<br/>per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,904,606 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,235,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted to shares, net of units withheld for taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,369,862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Units withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,550,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004,172 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock units and performance stock units granted under the Performant Financial Corporation Amended and Restated 2012 Stock Incentive Plan generally vest over periods between one year and four years. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2023, there was approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10.5 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of total unrecognized compensation cost related to unvested restricted stock units granted to employees. This unrecognized compensation cost is expected to be recognized over an estimated weighted-average amortization period of approximately three years.</span></div> 1100000 900000 2800000 2200000 <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the Company's stock option activity for the nine months ended September 30, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:49.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.632%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>exercise price<br/>per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>remaining<br/>contractual life<br/>(Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.16 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested, exercisable, expected to vest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> at September 30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> (1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options expected to vest reflect an estimated forfeiture rate.</span></div> 250000 10.31 P0Y10M24D 20000 0 0 178000 12.16 0 0 72000 5.74 P2Y9M18D 5000 72000 5.74 P2Y9M18D 5000 72000 5.74 P2Y9M18D 5000 P4Y 0 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes restricted stock unit and performance stock unit activity for the nine months ended September 30, 2023:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>average<br/>grant date fair value<br/>per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,904,606 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.85 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,235,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.49 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,806)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and converted to shares, net of units withheld for taxes </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,369,862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.46 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Units withheld for taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,550,154 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest at September 30, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004,172 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78 </span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 3904606 2.85 2235207 2.49 136806 3.37 1369862 2.46 82991 2.26 4550154 2.78 4004172 2.78 P1Y P4Y 10500000 P3Y Income Taxes<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective income tax rate was 4% for the nine months ended September 30, 2023 and (1)% for the nine months ended September 30, 2022. The primary driver of the effective income tax rate as of September 30, 2023 is the benefits realized related to the recognition of previously unrecognized tax benefits as a result of an audit closing, receipt of interest on tax refunds during the quarter, and overall losses from operations for the nine months ended September 30, 2023, for which no benefit is recognized due to valuation allowance. The primary driver of the effective income tax rate as of September 30, 2022 was the overall losses from operations for the nine months ended September 30, 2022, for which no benefit is recognized due to valuation allowance.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns with the U.S. federal government and various state jurisdictions. The Company operates in a number of state and local jurisdictions, most of which have never audited our records. Accordingly, the Company is subject to state and local income tax examinations based upon the various statutes of limitations in each jurisdiction. For tax years before 2018, the Company has been subject to examination and assessment to the extent of net operating losses carryback refunds requested. The federal examination by the Internal Revenue Service for the 2018 tax year concluded in July of 2023. As of September 30, 2023, the Company no longer has any ongoing audits.</span></div> 0.04 -0.01 Net Income (Loss) per ShareFor the three and nine months ended September 30, 2023 and 2022, basic net income (loss) per share is calculated by dividing net income (loss) by the sum of the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is calculated by dividing net income by the weighted average number of shares of common stock and dilutive common share equivalents outstanding during the period. Common share equivalents consist of stock options, restricted stock units, performance stock units, and warrants. When there is a loss in the period, dilutive common share equivalents are excluded from the calculation of diluted earnings per share, as their effect would be anti-dilutive. For example, for the nine months ended September 30, 2023 and 2022, respectively, diluted weighted average shares outstanding are the same as basic average shares outstanding. When there is net income in the period, the Company excludes stock options, restricted stock units, performance stock units, and warrants from the calculation of diluted earnings per share when their combined exercise price and unamortized fair value exceeds the average market price of the Company's common stock because their effect would be anti-dilutive. <div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended  <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended  <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding – basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,021 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding – diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,454 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,021 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,907 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share, as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):</span></div><div style="margin-bottom:9pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,721 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the basic to diluted weighted average shares outstanding using the treasury stock method (shares in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.098%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended  <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended  <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding – basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,454 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,021 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,907 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,480 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding – diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,454 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,021 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,907 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,480 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 76454000 74021000 75907000 72480000 0 0 0 0 76454000 74021000 75907000 72480000 Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows (shares in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,024 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,447 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,721 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table> 72000 250000 4550000 4024000 0 2447000 4622000 6721000 Subsequent Events<div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated subsequent events through the date these consolidated financial statements are filed with the Securities and Exchange Commission and identified the following event, which did not require adjustments to the consolidated financial statements.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 27, 2023 (the “Closing Date”), the Company entered into a new credit agreement with Wells Fargo Bank, National Association (the “New Credit Agreement”). The New Credit Agreement includes a $25 million revolving loan commitment, subject to borrowing base limitations based on a percentage of applicable eligible receivables and contract assets, of which $5.0 million was advanced on the Closing Date. A portion of the revolving loan commitment of up to $2.5 million is available for the issuance of letters of credit. Subject to certain customary exceptions, the Company’s existing and future, direct or indirect, domestic subsidiaries will be jointly and severally obligated as borrowers or guarantors for the obligations under the New Credit Agreement. The obligations of the Company under the New Credit Agreement are secured by liens on substantially all of the assets of the Company and each of its existing subsidiaries (and subject to customary exceptions, will be secured by the assets of future subsidiaries).</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Credit Agreement matures on October 27, 2026. A portion of the proceeds from the initial borrowing under the New Credit Agreement were used by the Company, together with cash on hand, to refinance its MUFG Credit Agreement (Note 3), and to pay fees and expenses in connection with the New Credit Agreement.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, at its option, prepay borrowings under the New Credit Agreement, in whole or in part, at any time and from time to time without premium or penalty (except in certain circumstances). Borrowings under the New Credit Agreement are also subject to mandatory prepayment in the event that outstanding borrowings and letter of credit usage exceed the lesser of the aggregate revolving loan commitments and the borrowing base then in effect.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may also increase commitments under the New Credit Agreement in an aggregate principal amount of up to $10 million by obtaining additional commitments from lenders, subject to obtaining commitments from any participating lenders and certain other conditions. Under the New Credit Agreement, loans generally may bear interest based on term SOFR (the secured overnight financing right) or an annual base rate, as applicable, plus, in each case, an applicable margin based on the Company’s average borrowing availability each quarter under the New Credit Agreement that may range between 2.50% per annum and 3.00% per annum, in the case of term SOFR loans and between 1.50% per annum and 2.00% per annum in the case of base rate loans. In addition, a commitment fee of 0.50% per annum based on unused availability of the credit facility is also payable. </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The New Credit Agreement contains certain customary representations, warranties, and affirmative and negative covenants of the Company and its subsidiaries that restrict the Company’s and its subsidiaries’ ability to take certain actions, including, </span></div>incurrence of indebtedness, creation of liens, making certain investments, mergers or consolidations, dispositions of assets, assignments, sales or transfers of equity in subsidiaries, repurchase or redemption of capital stock, entering into certain transactions with affiliates, or changing the nature of the Company’s business. The New Credit Agreement also contains financial covenants, which require the Company to maintain a minimum amount of liquidity and a consolidated fixed charge coverage ratio of not less than 1.25 to 1.00, provided that the fixed charge coverage ratio is only applicable when borrowing availability falls below a certain threshold. The obligations under the New Credit Agreement may be accelerated or the commitments terminated upon the occurrence of events of default under the New Credit Agreement, which include payment defaults, defaults in the performance of affirmative and negative covenants, the inaccuracy of representations or warranties, bankruptcy and insolvency related defaults, cross defaults to other material indebtedness, defaults arising in connection with changes in control, and other customary events of default.On the Closing Date, the Company terminated the MUFG Credit Agreement. As a result, all outstanding obligations of the Company under the MUFG Credit Agreement have been paid. 25000000 5000000 2500000 10000000 0.0250 0.0300 0.0150 0.0200 0.0050 1.25 false false false EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 55 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 113 225 1 false 39 0 false 6 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.performantcorp.com/role/CoverPage Cover Page Cover 1 false false R2.htm 0000002 - Statement - Consolidated Balance Sheets Sheet http://www.performantcorp.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 0000004 - Statement - Consolidated Statements of Operations Sheet http://www.performantcorp.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity Sheet http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity Consolidated Statement of Changes in Stockholders' Equity Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Disclosure - Organization and Description of Business Sheet http://www.performantcorp.com/role/OrganizationandDescriptionofBusiness Organization and Description of Business Notes 7 false false R8.htm 0000008 - Disclosure - Property, Equipment, and Leasehold Improvements Sheet http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovements Property, Equipment, and Leasehold Improvements Notes 8 false false R9.htm 0000009 - Disclosure - Notes Payable Notes http://www.performantcorp.com/role/NotesPayable Notes Payable Notes 9 false false R10.htm 0000010 - Disclosure - Leases Sheet http://www.performantcorp.com/role/Leases Leases Notes 10 false false R11.htm 0000011 - Disclosure - Stock-Based Compensation Sheet http://www.performantcorp.com/role/StockBasedCompensation Stock-Based Compensation Notes 11 false false R12.htm 0000012 - Disclosure - Income Taxes Sheet http://www.performantcorp.com/role/IncomeTaxes Income Taxes Notes 12 false false R13.htm 0000013 - Disclosure - Net Income (Loss) per Share Sheet http://www.performantcorp.com/role/NetIncomeLossperShare Net Income (Loss) per Share Notes 13 false false R14.htm 0000014 - Disclosure - Subsequent Events Sheet http://www.performantcorp.com/role/SubsequentEvents Subsequent Events Notes 14 false false R15.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 15 false false R16.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 16 false false R17.htm 9954471 - Disclosure - Organization and Description of Business (Policies) Sheet http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies Organization and Description of Business (Policies) Policies 17 false false R18.htm 9954472 - Disclosure - Organization and Description of Business (Tables) Sheet http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessTables Organization and Description of Business (Tables) Tables http://www.performantcorp.com/role/OrganizationandDescriptionofBusiness 18 false false R19.htm 9954473 - Disclosure - Property, Equipment, and Leasehold Improvements (Tables) Sheet http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsTables Property, Equipment, and Leasehold Improvements (Tables) Tables http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovements 19 false false R20.htm 9954474 - Disclosure - Notes Payable (Tables) Notes http://www.performantcorp.com/role/NotesPayableTables Notes Payable (Tables) Tables http://www.performantcorp.com/role/NotesPayable 20 false false R21.htm 9954475 - Disclosure - Leases (Tables) Sheet http://www.performantcorp.com/role/LeasesTables Leases (Tables) Tables http://www.performantcorp.com/role/Leases 21 false false R22.htm 9954476 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.performantcorp.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.performantcorp.com/role/StockBasedCompensation 22 false false R23.htm 9954477 - Disclosure - Net Income (Loss) per Share (Tables) Sheet http://www.performantcorp.com/role/NetIncomeLossperShareTables Net Income (Loss) per Share (Tables) Tables http://www.performantcorp.com/role/NetIncomeLossperShare 23 false false R24.htm 9954478 - Disclosure - Organization and Description of Business - Narrative (Details) Sheet http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails Organization and Description of Business - Narrative (Details) Details 24 false false R25.htm 9954479 - Disclosure - Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details) Sheet http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details) Details 25 false false R26.htm 9954480 - Disclosure - Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details) Sheet http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details) Details 26 false false R27.htm 9954481 - Disclosure - Property, Equipment, and Leasehold Improvements - Narrative (Details) Sheet http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsNarrativeDetails Property, Equipment, and Leasehold Improvements - Narrative (Details) Details 27 false false R28.htm 9954482 - Disclosure - Notes Payable - Narrative (Details) Notes http://www.performantcorp.com/role/NotesPayableNarrativeDetails Notes Payable - Narrative (Details) Details 28 false false R29.htm 9954483 - Disclosure - Notes Payable - Schedule of Outstanding Debt (Details) Notes http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails Notes Payable - Schedule of Outstanding Debt (Details) Details 29 false false R30.htm 9954484 - Disclosure - Notes Payable - Schedule of Maturities of Long-term Debt (Details) Notes http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails Notes Payable - Schedule of Maturities of Long-term Debt (Details) Details 30 false false R31.htm 9954485 - Disclosure - Leases - Narrative (Details) Sheet http://www.performantcorp.com/role/LeasesNarrativeDetails Leases - Narrative (Details) Details 31 false false R32.htm 9954486 - Disclosure - Leases - Schedule of Lease Cost (Details) Sheet http://www.performantcorp.com/role/LeasesScheduleofLeaseCostDetails Leases - Schedule of Lease Cost (Details) Details 32 false false R33.htm 9954487 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details) Sheet http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails Leases - Schedule of Maturities of Lease Liabilities (Details) Details 33 false false R34.htm 9954488 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 34 false false R35.htm 9954489 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details) Sheet http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails Stock-Based Compensation - Schedule of Stock Option Activity (Details) Details 35 false false R36.htm 9954490 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) Sheet http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails Stock-Based Compensation - Schedule of Restricted Stock Activity (Details) Details 36 false false R37.htm 9954491 - Disclosure - Income Taxes (Details) Sheet http://www.performantcorp.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.performantcorp.com/role/IncomeTaxes 37 false false R38.htm 9954492 - Disclosure - Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details) Sheet http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details) Details http://www.performantcorp.com/role/NetIncomeLossperShareTables 38 false false R39.htm 9954493 - Disclosure - Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details http://www.performantcorp.com/role/NetIncomeLossperShareTables 39 false false R40.htm 9954494 - Disclosure - Subsequent Events (Details) Sheet http://www.performantcorp.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.performantcorp.com/role/SubsequentEvents 40 false false All Reports Book All Reports pfmt-20230930.htm pfmt-20230930.xsd pfmt-20230930_cal.xml pfmt-20230930_def.xml pfmt-20230930_lab.xml pfmt-20230930_pre.xml http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 58 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "pfmt-20230930.htm": { "nsprefix": "pfmt", "nsuri": "http://www.performantcorp.com/20230930", "dts": { "inline": { "local": [ "pfmt-20230930.htm" ] }, "schema": { "local": [ "pfmt-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "pfmt-20230930_cal.xml" ] }, "definitionLink": { "local": [ "pfmt-20230930_def.xml" ] }, "labelLink": { "local": [ "pfmt-20230930_lab.xml" ] }, "presentationLink": { "local": [ "pfmt-20230930_pre.xml" ] } }, "keyStandard": 208, "keyCustom": 17, "axisStandard": 12, "axisCustom": 1, "memberStandard": 19, "memberCustom": 18, "hidden": { "total": 8, "http://xbrl.sec.gov/dei/2023": 5, "http://xbrl.sec.gov/ecd/2023": 3 }, "contextCount": 113, "entityCount": 1, "segmentCount": 39, "elementCount": 420, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 473, "http://xbrl.sec.gov/ecd/2023": 6, "http://xbrl.sec.gov/dei/2023": 30 }, "report": { "R1": { "role": "http://www.performantcorp.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "longName": "0000002 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R3": { "role": "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "0000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredFinanceCostsCurrentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DeferredFinanceCostsCurrentNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations", "longName": "0000004 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:LaborAndRelatedExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R5": { "role": "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity", "longName": "0000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity", "shortName": "Consolidated Statement of Changes in Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-32", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-32", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows", "longName": "0000006 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R7": { "role": "http://www.performantcorp.com/role/OrganizationandDescriptionofBusiness", "longName": "0000007 - Disclosure - Organization and Description of Business", "shortName": "Organization and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovements", "longName": "0000008 - Disclosure - Property, Equipment, and Leasehold Improvements", "shortName": "Property, Equipment, and Leasehold Improvements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.performantcorp.com/role/NotesPayable", "longName": "0000009 - Disclosure - Notes Payable", "shortName": "Notes Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.performantcorp.com/role/Leases", "longName": "0000010 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.performantcorp.com/role/StockBasedCompensation", "longName": "0000011 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.performantcorp.com/role/IncomeTaxes", "longName": "0000012 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.performantcorp.com/role/NetIncomeLossperShare", "longName": "0000013 - Disclosure - Net Income (Loss) per Share", "shortName": "Net Income (Loss) per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.performantcorp.com/role/SubsequentEvents", "longName": "0000014 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R15": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": null }, "R16": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-5", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "ecd:NonRule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies", "longName": "9954471 - Disclosure - Organization and Description of Business (Policies)", "shortName": "Organization and Description of Business (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessTables", "longName": "9954472 - Disclosure - Organization and Description of Business (Tables)", "shortName": "Organization and Description of Business (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsTables", "longName": "9954473 - Disclosure - Property, Equipment, and Leasehold Improvements (Tables)", "shortName": "Property, Equipment, and Leasehold Improvements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.performantcorp.com/role/NotesPayableTables", "longName": "9954474 - Disclosure - Notes Payable (Tables)", "shortName": "Notes Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.performantcorp.com/role/LeasesTables", "longName": "9954475 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LeaseCostTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.performantcorp.com/role/StockBasedCompensationTables", "longName": "9954476 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.performantcorp.com/role/NetIncomeLossperShareTables", "longName": "9954477 - Disclosure - Net Income (Loss) per Share (Tables)", "shortName": "Net Income (Loss) per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "pfmt:ReconciliationOfBasicToDilutedWeightedAverageSharesTableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "pfmt:ReconciliationOfBasicToDilutedWeightedAverageSharesTableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails", "longName": "9954478 - Disclosure - Organization and Description of Business - Narrative (Details)", "shortName": "Organization and Description of Business - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails", "longName": "9954479 - Disclosure - Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details)", "shortName": "Organization and Description of Business - Schedule of Disaggregated Revenue by Category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-50", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R26": { "role": "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails", "longName": "9954480 - Disclosure - Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details)", "shortName": "Property, Equipment, and Leasehold Improvements - Schedule of Property, Equipment, and Leasehold Improvements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsNarrativeDetails", "longName": "9954481 - Disclosure - Property, Equipment, and Leasehold Improvements - Narrative (Details)", "shortName": "Property, Equipment, and Leasehold Improvements - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": null }, "R28": { "role": "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "longName": "9954482 - Disclosure - Notes Payable - Narrative (Details)", "shortName": "Notes Payable - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LineOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "pfmt:DebtInstrumentDebtCovenantTotalLeverageRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R29": { "role": "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails", "longName": "9954483 - Disclosure - Notes Payable - Schedule of Outstanding Debt (Details)", "shortName": "Notes Payable - Schedule of Outstanding Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LineOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R30": { "role": "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails", "longName": "9954484 - Disclosure - Notes Payable - Schedule of Maturities of Long-term Debt (Details)", "shortName": "Notes Payable - Schedule of Maturities of Long-term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.performantcorp.com/role/LeasesNarrativeDetails", "longName": "9954485 - Disclosure - Leases - Narrative (Details)", "shortName": "Leases - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.performantcorp.com/role/LeasesScheduleofLeaseCostDetails", "longName": "9954486 - Disclosure - Leases - Schedule of Lease Cost (Details)", "shortName": "Leases - Schedule of Lease Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails", "longName": "9954487 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)", "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "longName": "9954488 - Disclosure - Stock-Based Compensation - Narrative (Details)", "shortName": "Stock-Based Compensation - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails", "longName": "9954489 - Disclosure - Stock-Based Compensation - Schedule of Stock Option Activity (Details)", "shortName": "Stock-Based Compensation - Schedule of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-89", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R36": { "role": "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "longName": "9954490 - Disclosure - Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)", "shortName": "Stock-Based Compensation - Schedule of Restricted Stock Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-91", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-91", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.performantcorp.com/role/IncomeTaxesDetails", "longName": "9954491 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails", "longName": "9954492 - Disclosure - Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details)", "shortName": "Net Income (Loss) per Share - Schedule of Reconciliation of Basic to Diluted Weighted Average Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "pfmt:ReconciliationOfBasicToDilutedWeightedAverageSharesTableTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } }, "R39": { "role": "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "longName": "9954493 - Disclosure - Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "shortName": "Net Income (Loss) per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.performantcorp.com/role/SubsequentEventsDetails", "longName": "9954494 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LineOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-110", "name": "pfmt:DebtInstrumentDebtCovenantFixedChargeCoverageRatio", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "pfmt-20230930.htm", "unique": true } } }, "tag": { "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r519" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r517" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/NotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturities of Long-term Debt", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r7" ] }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg." } } }, "auth_ref": [ "r559" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r515" ] }, "us-gaap_HealthCareMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HealthCareMember", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Healthcare Total", "label": "Health Care [Member]", "documentation": "Service provided for prevention, maintenance, diagnosis or treatment of physical and mental health." } } }, "auth_ref": [ "r558" ] }, "pfmt_TermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "TermLoanMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "label": "Term Loan [Member]", "documentation": "Term Loan" } } }, "auth_ref": [] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r515" ] }, "us-gaap_LitigationReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LitigationReserveCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated liability for appeals and disputes", "verboseLabel": "Estimated liability for appeals", "label": "Estimated Litigation Liability, Current", "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position." } } }, "auth_ref": [ "r21", "r551" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount", "label": "Line of Credit Facility, Increase (Decrease), Net", "documentation": "Amount of increase (decrease) of the credit facility." } } }, "auth_ref": [ "r539" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r516" ] }, "pfmt_PrepaidExpenseAndOtherAssetsPrepaidSoftwareLicensesAndMaintenanceAgreements": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "PrepaidExpenseAndOtherAssetsPrepaidSoftwareLicensesAndMaintenanceAgreements", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets, prepaid software licenses and maintenance agreement", "label": "Prepaid Expense And Other Assets, Prepaid Software Licenses And Maintenance Agreements", "documentation": "Prepaid Expense And Other Assets, Prepaid Software Licenses And Maintenance Agreements" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r522" ] }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, interest rate", "label": "Line of Credit Facility, Interest Rate at Period End", "documentation": "The effective interest rate at the end of the reporting period." } } }, "auth_ref": [ "r14" ] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Lender [Domain]", "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r14", "r539" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r515" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity under credit facility", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r14" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r494" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r516" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Discount Rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r312", "r439" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r493" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets amortization", "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction", "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease." } } }, "auth_ref": [ "r538" ] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lender Name [Axis]", "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r14", "r539" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted cash", "terseLabel": "Restricted cash", "label": "Restricted Cash and Cash Equivalents, Current", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r94", "r116" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r518" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r14", "r539" ] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of stock options (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r138", "r139", "r140", "r144", "r232" ] }, "pfmt_EligibilityBasedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "EligibilityBasedMember", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Eligibility-based", "label": "Eligibility-based [Member]", "documentation": "Eligibility-based" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r539" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r457" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r493" ] }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities and other current liabilities", "label": "Increase (Decrease) in Other Current Liabilities", "documentation": "Amount of increase (decrease) in current liabilities classified as other." } } }, "auth_ref": [ "r537" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total undiscounted cash flows", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r313" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r492" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r520" ] }, "us-gaap_LineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCredit", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount", "terseLabel": "Principal amount", "label": "Long-Term Line of Credit", "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r12", "r79", "r572" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r521" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r49" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r490" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r313" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r313" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less current maturities, net of unamortized discount and issuance costs", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r100" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares", "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r522" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other assets", "label": "Increase (Decrease) in Other Noncurrent Assets", "documentation": "Amount of increase (decrease) in noncurrent assets classified as other." } } }, "auth_ref": [ "r537" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee Stock Option", "terseLabel": "Options to purchase common stock", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r313" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r313" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r7", "r120", "r209" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r313" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r563" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Maturities of Lease Liabilities", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r563" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r522" ] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r523" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r241" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Trade accounts receivable", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r168", "r169" ] }, "us-gaap_IncreaseDecreaseInIncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInIncomeTaxesReceivable", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax receivable", "label": "Increase (Decrease) in Income Taxes Receivable", "documentation": "The increase (decrease) during the reporting period in income taxes receivable, which represents the amount due from tax authorities for refunds of overpayments or recoveries of income taxes paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r265", "r266", "r267", "r353", "r542", "r543", "r544", "r560", "r576" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued salaries and benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.performantcorp.com/role/NotesPayable" ], "lang": { "en-us": { "role": { "terseLabel": "Notes Payable", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r71", "r117", "r191", "r197", "r198", "r199", "r200", "r201", "r202", "r207", "r214", "r215", "r216" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par or stated value per share (in usd per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r48" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r89", "r121", "r122", "r123", "r125", "r131", "r133", "r172", "r173", "r265", "r266", "r267", "r275", "r276", "r286", "r288", "r289", "r291", "r292", "r344", "r346", "r353", "r576" ] }, "pfmt_DebtInstrumentInterestRateFloorRate": { "xbrltype": "percentItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtInstrumentInterestRateFloorRate", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument interest rate floor rate", "label": "Debt Instrument Interest Rate Floor Rate", "documentation": "Debt Instrument, Interest Rate, Floor Rate" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r443", "r444", "r445", "r447", "r448", "r449", "r450", "r542", "r543", "r560", "r574", "r576" ] }, "us-gaap_LettersOfCreditOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LettersOfCreditOutstandingAmount", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Letters of credit", "label": "Letters of Credit Outstanding, Amount", "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date." } } }, "auth_ref": [] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BaseRateMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base Rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r89", "r106", "r107", "r108", "r121", "r122", "r123", "r125", "r131", "r133", "r149", "r172", "r173", "r220", "r265", "r266", "r267", "r275", "r276", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r296", "r297", "r298", "r299", "r300", "r301", "r314", "r344", "r345", "r346", "r353", "r403" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current maturities of notes payable, net of unamortized debt issuance costs of $78 and $17, respectively", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r15" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r250" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property, Equipment, and Leasehold Improvements", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant\u00a0date fair value per share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for (benefit from) income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r84", "r88", "r132", "r133", "r156", "r270", "r278", "r336" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovements" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Equipment, and Leasehold Improvements", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r67", "r85", "r86", "r87" ] }, "us-gaap_LongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermNotesPayable", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, net of current portion and unamortized debt issuance costs of $423 and $316, respectively", "label": "Notes Payable, Noncurrent", "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion." } } }, "auth_ref": [ "r19" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r28", "r96", "r330" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PrimeRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrimeRateMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prime Rate", "label": "Prime Rate [Member]", "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r6" ] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants outstanding", "label": "Warrant [Member]", "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount." } } }, "auth_ref": [ "r443", "r444", "r447", "r448", "r449", "r450" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total notes payable", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r12", "r79", "r217" ] }, "pfmt_DebtLeverageRatioAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtLeverageRatioAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Leverage Ratio [Axis]", "label": "Debt Leverage Ratio [Axis]", "documentation": "Debt Leverage Ratio" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Lived Tangible Asset [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r68" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r229", "r233", "r261", "r262", "r264", "r438" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, issued shares (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r48" ] }, "pfmt_DebtInstrumentDebtCovenantFixedChargeCoverageRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtInstrumentDebtCovenantFixedChargeCoverageRatio", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed charge coverage ratio", "label": "Debt Instrument, Debt Covenant, Fixed Charge Coverage Ratio", "documentation": "Debt Instrument, Debt Covenant, Fixed Charge Coverage Ratio" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r178", "r179", "r180", "r181", "r227", "r228", "r256", "r257", "r258", "r318", "r319", "r343", "r355", "r356", "r406", "r407", "r408", "r409", "r410", "r412", "r413", "r421", "r429", "r437", "r442", "r445", "r550", "r556", "r567", "r568", "r569", "r570", "r571" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r57", "r153" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r31" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, authorized shares (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r48", "r365" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r178", "r179", "r180", "r181", "r228", "r319", "r343", "r355", "r356", "r406", "r407", "r408", "r409", "r410", "r412", "r413", "r421", "r429", "r437", "r442", "r556", "r566", "r567", "r568", "r569", "r570", "r571" ] }, "pfmt_RecoveryMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RecoveryMember", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recovery", "label": "Recovery [Member]", "documentation": "Recovery [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, outstanding shares (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r48", "r365", "r383", "r576", "r577" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r178", "r179", "r180", "r181", "r227", "r228", "r256", "r257", "r258", "r318", "r319", "r343", "r355", "r356", "r406", "r407", "r408", "r409", "r410", "r412", "r413", "r421", "r429", "r437", "r442", "r445", "r550", "r556", "r567", "r568", "r569", "r570", "r571" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r150", "r158", "r162", "r164", "r420" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r178", "r179", "r180", "r181", "r228", "r319", "r343", "r355", "r356", "r406", "r407", "r408", "r409", "r410", "r412", "r413", "r421", "r429", "r437", "r442", "r556", "r566", "r567", "r568", "r569", "r570", "r571" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash (received) paid for income taxes", "label": "Income Taxes Paid, Net", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes." } } }, "auth_ref": [ "r25" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r20" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r496" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r75" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Stock Activity", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r32" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r492" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfReportingUnits", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting units", "label": "Number of Reporting Units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unused commitment fee percentage", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax receivable", "label": "Income Taxes Receivable, Current", "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes." } } }, "auth_ref": [ "r42", "r532" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r496" ] }, "us-gaap_RevenueRecognitionInterest": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionInterest", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues, Accounts Receivable, Contract Assets, Contract Liabilities, Estimated Liability for Appeals and Disputes", "label": "Revenue Recognition, Interest [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognition of interest revenue. Disclosure may include the method of recognizing interest income on loan and trade receivables, the method of amortizing premiums or accreting discounts, and a statement about the policy for the treatment of related fees and costs, including the method of amortizing net deferred fees and costs." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events [Abstract]", "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r495" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations", "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding \u2013 diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r136", "r144" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r92", "r103", "r118", "r171", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r282", "r284", "r295", "r440", "r554", "r555", "r564" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in usd per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r110", "r126", "r127", "r128", "r129", "r130", "r135", "r137", "r142", "r143", "r144", "r148", "r293", "r294", "r322", "r334", "r418" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r9", "r10", "r32" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations", "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofReconciliationofBasictoDilutedWeightedAverageSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average shares outstanding \u2013 basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r135", "r144" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r492" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r302", "r316" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r495" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r113" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash (used in) provided by investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r113" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r494" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r60", "r61", "r62" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income (Loss) per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r134", "r145", "r146", "r147" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r495" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less unamortized discount and issuance costs", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r40", "r203", "r218", "r425", "r426" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r22", "r89", "r106", "r107", "r108", "r121", "r122", "r123", "r125", "r131", "r133", "r149", "r172", "r173", "r220", "r265", "r266", "r267", "r275", "r276", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r296", "r297", "r298", "r299", "r300", "r301", "r314", "r344", "r345", "r346", "r353", "r403" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r34", "r35", "r37", "r89", "r90", "r107", "r121", "r122", "r123", "r125", "r131", "r172", "r173", "r220", "r265", "r266", "r267", "r275", "r276", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r296", "r297", "r301", "r314", "r345", "r346", "r352", "r367", "r383", "r404", "r405", "r411", "r452", "r540", "r546", "r561", "r576" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Trade accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r112", "r114", "r115" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r504" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued liabilities, current", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r497" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r497" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r497" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r497" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r454" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r497" ] }, "pfmt_ClaimsBasedMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ClaimsBasedMember", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Claims-based", "label": "Claims-based [Member]", "documentation": "Claims-based" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r496" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r498" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under stock plans, net of shares withheld for employee taxes", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r33", "r47", "r48", "r74" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r496" ] }, "pfmt_CustomerCareAndOutsourcedServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "CustomerCareAndOutsourcedServicesMember", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Care / Outsourced Services", "label": "Customer Care And Outsourced Services [Member]", "documentation": "Customer Care And Outsourced Services [Member]" } } }, "auth_ref": [] }, "pfmt_PriorToEarlierOfDecember312023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "PriorToEarlierOfDecember312023Member", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior to earlier of December 31, 2023", "label": "Prior To Earlier Of December 31, 2023 [Member]", "documentation": "Prior To Earlier Of December 31, 2023" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r500" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r499" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r496" ] }, "pfmt_DebtInstrumentDebtCovenantTotalLeverageRatio": { "xbrltype": "pureItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtInstrumentDebtCovenantTotalLeverageRatio", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total leverage ratio", "label": "Debt Instrument, Debt Covenant, Total Leverage Ratio", "documentation": "Debt Instrument, Debt Covenant, Total Leverage Ratio" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r6" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r503" ] }, "pfmt_ProceedsFromSaleOfRecoveryContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ProceedsFromSaleOfRecoveryContracts", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of certain recovery contracts", "label": "Proceeds From Sale Of Recovery Contracts", "documentation": "Proceeds From Sale Of Recovery Contracts" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sales of property, equipment, and leasehold improvements", "label": "Proceeds from Sale of Property, Plant, and Equipment", "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r58" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r313" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r501" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract liabilities", "verboseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r221", "r222", "r226" ] }, "pfmt_WorkersCompensationLiabilityIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "WorkersCompensationLiabilityIncurred", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Workers' compensation liability, incurred", "label": "Workers' Compensation Liability, Incurred", "documentation": "Workers' Compensation Liability, Incurred" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r502" ] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued salaries and benefits", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r4" ] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining contractual\u00a0life (Years)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract]", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r502" ] }, "pfmt_PremiumInsuranceFinancingPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "PremiumInsuranceFinancingPayables", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Premium insurance financing payables", "label": "Premium Insurance Financing Payables", "documentation": "Premium Insurance Financing Payables" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r456" ] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIntrinsicValueAbstract", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic\u00a0Value (in thousands)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Intrinsic Value [Abstract]", "documentation": "Share Based Compensation Arrangement by Share Based Payment Award Intrinsic Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r18", "r93", "r118", "r171", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r283", "r284", "r285", "r295", "r440", "r554", "r564", "r565" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofLeaseCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Lease Term (in years)", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r311", "r439" ] }, "pfmt_RatioAsOfSeptember302023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RatioAsOfSeptember302023Member", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ratio as of September 30, 2023", "label": "Ratio As Of September 30, 2023 [Member]", "documentation": "Ratio As Of September 30, 2023" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of stock options", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r8", "r22", "r74" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Present value of lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r307" ] }, "pfmt_IanJohnstonMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "IanJohnstonMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Ian Johnston [Member]", "documentation": "Ian Johnston" } } }, "auth_ref": [] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldForTaxesWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldForTaxesWeightedAverageGrantDateFairValue", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Units withheld for taxes (in usd per share)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Withheld For Taxes, Weighted Average Grant Date Fair Value", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Withheld For Taxes, Weighted Average Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r307" ] }, "pfmt_WellsFargoBankMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "WellsFargoBankMember", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Wells Fargo Bank", "label": "Wells Fargo Bank [Member]", "documentation": "Wells Fargo Bank" } } }, "auth_ref": [] }, "pfmt_RestrictedStockandPerformanceStockUnitsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RestrictedStockandPerformanceStockUnitsMember", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock and Performance Stock Units", "label": "Restricted Stock and Performance Stock Units [Member]", "documentation": "Restricted Stock and Performance Stock Units [Member]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_PrepaidInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidInsurance", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets, prepaid insurance", "label": "Prepaid Insurance", "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r416", "r422", "r547" ] }, "pfmt_GainLossOnSaleOfRecoveryContracts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "GainLossOnSaleOfRecoveryContracts", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 }, "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows", "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on sale of certain recovery contracts", "negatedTerseLabel": "Gain on sale of certain recovery contracts", "label": "Gain (Loss) On Sale Of Recovery Contracts", "documentation": "Gain (Loss) On Sale Of Recovery Contracts" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued under stock plans, net of shares withheld for employee taxes (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r8", "r47", "r48", "r74" ] }, "pfmt_ReconciliationOfBasicToDilutedWeightedAverageSharesTableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ReconciliationOfBasicToDilutedWeightedAverageSharesTableTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Basic to Diluted Weighted Average Shares", "label": "Reconciliation Of Basic To Diluted Weighted Average Shares Table [Table Text Block]", "documentation": "Reconciliation of basic to diluted weighted average shares." } } }, "auth_ref": [] }, "pfmt_InterestExpenseDebtIssuanceCostsAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "InterestExpenseDebtIssuanceCostsAndAmortization", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense from debt issuance costs", "label": "Interest Expense, Debt Issuance Costs And Amortization", "documentation": "Interest expense from debt issuance costs and amortization of discount note payable." } } }, "auth_ref": [] }, "pfmt_IncreaseDecreaseInEstimatedLiabilityForAppealsAndDisputes": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "IncreaseDecreaseInEstimatedLiabilityForAppealsAndDisputes", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated liability for appeals, disputes, and refunds", "label": "Increase (Decrease) In Estimated Liability For Appeals And Disputes", "documentation": "Increase (Decrease) In Estimated Liability For Appeals And Disputes" } } }, "auth_ref": [] }, "pfmt_DebtInstrumentDebtCovenantAmortizationOfPrincipalPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtInstrumentDebtCovenantAmortizationOfPrincipalPercentage", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of principal, percentage", "label": "Debt Instrument, Debt Covenant, Amortization Of Principal, Percentage", "documentation": "Debt Instrument, Debt Covenant, Amortization Of Principal, Percentage" } } }, "auth_ref": [] }, "pfmt_RepaymentsOfLongTermNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RepaymentsOfLongTermNotesPayable", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of notes payable", "label": "Repayments Of Long Term Notes Payable", "documentation": "Repayments of long term notes payable." } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r307" ] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsWithheldForTaxes": { "xbrltype": "sharesItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsWithheldForTaxes", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Units withheld for taxes (in shares)", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instrument Other Than Options, Withheld For Taxes", "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instrument Other Than Options, Withheld For Taxes" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on variable rate (as a percent)", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r19", "r120", "r192", "r193", "r194", "r195", "r196", "r198", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r304", "r424", "r425", "r426", "r427", "r428", "r539" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r504" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r466", "r477", "r487", "r504", "r512" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r467", "r478", "r488", "r513" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r491" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r504" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r515" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.performantcorp.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r315", "r317" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r460", "r471", "r481", "r506" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r466", "r477", "r487", "r512" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r504" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r466", "r477", "r487", "r512" ] }, "us-gaap_LaborAndRelatedExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LaborAndRelatedExpense", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Salaries and benefits", "label": "Labor and Related Expense", "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit." } } }, "auth_ref": [ "r535" ] }, "pfmt_RohitRamchandaniMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RohitRamchandaniMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rohit Ramchandani [Member]", "documentation": "Rohit Ramchandani" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r469", "r477", "r487", "r504", "r512", "r516", "r524" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofLeaseCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r308", "r310" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r467", "r478", "r488", "r513" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r469", "r477", "r487", "r504", "r512", "r516", "r524" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r466", "r477", "r487", "r512" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (note 3 and note 4)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r21", "r43", "r326", "r364" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r466", "r477", "r487", "r512" ] }, "us-gaap_DeferredFinanceCostsNoncurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNoncurrentNet", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs, net of current portion", "label": "Debt Issuance Costs, Noncurrent, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r40" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r459", "r470", "r480", "r505" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.performantcorp.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate (as a percent)", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r271" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r455" ] }, "pfmt_BuildingAndLeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "BuildingAndLeaseholdImprovementsMember", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Building and leasehold improvements", "label": "Building And Leasehold Improvements [Member]", "documentation": "Building and leasehold improvements." } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r461", "r472", "r482", "r507" ] }, "us-gaap_DeferredFinanceCostsCurrentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsCurrentNet", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs, current portion", "label": "Debt Issuance Costs, Current, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as current. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r40" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r455" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period [Domain]", "label": "Debt Instrument, Redemption, Period [Domain]", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r11" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r468", "r479", "r489", "r514" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails", "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r12", "r45", "r46", "r78", "r79", "r120", "r192", "r193", "r194", "r195", "r196", "r198", "r203", "r204", "r205", "r206", "r208", "r209", "r210", "r211", "r212", "r213", "r304", "r424", "r425", "r426", "r427", "r428", "r539" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r459", "r470", "r480", "r505" ] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period [Axis]", "label": "Debt Instrument, Redemption, Period [Axis]", "documentation": "Information about timing of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r11" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows", "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization expense", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r5", "r155" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r241" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r13", "r440" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r455" ] }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodTwoMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Period Two", "label": "Debt Instrument, Redemption, Period Two [Member]", "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r242" ] }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodOneMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Period One", "label": "Debt Instrument, Redemption, Period One [Member]", "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r11" ] }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodThreeMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Period Three", "label": "Debt Instrument, Redemption, Period Three [Member]", "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r11" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r465", "r476", "r486", "r511" ] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Debt issuance costs paid", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r23" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r455" ] }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPeriodFourMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption Period Four", "label": "Debt Instrument, Redemption, Period Four [Member]", "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r11" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average exercise\u00a0price per share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r462", "r473", "r483", "r508" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Forfeited (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated." } } }, "auth_ref": [ "r243" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r121", "r122", "r123", "r149", "r320", "r349", "r354", "r357", "r358", "r359", "r360", "r361", "r362", "r365", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r386", "r387", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r446" ] }, "pfmt_DebtLeverageRatioDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "DebtLeverageRatioDomain", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Leverage Ratio [Domain]", "label": "Debt Leverage Ratio [Domain]", "documentation": "Debt Leverage Ratio [Domain]" } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r462", "r473", "r483", "r508" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r165", "r320", "r337", "r338", "r339", "r340", "r341", "r342", "r414", "r430", "r441", "r531", "r552", "r553", "r557", "r573" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r515" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r463", "r474", "r484", "r509" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Allowance for doubtful accounts", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r102", "r170", "r174" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r121", "r122", "r123", "r149", "r320", "r349", "r354", "r357", "r358", "r359", "r360", "r361", "r362", "r365", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r378", "r379", "r380", "r381", "r382", "r384", "r386", "r387", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r403", "r446" ] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber": { "xbrltype": "sharesItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected to vest (in shares)", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested And Expected To Vest, Number", "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Vested And Expected To Vest, Number" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r530", "r537" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r515" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r165", "r320", "r337", "r338", "r339", "r340", "r341", "r342", "r414", "r430", "r441", "r531", "r552", "r553", "r557", "r573" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r464", "r475", "r485", "r510" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill, accumulated impairment loss", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r176", "r177", "r423" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r26" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r515" ] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r17", "r440" ] }, "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss on disposal of assets and impairment of long-lived assets", "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges", "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value." } } }, "auth_ref": [ "r538" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r466", "r477", "r487", "r512" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r529" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Restricted Stock Units (RSUs)", "terseLabel": "RSUs", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss per share", "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, equipment and leasehold improvements, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r68", "r95", "r331" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before provision for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r1", "r54", "r81", "r150", "r158", "r162", "r164", "r323", "r332", "r420" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, equipment, and leasehold improvements", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r59" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r53", "r80", "r329", "r440", "r540", "r546", "r561" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Abstract]", "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, equipment, and leasehold improvements, net", "totalLabel": "Property, equipment and leasehold improvements, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r6", "r324", "r331", "r440" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r306" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Stockholders\u2019 Equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "verboseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r534" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 }, "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r24", "r94", "r415" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Options", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities." } } }, "auth_ref": [ "r26" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r26" ] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows", "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on sale of land and buildings", "negatedTerseLabel": "Gain on sale of land and buildings", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r5" ] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounting Policies [Abstract]", "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "presentation": [ "http://www.performantcorp.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Awards", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "verboseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r97", "r175", "r321", "r423", "r440", "r548", "r549" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r60" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "totalLabel": "Total cash, cash equivalents and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r24", "r60", "r116" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenues", "terseLabel": "Total Revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r151", "r152", "r157", "r160", "r161", "r165", "r166", "r167", "r224", "r225", "r320" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r497" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 }, "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity", "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows", "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net loss", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r55", "r62", "r82", "r91", "r104", "r105", "r108", "r118", "r124", "r126", "r127", "r128", "r129", "r132", "r133", "r141", "r150", "r158", "r162", "r164", "r171", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r294", "r295", "r333", "r385", "r401", "r402", "r420", "r451", "r554" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperationsAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Reconciliation of the Consolidated Statements of Cash Flows to the Consolidated Balance Sheets:", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, exercisable, expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r253" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r16", "r118", "r171", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r283", "r284", "r285", "r295", "r363", "r419", "r453", "r554", "r564", "r565" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r260", "r268" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, exercisable, expected to vest (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r253" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, exercisable, expected to vest", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r254" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested, exercisable, expected to vest (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r253" ] }, "us-gaap_OtherCostAndExpenseOperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCostAndExpenseOperating", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Other operating expenses", "label": "Other Cost and Expense, Operating", "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r56", "r335" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value. Authorized, 500,000 shares at September\u00a030, 2023 and December\u00a031, 2022 respectively; issued and outstanding 76,875 and 75,505 shares at September\u00a030, 2023 and December\u00a031, 2022, respectively", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r48", "r327", "r440" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r98" ] }, "pfmt_RevolvingLoanCommitmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RevolvingLoanCommitmentMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Loan Commitment", "label": "Revolving Loan Commitment [Member]", "documentation": "Revolving Loan Commitment" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementofChangesinStockholdersEquity", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of stock options (in shares)", "negatedLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r8", "r47", "r48", "r74", "r242" ] }, "us-gaap_OtherPrepaidExpenseCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPrepaidExpenseCurrent", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets, various other prepaid expenses", "label": "Other Prepaid Expense, Current", "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r533", "r547" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r523" ] }, "pfmt_MUFGUnionBankNAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "MUFGUnionBankNAMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MUFG Union Bank, N.A.", "label": "MUFG Union Bank, N.A. [Member]", "documentation": "MUFG Union Bank, N.A." } } }, "auth_ref": [] }, "pfmt_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAveragePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestWeightedAveragePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Expected to vest (in usd per share)", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Weighted Average Price" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term notes payable, net of current maturities and unamortized discount and issuance costs", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r101" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r523" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r48", "r51", "r52", "r66", "r367", "r383", "r404", "r405", "r440", "r453", "r540", "r546", "r561", "r576" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r497" ] }, "pfmt_RatioAsOfDecember302023Member": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "RatioAsOfDecember302023Member", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ratio as of December 31, 2023", "label": "Ratio As Of December 30, 2023 [Member]", "documentation": "Ratio As Of December 30, 2023" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r40", "r83", "r109", "r154", "r303", "r388", "r451", "r575" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r523" ] }, "pfmt_NewCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "NewCreditAgreementMember", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Credit Agreement", "label": "New Credit Agreement [Member]", "documentation": "New Credit Agreement" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofMaturitiesofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Remainder of 2023", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r541" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r523" ] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r545" ] }, "pfmt_TheCreditAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "TheCreditAgreementMember", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "The Credit Agreement", "label": "The Credit Agreement [Member]", "documentation": "The Credit Agreement" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r524" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-cash impairment charge", "label": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r5", "r27", "r69" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Options vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r438" ] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/NotesPayableScheduleofOutstandingDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Notes payable, net of unamortized discount and issuance costs", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r12", "r79", "r204", "r219", "r425", "r426", "r572" ] }, "pfmt_SimeonKohlMember": { "xbrltype": "domainItemType", "nsuri": "http://www.performantcorp.com/20230930", "localname": "SimeonKohlMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Simeon Kohl [Member]", "documentation": "Simeon Kohl" } } }, "auth_ref": [] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Lease Cost", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r562" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r524" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/LeasesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r309", "r439" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense, recognition term", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r263" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r525" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r524" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r526" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregated Revenue by Category", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r557" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r525" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Goodwill and Long-Lived Assets", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r0", "r70" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r527" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Organization and Description of Business", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r63", "r64", "r65", "r76" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r458", "r528" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r458", "r528" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r145" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r248" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r225", "r430", "r431", "r432", "r433", "r434", "r435", "r436" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r250" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.performantcorp.com/role/NetIncomeLossperShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r26" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r458", "r528" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r496" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r248" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in shares)", "periodEndLabel": "Outstanding at end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r245", "r246" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and converted to shares, net of units withheld for taxes (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r249" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessScheduleofDisaggregatedRevenuebyCategoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r225", "r430", "r431", "r432", "r433", "r434", "r435", "r436" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Vested and converted to shares, net of units withheld for taxes (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r249" ] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r302", "r316" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding at beginning of period (in usd per share)", "periodEndLabel": "Outstanding at end of period (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r245", "r246" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r230", "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTable", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued." } } }, "auth_ref": [ "r302", "r316" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation expense", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r263" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r302", "r316" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.performantcorp.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r302", "r316" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Computer hardware and software", "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.performantcorp.com/role/NotesPayableTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Outstanding Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r19", "r29", "r30", "r38", "r39", "r41", "r44", "r72", "r73", "r425", "r427", "r541" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Organization", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r36", "r417" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.performantcorp.com/role/PropertyEquipmentandLeaseholdImprovementsScheduleofPropertyEquipmentandLeaseholdImprovementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and equipment", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash provided by (used in) operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Taxes paid related to net share settlement of stock awards", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r111" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r50", "r74", "r328", "r347", "r348", "r350", "r366", "r440" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Forfeited (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r243" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r455" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.performantcorp.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r305" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInContractWithCustomerAsset", "crdr": "credit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Contract assets", "label": "Increase (Decrease) in Contract with Customer, Asset", "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r537" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r31" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period (in shares)", "periodEndLabel": "Balance at end of period (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r237", "r238" ] }, "us-gaap_ProceedsFromWarrantExercises": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromWarrantExercises", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from exercise of warrants", "label": "Proceeds from Warrant Exercises", "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants." } } }, "auth_ref": [ "r536" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning of period (in usd per share)", "periodEndLabel": "Balance at end of period (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r237", "r238" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r239" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r239" ] }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDebtExtinguishmentCosts", "crdr": "credit", "presentation": [ "http://www.performantcorp.com/role/NotesPayableNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt prepayment costs", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest." } } }, "auth_ref": [ "r3" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.performantcorp.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in usd per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r110", "r126", "r127", "r128", "r129", "r130", "r137", "r142", "r143", "r144", "r148", "r293", "r294", "r322", "r334", "r418" ] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.performantcorp.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r119", "r269", "r272", "r273", "r274", "r277", "r279", "r280", "r281", "r351" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r455" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r77", "r99", "r118", "r150", "r159", "r163", "r171", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r282", "r284", "r295", "r325", "r377", "r440", "r453", "r554", "r555", "r564" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.performantcorp.com/role/StockBasedCompensationNarrativeDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofRestrictedStockActivityDetails", "http://www.performantcorp.com/role/StockBasedCompensationScheduleofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r230", "r231", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259" ] }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNetCurrent", "crdr": "debit", "calculation": { "http://www.performantcorp.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.performantcorp.com/role/ConsolidatedBalanceSheets", "http://www.performantcorp.com/role/OrganizationandDescriptionofBusinessNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract assets", "verboseLabel": "Contract assets", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r221", "r223", "r226" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r495" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.performantcorp.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-4" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//842-20/tableOfContent" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r415": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r417": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r419": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r420": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r421": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r422": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482955/340-10-05-5" }, "r423": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r424": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r425": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r426": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r427": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r428": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r429": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r430": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r431": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r432": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r433": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r434": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r435": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r436": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r437": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r438": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53" }, "r440": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r441": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r443": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r445": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r450": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r451": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r452": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r453": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r454": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r455": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r456": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r458": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r459": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r460": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r461": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r462": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r463": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r464": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r465": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r466": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r467": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r468": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r469": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r470": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r471": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r472": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r473": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r474": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r475": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r476": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r477": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r478": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r479": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r480": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r481": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r482": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r483": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r484": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r485": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r486": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r487": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r488": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r489": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r490": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r492": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r493": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r494": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r495": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r496": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r497": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r498": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r499": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r500": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r501": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r502": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r503": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r504": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r505": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r506": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r507": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r508": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r509": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r510": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r511": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r512": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r513": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r514": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r515": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r516": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r517": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r518": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r519": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r520": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r521": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r522": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r523": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r524": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r525": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r526": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r527": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r528": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r529": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(b)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18" }, "r546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "340", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483032/340-10-45-1" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480682/815-20-25-6A" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" } } } ZIP 59 0001550695-23-000071-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001550695-23-000071-xbrl.zip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end